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 The fundamental components of bone tissue engineering are (a) progenitor cells 
which subsequently express tissue matrix, (b) scaffolds which can act as temporary 
frameworks to support bone growth, and (c) growth factors to induce osteoblast 
regeneration.  A variety of growth factors are involved during the differentiation 
cascade and these chemical and biological signals dynamically interact with cell 
populations to facilitate the differentiation.  Therefore, enhanced expression of 
endogenous growth factor genes might facilitate abundant existence of growth factors 
in the surrounding microenvironment, stimulate the osteogenic differentiation of 
progenitor cell population, and finally induce bone regeneration.  This work is 
focused on the augmentation of osteogenic signal expressions to stimulate the 
downstream differentiation of transplanted bone marrow stromal cells (BMSCs) 
population through the optimization of a variety of properties of three dimensional 
(3D) biodegradable poly(propylene fumarate) (PPF) scaffold.  Changes in the 
  
microenvironment of cell population would affect the responses of localized cell 
population and the manipulated scaffold properties might be associated with 
induction of endogenous osteogenic signal expressions.   
 First, the effect of cell-to-cell paracrine signaling distance, which can by 
modulated by initial cell seeding density, on the osteogenic signal expressions and 
osteoblastic differentiation of BMSCs on 2D PPF disks was investigated.  Next, in 
order to investigate the improvement of the 3D macroporous PPF scaffold by the 
incorporation with nanoparticle filler materials, PPF/hydroxyapatite (HA) 
nanocomposite scaffolds were fabricated. The effect of HA content and initial cell 
seeding density on the osteogenic signal expression in 3D porous system was then 
determined.  Finally, the incorporation of diethyl dumarate (DEF) with PPF was 
tested based on the photocrosslinking characteristics of PPF/DEF composite material 
with increased mechanical properties. The effect of two scaffold design parameters 
including the stiffness by modulating the DEF content as well as the pore size of 
porous scaffold on the signal expression and downstream osteoblastic differentiation 
was investigated.  In addition, the feasibility of PPPF/DEF materials for 
stereolithographical fabrication was also tested in this work.   
 Controlling these construction parameters to optimize engineered bone 
substitutes could affect various cellular functions of attachment, proliferation, signal 
expression, and differentiation. This research provided the insight of stimulation of 
the expression of target endogenous genes to induce the osteogenic differentiation 
and bone regeneration as well as the fabrication of improved bone substitute implant 
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Chapter 1: Introduction 
 
 A variety of growth factors, cytokines, and hormones are involved during the 
differentiation cascade and these chemical and biological signals dynamically interact 
with cell populations to facilitate the differentiation. Therefore, enhanced expression 
of endogenous growth factor genes might facilitate abundant existence of growth 
factors in the surrounding microenvironment, stimulate the osteogenic differentiation 
of progenitor cell population, and finally induce bone regeneration. This work is 
focused on the augmentation of expression of these osteogenic signals in order to 
stimulate the downstream differentiation by optimizing the properties of 3D 
poly(propylene fumarate) (PPF) scaffold and the microenvironment of cell 
population. It has been demonstrated that scaffold construction parameters including 
cell-to-cell paracrine signaling distance, the types and amounts of nano-sized mineral 
filler material for the fabrication of nanocomposite scaffolds, and physical scaffold 
construction factors such as porosity, pore size, scaffold interconnectivity, and 
mechanical strength (stiffness), influence the osteogenic growth factor gene 
expression. By using a biodegradable PPF polymer, cell/scaffold parameters were 
investigated for the optimal stimulation of desired signal expression and the induction 
of osteogenic differentiation of a recruited cell population for bone tissue 
regeneration. Controlling these construction parameters to optimize engineered bone 
substitutes could affect various cellular functions of attachment, proliferation, signal 
expression, and differentiation. Stereolithographical fabrication of controlled 




development of patient specific implants. This research provided the insight of 
stimulation of the expression of target endogenous genes to induce the osteogenic 
differentiation and bone regeneration as well as the fabrication of improved bone 




Chapter 2: Stereolithographic Bone Scaffold Design Parameters 
– Osteogenic Signal Expression and Differentiation  
 
2.1. Introduction 
Tissue engineering strategies involving cell/scaffold constructs represent a 
promising alternative for the treatment of bone injuries.  However, the nature and 
extent of the interactions between cells and the scaffolds are not yet fully understood.  
Recent research in bone tissue engineering has utilized mesenchymal stem cells 
(MSCs) for the preparation of cell/scaffold complexes. (Please see Table 1 for a list 
of abbreviations.)  Due to the capability of MSCs to differentiate into multiple tissues, 
it is of importance to optimize a variety of parameters including chemical, biological, 
and mechanical cues to induce the osteogenic differentiation of a scaffold-localized 
cell population.  Progenitor MSCs either transplanted to scaffolds before implantation 
or recruited from surrounding host tissues, may differentiate into osteogenic lineages 
through a series of steps including proliferation, matrix formation, and mineralization 
[1].  During these stages, a variety of growth factors, cytokines, and hormones are 
involved and these chemical/biological signals dynamically interact with cell 
populations to facilitate differentiation cascades.  Bone morphogenetic protein-2 
(BMP-2),[2-5] fibroblast growth factor,[6, 7] transforming growth factor,[8, 9] 
vascular endothelial growth factor,[10-12] and platelet-derived growth factor[7, 13] 
are the major osteogenic growth factors while alkaline phosphatase (ALP) and  
 
As published in K. Kim, A. Yeatte, D. Dean, and J.P. Fisher, “Stereolithographic Bone Scaffold 





osteocalcin (OC) are osteogenic differentiation marker proteins.  In addition,  
osteopontin (OP), osteonectin, and bone sialoprotein (BSP) are the important protein 
components of bone extracellular matrix [14, 15].  Therefore, secreted growth factors 
from cells may be closely related to the regulation of osteogenic differentiation of a 
scaffold-localized cell population prior to implantation as well as a recruited cell 
population from the surrounding host tissues.  Enhanced expression of endogenous 
growth factor genes might facilitate abundant existence of growth factors in the 
surrounding microenvironment, stimulate the osteogenic differentiation of progenitor 
cell population, and finally induce bone regeneration.  In addition to the upregulation 
of osteogenic signal expression but also the control of dynamic signaling pathways 
such as Smad, mitogen activated protein kinase (MAPK) [5, 16], Wnt [17], and the 
involvement of runt-related transcription factor-2 (Runx2) [18, 19] and receptor 
activator of nuclear factor κB ligand (RANK-L) [20] might facilitate a tissue 
engineered cell/scaffold construct in bringing about bone tissue regeneration.  
The association of many cell/scaffold construction parameters influences 
osteogenic signal expression.  Among those parameters, physical construction factors, 
specifically scaffold design parameters including porosity, pore size, scaffold 
interconnectivity, and mechanical strength (stiffness) have been shown to influence 
the osteogenic signal expression and subsequent differentiation of cells seeded on 
scaffolds both in vitro and in vivo [21-24].  Furthermore, it has also been 
demonstrated that these properties might impact the architecture and the amount of in 
vivo bone formation [25-28].  Therefore, the demonstrated importance of these 




achieved for the stimulation of desired signal expression and the induction of 
osteogenic differentiation of the recruited cell population.  Along with the 
combination of other chemical and biological factors such as the administration of 
growth factor proteins, the repeated construction of precisely controlled architectures 
with the optimal design parameters is necessary to achieve an optimal bone tissue 
engineering scaffold.  Stereolithography (SLA) represents a promising advanced 
scaffold manufacturing technique to achieve this goal [29-31].  SLA is the rapid 
prototyping technique which uses photopolymerization to create 3D scaffolds layer 
by layer to a design specification that is input via computer [32-34].  This method will 
enable scaffolds to be reproduced with controlled porosity, pore size, 
interconnectivity and mechanical properties all of which greatly influence osteogenic 
signaling and differentiation.  Therefore, this review will (1) discuss the influence of 
scaffold construct parameters on in vitro osteogenic signaling and in vivo bone 
formation and (2) evaluate SLA as a manufacturing technology to fabricate scaffolds 
to meet the requirements set forth in the literature.  
 
 
2.2. Structural Parameters to Control Cell Signaling 
2.2.1. Effect of porosity and pore size on cell signaling 
The ability of a scaffold to enhance osteogenic signal expression and support 
new bone formation is largely dependent on the pore size and porosity of the scaffold 
(See Table 2).  Porosity refers to the overall percentage of void space within a solid, 
while pore size reflects the diameter of individual voids in the scaffold [35].  The 




of bone which itself is a porous tissue.  Cortical bone is largely a dense structure, but 
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bone is a highly porous structure with typical porosity values between 50 and 90% 
[36].   Porous regions of cortical bone allow for vascularization and cellular 
infiltration of the structure. Porosity and pore size have significant ramifications on 
the ability of tissue engineering scaffolds to support bone regeneration for several 
reasons.  First, porosity and pore size have been shown to affect cell attachment 
efficiency which consequently impacts the cell seeding density, cell distribution and 
cell migration [37].  These factors have been shown to affect osteogenic 
differentiation through changes in signaling distances [38].  Moreover, pore size and 
porosity have a significant effect on the mechanical strength of a scaffold.  Sufficient 
scaffold strength to provide mechanical support to a defect is often required of a hard 
tissue engineering scaffold such as bone, especially when the bone is load bearing 
[39].  Furthermore, porosity and pore size affect the ability of the scaffold to promote 
in vivo osteoconduction and vascularization.  Integration of native tissue into a 
scaffold is fostered through growth into interconnected pores, thus both optimal and 
minimal pore sizes have been established to support tissue ingrowth [35, 40].  Finally, 
pore size and porosity affect in vivo and in vitro cell signaling which in turn affects 
osteoblastic differentiation of MSCs and the production of extracellular matrix 
(ECM) proteins [35, 41-45]. 
Not only must the optimal bone tissue engineering scaffold support the growth 
and osteogenesis of a seeded cell population, it must also support osteoconduction 
and vascularization from the surrounding tissue [46, 47].  Both osteoconduction and 
vascularization are influenced by scaffold pore size, porosity and interconnectivity of 




sizes of at least 40 µm are required for minimal bone in growth while pore sizes of 
100-350 µm are considered optimal [47, 48].  In a study analyzing the effect of pore 
size and porosity on bone healing in a critical size rat cranial defect, it was shown that 
smaller pore sizes (100 µm) induce greater amounts of bone healing than larger pore 
sizes (500 µm) [49].  This study also found a link to porosity, scaffold swelling, and 
degradation.  It may be desirable to have the scaffold size and shape change over time 
as the scaffold material is resorbed, and to have the regenerated bone tissue remodel.  
In these remodeling cases, the material type and degradation rate should be factored 
into determining optimal pore volume, pore geometry, inter-pore wall thickness and 
porosity.  Scaffolds with the larger pore sizes were found to have limited bone growth 
after about 4 weeks [49, 50].  Thus it was hypothesized that the smaller pore sizes 
may enhance continuous host tissue ingrowth.   It was also concluded that pore size 
influences the location of tissue ingrowth, indicating that porosity and pore size 
should be tailored to different bone types and injury sites, a difficult task with 
traditional scaffold manufacturing methods.   
In another study, femoral bone scaffolds with pore sizes of 565 µm exhibited 
higher amounts of bone formation than scaffolds with pore sizes of 300 µm.  Within 
these pore size groups, porosity was also varied from 40% to 50%, but no significant 
change in bone growth was observed indicating that porosity may have less of an 
effect on bone growth than pore size [26].  Despite numerous studies on the topic, 
there is still disagreement over the significance of pore size on in vivo bone 
formation.  In polycaprolactone (PCL) scaffolds made with pore sizes of 350, 550, 




weeks [50].  After 4 weeks, the largest pore size group did exhibit greater bone 
growth, which could indicate that pore size does influence the amount of bone 
ingrowth, but after 8 weeks that influence could no longer be discernable.  It might be 
possible that more dramatic responses to pore size are only seen at lower pore sizes.  
For example, it was found that pore sizes of 300 µm induced significantly increased 
amounts of bone growth after 4 weeks using PCL scaffolds in a rabbit cranial defect 
than 100, 200, or 400 µm pore sizes [27].  The discrepancy between these studies 
could indicate that pore size is not the only variable influencing bone growth. The 
material type and pore shape as well as the implant size and surrounding tissue 
vascularization could also influence the effects of pore size on bone ingrowth.   
Despite these discrepancies, the influence of pore size and porosity on in vivo 
bone growth has been noted.  Pore size has been observed to not only influences the 
osteoconduction of a scaffold, but also the vascularization, which is crucial to 
successful bone formation.  In a study utilizing calcium phosphate ceramics, pore 
sizes of 140 - 280 µm exhibited faster vessel formation than those of 40 - 140 µm.  
Also larger pore sizes had significantly higher capillary density than small pore sizes.  
The volume of new bone correlated with these results as the largest pore size group 
(210-280 µm) had the most new bone growth [40].  Rapid vascularization is 
important for bone tissue growth in an implanted scaffold as cells on the interior 
portions of the scaffolds will not survive without a blood and nutrient supply.  
Oxygen and nutrient transfer distances are limited to approximately 200 µm making 
vascularization a concern even in smaller scaffolds [51].  The degree of 




by which bone formation occurs [40, 52].  Hydroxyapatite (HA) scaffolds with pore 
sizes of 90-120 µm were shown to support bone formation by a process of 
endochondral ossification where MSCs proliferate on the scaffold and begin to form 
cartilage tissue [53].  The cartilage then begins to become vascularized and is 
resorbed by phagocytotic cells.  MSCs migrate to the site, differentiate into 
osteoblasts and begin to form bone.  This process can lead to the highly organized 
bone structures observed in long bones [36].  Scaffolds with pore sizes of 350 µm 
were observed to form bone through intramembranous ossification where MSCs 
initially migrate in with vascularization and form new bone directly without any 
cartilage formation [53].  This type of bone formation is typical in the cranium and 
other flat bones.  Pore size can influence the method of bone formation as it affects 
the degree of vascularization, which in turn affects the oxygen present in the tissue 
and ultimately whether chondrogenesis or osteogenesis occurs.  Therefore, the effect 
of pore size on the mechanism that results in bone formation underscores the 
importance of precise control over the pore size and porosity of the scaffold and pore 
architecture may need to be tailored to specific bones for effective tissue engineering.   
In addition to in vivo bone growth, it has also been shown that in vitro cell 
growth and differentiation on scaffolds are greatly affected by pore size and porosity.  
While in vivo porosity and pore size mainly influence bone growth by influencing the 
native tissue that invades the scaffold, in vitro studies have emphasized the influence 
of pore size and porosity on the migration, proliferation, differentiation and signaling 
of cells within a scaffold [35].  For instance, Mygind et al have shown the effect of 




cultured on coralline HA scaffolds exhibited lower proliferation rate and higher 
degree of differentiation as shown by increased ALP, OC, and BMP-2 mRNA 
expression on scaffolds with a smaller pore size (200 µm) as opposed to a larger pore 
size (500 µm).  The enhancement of osteogenic differentiation and a lower 
proliferation rate may both be explained by the difference in surface area and 
transport efficiency resulting from the change in pore size.  It might be suggested that 
a scaffold geometry with smaller pore size resulted in increasing tortuosity, thereby 
decreasing transport efficiency of soluble factors in the aqueous surrounding 
environments, and limiting the cell infiltration.  Subsequently, decreased proliferation 
might be observed because of changes in signaling distances through varying the pore 
geometry that induces a higher level of differentiation.  Another study has also shown 
that pore size and porosity influence expression levels of osteogenic signals.  In 
collagen-glycosaminoglycan (GAG) scaffolds greater expression of OC and type one 
collagen in MSCs after 21 days of culture was observed in scaffolds with pore sizes 
of 151 µm as compared to 96 µm [41].  Moreover, pore size has also been shown to 
influence the differentiation of human MSCs on β-tricalcium phosphate (ß-TCP) 
scaffolds with varying porosities (25 to 75%) and pore sizes (10 to 600 µm, 
respectively) [21].  In this research, no significant difference was observed in the in 
vitro osteogenic differentiation between the groups.  However, when the samples 
were implanted into skin folds of mice, a significantly higher amount of osteoblastic 
differentiation was observed as shown by ALP production in scaffold constructs with 
65 and 75% porosities with the highest amount observed in the 65% group.  This 




differentiation and that differences in signal expression might be observed relating 
from pore size in vivo even without bone ingrowth from surrounding tissues [21].  
Using an hydrogel fabricated from PEG-DA and 5-ethyl-5-(hydroxymethyl)-β,β-
dimethyl-1,3-dioxane-2-ethanol diacrylate, the effect of pore size and porosity on the 
BMP-2 signaling of human MSCs was investigated in scaffolds with pore sizes of 
100 and 250 µm [45].  In this study, BMP-2 signaling was upregulated in the 
scaffolds with 250 µm pore size as compared to those with 100 µm pore size with the 
same porosity on day of 4, 8 and 12.  This indicates pore size has an effect on BMP-2 
signal expression.  Furthermore, 50-70 fold increases in BMP-2 expression were 
observed in 3D porous gels as compared to 2D monolayer culture, highlighting the 
effect of 3D architecture on signal expression. It was hypothesized that this effect 
resulted from a concentration of signaling molecules within the hydrogel enhancing 
autocrine and paracrine cell signaling. 
Scaffold porosity and pore size can influence in vitro growth and 
differentiation of a seeded MSC population, although these effects are often less 
pronounced ways than in vivo bone growth.  While much research has been done in 
this area, further studies are necessary to determine the optimal pore size for in vitro 
bone growth and to fully elucidate the effect of pore size and porosity on cell 
signaling.   For the future of bone tissue engineering highly controlled and 
characterized scaffolds must be created to not only further evaluate the influence of 
porosity and pore size, but also to create scaffolds with reliable geometries to ensure 







Materials Function and Biological Improvements Reference 
Pore size affects OC, OP, collagen I and BSP 
mRNA expression. 
[41] Collagen-GAG 
Improved migration in pore sizes larger than 300 
µm. 
[54] 
Higher pore sizes (280 µm) result in greater 
osseointegration.  Pore size also affects blood 
vessel formation. 
[40] Calcium  
Phosphate 
Bone growth affected more by pore size than 
porosity.  Larger pore size induces greater bone 
formation. 
[26] 
ß-TCP ALP expression affected by size of pores and 
porosity of scaffolds.  Higher mineralization with 
higher porosity. 
[21] 
PLGA Pore size and porosity affects spatial distribution of 
new bone formation in cranial defect. 
[49] 
Pore sizes between 350-800 µm have limited role on 
bone regeneration after 8 weeks of implantation 
subcutaneously in mice. 
[50] PCL 
Pore size affects bone formation and type of tissue 
formed. 
[27] 
EH-PEG Pore size affects BMP-2 expression. [45] 
HA Higher ALP expression of human MSCs in smaller 
pore sizes (200µm). 
Higher proliferation in larger pore sizes (500 µm). 
[23] 
 




2.2.2. Scaffold interconnectivity 
Another important characteristic of scaffold architecture is the degree of 
interconnectivity between the pores of a scaffold.  Scaffolds that feature a highly 
interconnected architecture allow for enhanced communication between cells at 




interconnectivity has been shown to have a limited direct effect on MSC signaling 
and differentiation, but a profound effect on the morphology of bone formed within a 
scaffold [55-57].  When human MSCs were seeded on silk constructs, no significant 
differences were observed in ALP expression and calcium deposition after 4 weeks of 
culture between scaffolds with different levels of interconnectivity [55].  Significant 
differences were observed however in the degree of cellular ingrowth into the 
scaffolds.  It was observed that growth into scaffolds with low interconnectivity was 
confined to surface pores, while highly interconnected scaffolds featured homogenous 
mineralization and a network of bonelike tissue.  In another study using poly(L-
lactide-co-glycolide) (PLG), levels of vinculin, β-actin, OC, and OP of human MG63 
cells were similar for scaffolds with varying interconnectivities [58].  Greater 
penetration depth was observed in scaffolds with larger pore sizes and higher 
interconnectivity although these differences diminished after 15 days.  This study 
suggested that increasing pore size and interconnectivity yielded faster colonization 
of cells and that degree of interconnectivity should be tailored to bone cells as 
connective tissues may infiltrate more quickly into smaller connections, resulting in 
inhibition of bone tissue infiltration.  Scaffold interconnectivity may also affect bone 
formation and osteogenic signal expression by affecting the degree of nutrient 
diffusion into a scaffold [59].  As previously described bone nutrient and oxygen 
transfer are a concern in any 3D construct.  
Degree of interconnectivity is not the sole factor influencing bone ingrowth as 
the diameter of channels connecting pores has also been shown to influence cell 




penetration in vitro using HA scaffolds and human osteosarcoma cells, it was found 
that larger channel diameter resulted in both increasing cell coverage and deeper 
penetration into the center of the scaffold [56].  Furthermore, it was also found that 
there was a minimum level of channel diameter required for  cell penetration (82 µm) 
[56].  Similarly, in another study human osteoblasts were shown to penetrate channels 
over 20 µm, but a pore size of 50 µm was required to support new bone formation 
through the channels [60].  This study indicated that the minimum channel size might 
vary with the dimension and material of a scaffold, as interconnectivity fosters not 
only cell infiltration but also vascularization and nutrient transfer, highlighting the 
need for controlled scaffold interconnectivity.   
Scaffold degradation impacts ingrowth as well, therefore this factor needs to 
be considered in tandem with interconnectivity for optimal tissue formation.  Due to 
the complexity of the network inside of a scaffold, pore interconnectivity can be 
difficult to assess, but the use of micro-CT to quantify pore interconnectivity allows 
for a more precise definition and better assessment of scaffold characteristics [61-63].  
Precise scaffold interconnectivity is difficult to create using traditional scaffold 
fabrication techniques, thus advanced scaffold manufacturing may be necessary to 
achieve repeatable interconnectivity.  Advanced manufacturing techniques include 
scaffolds made through the use of rapid prototyping, which is also known as solid 
freeform fabrication (SFF) and additive manufacturing.  In one example of enhanced 
scaffold interconnectivity using SFF, poly(lactic-co-glycolic acid) (PLGA)- ß-TCP 
scaffolds were fabricated using the commercially available TheriFormTM  3D printing 




on bone ingrowth, scaffolds were manufactured either with macroscopic channels or a 
microscopic porosity gradient.  Using a rabbit cranial defect model, 
histomorphometric analysis after 8 weeks of implantation demonstrated that scaffolds 
with macroscopic channels had a higher new bone area than both the scaffolds  
 
Scaffold 
Materials Function and Biological Improvements Reference 
PLG Faster colonization in scaffolds with large scaffold 
interconnectivity.  No change observed in gene 
expression levels of vinculin, β-actin, OC or OP with 
changes in scaffold interconnectivities. 
[58] 
Silk Fibroin Interconnectivity influences morphology of in vitro 
bone growth of hMSCs but not ALP protein 
expression. 
[55] 
In vitro cell penetration enhanced by large 
interconnected channels, established minimum 
channel size of 80 µm for cell penetration. 
[56] 
Enhancement of bone ingrowth observed in channels 
over 100 µm.  Micro CT used to assess bone growth. 
[61, 62] 
Scaffolds manufactured using solid freeform 




Scaffolds formed from mold using SLA.  Individual 
channels should be interconnected for increased 
bone growth. 
[25] 
HA/ß-TCP Osteoblasts could penetrate channels as small as 20 
µm but not form bone until channel diameter reached 
50 um.  Also observed changes with material type. 
[60] 
Titanium Length and size of pore connection to surface of 
scaffold influenced amount of bone ingrowth. 
[63] 
PLGA/ß-TCP Scaffolds manufactured using solid freeform 
fabrication.  Macroscopic channels guide bone growth 
and dictate tissue type produced. 
[28] 
 






without channels or the defect without any scaffold.  These results indicated that in  
vivo bone formation was guided down the channels of the scaffold.  Furthermore, the 
porosity gradient of the scaffold was shown to dictate the type of tissue that was 
produced, as only soft tissue was produced outside the radial channels of the scaffold.  
This suggests that the precise architecture of a scaffold can be used to guide tissue 
growth [28].   
By manipulating the porosity and interconnectivity, the rate of bone tissue 
regeneration may be enhanced.  Based on an in vivo study utilizing HA scaffolds 
fabricated by 3DP and rabbit cranial defects, it was suggested that the direction and 
the extent of void space in the scaffold might influence new bone formation [24].  
Histological evaluation indicated that the channels direct the growth of new bone as 
radial channels penetrating from the sides of the scaffold were shown to successfully 
guide bone from the surrounding tissue and axial channels extending inward from the 
bottom of the scaffold directed the migrating cells into the center of the scaffold.  
This study provided even further evidence that in vivo bone growth could be 
influenced by the scaffold architecture and interconnectivity.  Moreover, a similar 
result in regards to controlling in vivo bone growth through scaffold architecture and 
interconnectivity was observed in SLA-fabricated HA scaffolds [64].  To investigate 
in vivo performance of channel directions, scaffolds with orthogonal or radial 
channels were implanted into porcine mandibles.  The scaffold architecture was 
shown to influence the amount of regenerated bone as the orthogonal scaffolds 
exhibited larger bone growth area than scaffolds with radially-oriented channels.  The 




bone growth in radially-channeled scaffolds.  In addition, it appears that the 
architecture in the porous regime might influence bone geometry as bone formation 
was integrated throughout the orthogonal HA scaffolds while the bone in the radial 
scaffolds formed in an intact piece in the center of the scaffold [64].  These studies 
may validate the use of scaffold interconnectivity and architecture can be used to 
guide bone growth and enhance in vivo bone tissue regeneration.  Additional work 
using scaffolds with highly characterized and controlled interconnectivity should be 
completed to further elucidate the connection between the two. 
 
2.2.3. Mechanical stiffness and mechanosensing 
Dynamic cell-ECM interaction may regulate initial cell attachment, 
proliferation, differentiation, and osteogenic and chondrogenic signal expressions.  
Among a variety of scaffold design parameters, including pore geometry and 
interconnectivity, substrate stiffness (rigidity) is another critical factor governing 
cellular behavior in terms of mechano-transduction and cell-matrix interaction.  There 
have been many studies of the effect of substrate stiffness on the cellular behaviors in 
several tissue types including bone [65], the central nervous system [66], the cornea 
[67], and kidney epithelial cells [68].  Different tissues present characteristic 
elasticities, ranging from ~1 kPa in the brain to 100 kPa in collagenous bone.  The 
specific type of cells in each tissue favored to differentiate into different lineages 
depending on the scaffold’s mechanical stiffness [69].  Recent studies have revealed 
that the substrate stiffness is directly related to the specific differentiation cascades 




scaffold could be another critical parameter in designing the optimal 3D scaffold for 
bone tissue engineering (See Table 4).  
It has been investigated that the responses of osteoblast cell populations could 
be affected by intrinsic ECM mechanical properties [22].  In this study, 
polyacrylamide hydrogels were functionalized with type I collagen and fabricated 
with various Young’s moduli depending on the amount of crosslinker, N,N’-
methylene-bis-acrylamide.  The substrate stiffness ranged from 11.78 to 38.89 kPa by 
varying the amount of crosslinker from 0.1 to 0.3 %.  When the collagen density was 
low, the proliferation of MC3T3-E1 cells was higher on a rigid polystyrene (PS) 
substrate than on the softest gel and the random motility speed of cell migration was 
also faster on PS than on a soft substrate.  The result suggested that the modification 
of ECM mechanical properties might influence the contractility in the actin 
cytoskeleton, and immature focal contact and cytoskeleton development in the softest 
gel could verify this rationale.  Moreover, both focal adhesion kinase (FAK) activity 
measured by detecting phosphorylated Y397-FAK and mineralization determined by 
qualitative Von Kossa staining demonstrated that signaling mechanisms of cell-ECM 
and osteogenic phenotypic differentiation were modulated by the ECM stiffness.  A 
similar study has shown that cellular responses to scaffold mechanical properties may 
regulate the osteogenic differentiation by modulating the mitogen-activated protein 
(MAPK) and the extracellular signal regulated kinase (ERK) activity [16, 70].  The 
results demonstrated that osteogenic differentiation of MC3T3-E1 cells cultured on 
mechanically tunable poly(ethylene glycol) (PEG) hydrogels could be regulated by 




the rigidity increased and this regulation of MAPK activity might be related with 
upregulation of ALP activity as well as the OC and BSP gene expression level [70].  
In addition, it was also found that altered ECM mechanics activates the FAK activity 
through integrin-mediated signal transduction [16].  Enhanced FAK activity 
stimulates Ras homolog gene family, member A (RhoA)/ Rho-associated, coiled-coil 
containing protein kinase 1 (ROCK) activity, and this signal subsequently stimulates 
the ERK/MAPK kinase.  Finally, Runx2 in a nucleus is activated and osteogenic gene 
expression including OC, BSP, and ALP may be upregulated.  This sequential signal 
transduction triggered by matrix stiffness would ultimately lead to osteogenic 
differentiation of cells on the substrate material.  Furthermore, stiffness dependent 
osteogenic signal expression was also observed in embryonic stem cells [71].  The 
expression levels of osteogenic marker genes including Runx2 and OP were 
dependent on the surface Young’s modulus of collagen coated PDMS substrates.  
Upregulation of the primitive streak and mesoderm precursors including forkhead 
transcription factor (Foxa2), Brachyury, Mix 1 homebox-like 1 (Mixl1), cadherin-2 
(Cdh2), and eomesodermin homolog (Eomes) was observed.  In addition, 
mineralization assessed by alizarin red S was also positively correlated with the 
stiffness substrates from 0.041 to 2.7 MPa. 
However, downstream differentiation of cells and changes in phenotype do 
not solely depend on mechanical cues that the cell receives from a scaffold, but also 
on a combination of factors of the cell’s physical, chemical, and biological ECM 
properties.  Rowlands et al. demonstrated that varying substrate stiffness could 




[72].  In this study, polyacrylamide gels coated with ECM proteins including collagen 
I, collagen IV, laminin, and fibronectin were investigated.  Physiologically relevant 
stiffness (0.7 to 80 kPa) was obtained by crosslinker fraction and cultured MSCs 
exhibited different levels of Runx2 and myogenic differentiation1 (MyoD1) 
expressions, which represented osteogenic and myogenic transcription factors 
respectively.  Specifically, the substrate model with an 80 kPa of modulus and a 
collagen type I coating showed the highest expression level of both transcription 
factors.  This might suggest that mechano-transduction is related to both scaffold 
stiffness and adhesive ligand presentation on the ECM.  This observation was also 
made in 2D gel systems as the osteoblastic function of cells was altered by changing 
type I collagen density [22] and other ECM protein coatings [73]. 
In addition to osteoblastic cells, smooth muscle cells have been observed to 
exhibit similar behavior on substrates with varying stiffness [74].  In this study, 3D 
crosslinked PEG-fibrinogen hydrogel encapsulating cells exhibited 4.48 to 5.41 kPa 
of compressive modulus.  This range of stiffness in the 3D environment appeared to 
modulate cytoskeletal assembly.  From this research, it may be suggested that small 
changes in the mechanical stiffness of scaffold materials may alter the biological 
functions and phenotype of transplanted cell populations.  Another fundamental 
finding of this study was a synergetic effect between substrate stiffness and RhoA 
activation appears to be critical to the regulation of cytoskeletal contractility.  As 
shown in another study, cell shape and morphology and the subsequent changes in 





2.2.3.1. Crosslinking density 
Mechanical properties of 3D polymeric scaffolds such as compressive 
modulus could be controlled by changing the crosslinking density during fabrication 
or by varying the ratio of composite filler materials.  For instance, crosslinking 
density of polyester scaffolds fabricated with D,L-lactide, ε-caplolactone, and 
trimethylene carbonate could be controlled by varying the composition of copolymers 
and the type of initiator, and therefore the degradation ratio, as well as the 
compressive modulus, of scaffolds could be also varied [76].  Similar to the 
modulation of crosslinking density of 2D gel systems described previously, the 
amount (or the ratio) of crosslinker within polymeric matrices could be used to 
control the modulus of porous scaffolds.  In addition, a study of poly(propylene 
fumarate) (PPF) photocrosslinking characteristics also demonstrated that mechanical 
properties could be controlled by fabrication parameters including the molecular 
weight of the PPF polymer, photoinitiator content, and the amount of the present 
diester precursor, diethyl fumarate (DEF) [77].  In this study, sol fraction, swelling 
degree, elastic modulus, and fracture strength were examined based on the factorial 
design of three fabrication factors.  In particular, the results indicated that varying 
these factors could control crosslinking and compressive mechanical properties.  
Moreover, this study exhibited the feasibility of PPF/DEF mixture for the reduction 
of viscosity to use PPF as an SLA resin material and the suitability of this polymer 
network with compressive strength for trabecular bone replacement.  Thus, 




mechanical stiffness of a scaffold, and this controllability could be utilized in SLA-
rendering.  
 
2.2.3.2. Filler incorporation:  
Another method to control the stiffness of 3D scaffolds is incorporation of 
fillers into polymeric scaffold resins.  For example, the gelatin scaffold incorporated 
with ß-TCP also exhibited varying compressive modulus from 0.27 (no ß-TCP 
incorporation) to 4.97 MPa (90 wt% of ß-TCP) depending on the amount of ß-TCP 
particles [78].  The highest ALP activity and OC content of rat MSCs were observed 
in 50 wt% of ß-TCP, and it could be concluded that the composition ratio of 
composites might change the compressive modulus of a 3D scaffold, and the 
expression of osteogenic marker proteins might be related to this ratio with the 
threshold up to 50 wt%.  Similarly, when chitosan was incorporated in PLGA 
polymeric scaffolds, increasing the chitosan/PLGA ratio resulted in increasing 
adhesion efficiency of seeded rat bone marrow stromal cells (BMSCs) as well as 
increased calcium deposition, which indicated that the majority of cell population 
underwent osteogenic differentiation [79].  In addition to mineral particle 
incorporation, microfabricated SU-8 microrods (15 x 15 x 100 µm) in a 3D 
commercialized Matrigel might result in increasing stiffness of the 3D matrix and 
influence the fibroblast attachment pattern [80].  Given changes in morphology and 
cytoskeletal architecture, the mechano-transduction mechanism might be altered and 




exhibited upregulation of ACTR and PHACTR as well as downregulation of collagen 
I and BMP-6 expression [81].   
However, incorporation of filler material into polymeric resin may alter not 
only the stiffness of composites but also the surface characteristics including 
topology, roughness, passive adsorption of soluble contents, and the overall scaffold’s 
chemical composition [82, 83].  In addition to changing the mechanical stiffness by 
incorporating filler material into polymeric scaffolds, controlling of physico-chemical 
surface properties may facilitate the interaction of hosted cell population and a 
scaffold.  Inorganic particle incorporation of ß-TCP or HA provides a biochemical 
environments that closely mimics native bone, and this might result in dynamic 
interaction of Ca2+ ions with the seeded cells [84] as well as in vivo tissue 
regeneration [8, 85].  
 
 2.2.3.3. Collagen  
Since collagen is an important ECM protein found in the native bone, its 
structural properties have been researched in bone tissue engineering in order to lead 
to skeletal tissue regeneration strategies [86].  Therefore, the proper production and 
crosslinking of collagen in the ECM environment could lead to osteogenic 
differentiation of recruited cells [87].  The stiffness of the collagen matrix has also 
shown that it functionally stimulates implanted cell populations [88, 89].  The 
compressive modulus of collagen-GAG scaffolds could be controlled by varying the 
collagen amount as well as by altering the dehydrothermal (DHT) crosslinking 




higher crosslinking temperature exhibited increased cell numbers and metabolic 
activity up to 7 days after culture.  Another study using a dense collagen matrix 
showed upregulation of osteogenic signal expression in primary mouse calvarial 
osteoblasts [88].  Osteogenic differentiation of cells in the matrix were verified 
through the observation of increased expressions of ALP and BSP in the first 7 days 
of culture in osteogenic supplemented media which was compared to culture on a  2D 
plastic surface. 
It might not be concluded that the stiffness or compressive modulus of 
scaffolds directly govern the specific signal expressions that would bring about bone 
tissue differentiation cascades.  The complex signal transduction involved in 
osteogenesis is dynamically related to cell-cell and cell-ECM interaction as well as 
intracellular mechanisms.  However, the combinational approaches of controllable 
mechanical strength and other stimulatory factors such as ECM protein incorporation 
and topological changes of the substrate surface may allow manipulation of the level 
of expressions of osteogenic signals and, eventually, differentiation.  Given this 
concept, SLA can also be applied to create the tunable stiffness or other mechanical 














Scaffold Materials Function and Biological Improvements Reference 
Tunable stiffness by varying the amount of 
crosslinker.  Proliferation of MC3T3-E1 cells and 
random motility speed, FAK activity, and 




Controlling the ECM stiffness and incorporation of 
ECM protein may regulate the human MSC 
differentiation into osteogenic and myogenic 
lineages. 
[72] 
PEG hydrogel ECM rigidity may regulate ALP, OC, and BSP 
expression via MAPK activation.  Sequential 
activation of FAK, RhoA/ROCK, ERK/MAPK by 
controlling ECM rigidity. 
[16, 70] 
2D Polystyrene Stiffness dependent osteogenic signal expression 




Modulation of cytoskeletal assembly of smooth 
muscle cells by varying the stiffness.  Synergetic 





Controllable crosslinking density by varying the 
composition of copolymer and the type of initiator. 
[76] 
Gelatin/ß-TCP ß-TCP amount may affect compressive modulus, 
ALP activity and OC expression. 
[78] 
PLGA/chitosan Cell adhesion and calcium deposition could be 





mRNA expression of osteogenic signals of human 
MSC may be influenced by embedded SU-8. 
[81] 
Collagen-GAG Tunable compressive modulus of scaffolds 




Denser collagen matrix exhibited increased 
expression of ALP and BSP. 
[88] 
 








2.3. Computer Aided Rapid Prototyping 
Stem cell-based tissue engineering approaches may benefit from optimization 
of scaffold design parameters with the aid of chemical and biological stimuli in order 
for the stages of cell proliferation and osteogenic differentiation during in vitro, as 
well as in vivo osteogenesis.  As discussed above, the architectural parameters, 
including porosity, pore size, interconnected channel geometry, chemical properties 
such as crosslinking density, and mechanical cues such as stiffness, are important 
factors for bone scaffold fabrication.  These factors might stimulate cell responses  
including the signal expressions facilitating cell differentiation.  Due to the variations 
observed when altering these factors, it is necessary to first define the optimal values 
of parameters to enhance cellular responses.  Then, accurate fabrication and  
continuous production of the scaffolds with the optimal architectural, chemical, and 
mechanical parameters could justify extending the use of bone tissue engineering to 
clinical regenerative medicine with improved levels of bone regeneration at implanted 
sites.  Therefore, computer aided rapid prototyping (CARP) is considered to meet 
these criteria with sufficient control in scaffold preparation to provide improved 
tissue regeneration, proper vascularization after implantation, and sufficient tissue 
integration with scaffold degradation.  The CARP process produces scaffolds layer by 
layer through SFF with design parameters inputted from computer aided design 
(CAD) software.  Precise control of these parameters is the most significant 
advantage of CARP, thus when designing a scaffold’s inner architecture the ability of 
the design to influence the forming bone geometry should be considered in addition 




Another advantage of CARP for the fabrication of scaffolds is its feasibility of 
patient- and defect-specific design of bone implants [91, 92].  SFF includes several 
types of commercially or readily available techniques that have been utilized to 
produce directly implantable tissue engineered (i.e., resorptive) implants [29, 93].  3D 
Printing (3DPTM, Therics Inc., Princeton, NJ) injects a liquid binder, which may 
contain cells and/or growth factors, into a powder [94].  Fused deposition modeling 
(Stratasys Inc., Eden Prairie, MN) uses an inkjet to extrude material that is heated just 
above melting temperature [95].  3D Plotting is another heat-based extrusion 
technique [96].  In selective laser sintering (3D Systems, Rock Hill, SC), a laser is 
used to sinter powder, layer by layer, into a plastic part [97].  Selective laser melting 
(MTT, Staffordshire, UK) uses a laser to sinter metal powders [98].  Solidscape 
(Merrimack, NH) devices print an implant shape in wax that can then be replaced 
with resorbable materials [99].  Soft lithography (Nanoterra, Cambridge, MA) [100] 
and electrospinning [101] are technologies that can produce very high resolution 
surface features, such as roughness on a scale relevant to cells.   
 
2.4. Stereolithography 
One of the most researched SFF methods is stereolithography (3D Systems, 
Rock Hill, SC), which utilizes a laser to crosslink photo-polymerizable polymers and 
fabricate 3D parts by vertical layering [102].  Figure 1 shows a schematic of SLA 
fabrication.  The modeling of pore structure in porous tissue engineered scaffolds was 
highlighted in elsewhere [29].  Therefore, SLA is a useful strategy to fabricate 




patient’s 3D CT scan, as well as parameters such as pore size, porosity, 
interconnectivity, and mechanical stiffness optimized to influence osteogenic signal 
expression and differentiation (See Table 5).  
 
Figure 1: A schematic of the stereolithography process.  A laser crosslinks the liquid 
polymer at the surface of the polymer vat to computer inputted pecifications by 
moving in the x and y directions.  Following completion of a layer the elevator lowers 
the completed scaffold one layer in the z direction and the process repeats. 
 
2.4.1. Poly(propylene fumarate) 
PPF is one of the most studied biodegradable and photocrosslinkable 
polymers [38, 77].  With the aid of the photoinitiator, bis(2,4,6,-trimethylbenzoyl) 
phenylphosphine oxide, PPF chains can be crosslinked into networks.  Due to the 
controllability of PPF photocrosslinking characteristics and mechanical properties as 
well as the suitable mechanical strength of UV crosslinked PPF networks [77], a 
mixture of PPF and DEF has been investigated for use as an SLA resin material.  
DEF is added as a solvent to reduce the viscosity, an important criterion for a device 




wall thickness features in the hundred micron range [102-106].  By utilizing a 
commercially available laser curing device, an SLA 250/40 (3D systems), the first 
tissue engineering study to fabricate PPF scaffolds with controlled geometry designed 
using CAD software was published in 2003 [102].  An example of a CAD file prior to 
SLA scaffold fabrication is shown in Figure 2.  Figure 3 shows scanning electron 
microscope (SEM) images of the morphology of controlled architecture 3D PPF/DEF 
scaffolds with continuous channels, which were fabricated by 3D systems Viper.  In 
addition, it has been shown that a PPF/DEF mixture could be applicable to both SLA 
[104, 105] and other SFF methods such as 3D printing and injection molding [106].  
Recent work has demonstrated the feasibility of surface modification of scaffolds by 
soaking them in a concentrated inorganic ion solution [103].  Moreover, controlling 
the degradability by varying the molecular weight of PPF during the synthesis could 
be a clinical advantage facilitating neobone development and complete resorption of 
implanted scaffolds [107].  Given this controllable degradability, PPF polymer with a 







Figure 2:  An example of a CAD file prior to the scaffold fabrication by SLA.  
Dimensions of total length, plate thickness, gap between plates, pole diameter,and 

























Figure 3: SEM images of SLA fabricated PPF/DEF scaffolds.  Images show 






2.4.2. Other polymeric scaffolds fabricated by SLA  
A series of recent studies investigated the fabrication of scaffolds with 
controlled geometry using several types of resin materials and in vitro cell attachment 
was assessed.  Fumaric acid monoethyl ester (FAME) functionalized with poly(D,L-
lactide) (PDLLA) oligomers has been used to create a gyroid architecture [109].  N-
Vinyl-2-pyrrolodone (NVP) was used as the accelerator and Lucirin TPO-L was used 
as the photoinitiator.  Initial in vitro data demonstrated that mouse preosteoblasts 
could adhere and spread on this scaffold.  Another gyroid scaffold fabricated with 
PDLLA have also exhibited M3TC3 cell adhesion on day 1 [110].  SLA fabrication 
might also allow control of surface features of 3D porous scaffolds to provide a 
favorable environment for bone tissue formation [111].  Nano-fibrous poly(L-lactic 
acid) (PLLA) scaffolds have been developed with a micro pore structure in the struts 
that mimics the morphological function of type I collagen and significantly increased 
surface area compared to a solid-walled scaffold.  These nanofibrous scaffolds with 
rectangular channels were created by using an SLA-fabricated negative mold and 
thermal phase separation of PLLA solution.  Interestingly, mRNA expression levels 
of OC and BSP of MC3T3-E1 cells in fibrous scaffolds were higher than solid-walled 
scaffolds after 2 and 6 weeks of culture.  Furthermore, one recent study has revealed 
that the critical importance of 3D porous scaffold structural cues to induce in vivo 
bone regeneration [112].  In addition to the importance of the design and fabrication 
of accurate morphology of implantable bone substitutes [113], it is also essential that 
the internal geometry closely mimic the native bone tissue in order to induce bone 




terephthalate (PBT) scaffolds designed from micro-CT scans of a native cadaveric 
canine femur exhibited up to 6 times higher bone growth into and adjacent to the 
scaffolds compared to simple porous scaffolds [112].  This study emphasized that 
macroscopic structural characteristic, specifically inner pore architecture, might 
facilitate accelerated bone regeneration, specifically inner pore architecture. 
 
2.4.3. Photopolymerized hydrogels 
In addition to controlled design of macroporous scaffolds, SLA can be applied 
to photopolymerized hydrogel systems.  For example, 2D patterning on bilayer films 
has been achieved via soft-photolithography stamping and micro-patterning of 
interpenetrating polymeric network within 3D hydrogels of collagen and hyaluronic 
acid was also investigated.  This technique may allow the zonal differential 
distribution of several scaffold properties within a bulk hydrogel, including 
crosslinking density, swelling degree, water content, and mechanical stiffness [114].  
Cell encapsulation within a photopolymerized hydrogel has also been developed.  3D 
Poly(ethylene oxide) (PEO) hydrogel encapsulating Chinese hamster ovary cells were 
fabricated using a commercially available SLA process.  This hydrogel system 
exhibited elastic mechanical property similar to soft tissues along with high viability 
of the encapsulated cells on day 2 [115].  PEG can be crosslinked into a hydrogel by 
the incorporation of acrylate or methacrylate as photoreactive and crosslinkable 
groups.  Photoencapsulated MSCs in PEG-diacrylate (PEG-DA) hydrogel exhibited 
chondrogenic differentiation for 6 weeks [116], and encapsulation of human dermal 




with SLA [117].  Furthermore, this method can be applied to functionalization of the 
PEG hydrogel with arginine-glycine-aspartic acid (RGD) ligands for specific 
localization of cells [118].  These studies have shown the possibility of multi-material 
spatial control using SLA.  Therefore, an SLA fabricated hydrogel containing an 
encapsulated cell population may be a promising technique for providing sufficient 
cell mass for large constructs.  Moreover, Mapili et al have demonstrated 
spatiotemporal incorporation of a variety of materials within 3D PEG-DMA scaffolds 
fabricated by SLA [119].  Fluorescently-labeled polymer microparticles such as FITC 
or Cy5 labeled latex particles were spatially patterned in the scaffold layers.  
Fibronectin-derived peptides and heparin sulfate have also been successfully 
conjugated in the scaffold material.  This result illustrated the capability of SLA for 
the accurate distribution of multiple factors such as growth factors within the 
scaffolds by point-by-point photopolymerization, resulting in a hybrid tissue 
structure.  
 
2.4.4. Hydroxyapatite materials 
HA is one of the most intensively researched bioceramics in bone tissue 
engineering due to its biocompatibility as well as physical and chemical similarity to 
the inorganic compound in the native bone tissue [120].  Although SLA has been 
traditionally applied to synthetic polymeric resins to create 3D complex architectures, 
recent studies have demonstrated the feasibility of controlled HA scaffold design.  
While the direct photopolymerization of polymeric resin results in simultaneous 




from a negative mold prepared via SLA as well as the casting and subsequent curing 
of a  suspension containing HA, dispersant, monomers, and initiators [121].  Goat 
BMSCs seeded onto the HA scaffold fabricated by this technique showed in vitro 
proliferation on the exterior surface of these scaffolds over 7 days and methylene 
blue/basic fuchsin-stained histology data indicated that the mineralized bone tissue 
was observed after 6 weeks of subcutaneous implantation in athymic nude mice.[99]  
Another in vivo study using designed HA scaffolds in a minipig model demonstrated 
that the overall shape of regenerated bone tissue may depend on the architecture of 
scaffold internal channel geometry [25].  
Furthermore, HA could be used in composite fabrication with photocurable 
acrylate resins [122, 123].  In these studies, micron-sized HA particles were 
incorporated with olygocarbonate dimethacrylate (OCM) resin material, and simple 
stirring created homogenous mixture of HA particles and resin polymers, which 
blocked the inhibition of photocrosslinking by solid particles.  Although increasing 
the amount of HA particles might limit the versatility of SLA fabrication due to 
increased viscosity, the result of 4 and 8 week in vivo studies on distal epiphysis 
implants in rat femora exhibited extensive periosteal and endosteal osteogenesis, as 
observed by SEM of sectioned tissue samples [123].  In addition, cell attachment 
measured by propidium iodide staining and proliferation assessed by DNA contents 
showed higher levels in composite scaffolds than in the control OCM scaffold [122].  
Similarly, bioactive glass has also been used for the fabrication of CAD scaffolds 
with the aid of the combined methods of both SLA and gel-casting [124].  An SLA-




Scaffold Materials Function and Biological Improvements Reference 
Controllable mechanical properties and crosslinking 
characteristics of PPF/DEF/photoinitiator mixture. 
[77] 
Initial trial of PPF resin by using a commercialized SLA 
machine (3D systems). 
[102] 
Surface modification after scaffold fabrication. [103] 
Fabrication of controlled architecture with 250 ∼ 260 µm 
pore size and 132 ∼ 143 µm line width. 
[104] 
PPF 
Utilization of PPF with low number average molecular 
weight (less than 800 Da). 
[103, 107] 
PDLLA/NVP FAME functionalized PDLLA/NVP could be used with 
SLA resin material and aid of accelerator / photoinitiator 
to form 240 ∼ 350 µm pore sizes in gyroid structures. 
[109] 
PDLLA Formed scaffold with 73 vol % porosity and 170 ∼ 240 
µm pore size in gyroid structures. 
[110] 
PLLA Used a negative mold fabricated by SLA.  Upregulation 
of OC and BSP mRNA expression in nanofibrous 
scaffold with microporous surface features. 
[111] 
PBT The inverse trabecular inner structure from a native 
canine bone tissue was fabricated by SLA.  Intensive 





Zonal micropatterning in a bulk hydrogel with 500 µm 
thickness. 
[114] 
PEO gel Cell encapsulation in a PEO gel using SLA.  
Encapsulated CHO cells were viable on day 2  
[115] 
PEG-DA Chondrogenic differentiation of MSCs encapsulated in 
PEG-DMA gel. 
[116] 
Viable human fibroblast encapsulated in PEG-DMA gel. [117] PEG-DMA 
Spatial control of multiple materials including RGD 
ligands and fluorescently labeled microparticles by SLA. 
[118, 119] 
Using a negative epoxy mold fabricated by SLA. [121] 
In vitro proliferation of BMSCs and mineralized bone 
tissue formation were observed. 
[99] 
HA 
C Composite fabrication with photocurable acrylate resin. [122, 123] 







a homogeneous suspension of a glass slurry.  This material was then cast in this mold.  
It has been hypothesized that bioactive glass material is biocompatible like HA [125], 
could control osteogenic differentiation, and could bring about osteogenic gene 
expression [126-128].  These indirect fabrication techniques using an SLA fabricated 
mold and ceramic suspension have shown the versatility of controlled architecture 
manufacturing and its application in animal models. 
 
2.5. Clinical Approaches utilizing SLA 
Since 1987, 3D CT-scans of the skull have been used for maxillofacial 
preoperative planning [129].  Indeed, SLA-derived models have become widely used 
in the preparation of surgical guides or for planning the manipulation of boney and/or 
soft tissue structures [130].  More recently CAD techniques have been used to model 
[131-133] the performance of inert [113]  and tissue engineered implant models that 
are to be produced via SFF techniques. 
 
2.5.1. Limitations 
The clinical application of SLA fabricated scaffolds involve several critical 
steps, including (1) scaffold manufacturing based on 3D CT images, (2) virtual 
surgical procedure simulation and validation, and (3) the final surgical procedure of 
implantation [91, 92, 129, 134].  Specifically, the first step of scaffold fabrication 




virtual model reconstruction using computer software, physical 3D scaffold 
manufacturing using SLA, and 3D model validation.  Therefore, for the successful 
manufacturing of 3D SLA scaffold architectures, close cooperation of surgeons and 
tissue engineers is of critical importance.  However, research into SLA scaffolds is 
still limited to fabrication itself and simple in vitro (cell attachment) or in vivo 
(animal trial) studies, rather than successful surgical implantation into defect sites in 
human clinical trials.  Moreover, a variety of technical limitations still remain 
unsolved [135, 136].  During the step of image acquisition, CT data import error may 
occur when determining the pixel size and slice thickness and numerical errors in this 
step may lead to incorrect virtual reconstruction.  Moreover, other drawbacks on 
obtaining CT data from the patient are also reported such as inhibition of metal or 
other implant material on the patient’s body due to the signal intervention and 
patient’s movement during the CT scan.  In addition, during the step of scaffold 
manufacturing, model stair-step artifact and irregular surface feature may also be 
found [136, 137].  Furthermore, the degree of skin contractures can become an issue 
for surgical procedures [92, 135].  Since obtaining the accuracy of both external 
implant surface geometry is critical for fitting the implant into the defect sites while 
the inner pore architecture of a 3D scaffold is related to promoting host tissue 
ingrowth, the technical difficulties related to scaffold fabrication will need to be 
addressed in the future.  Due to these complex limitations as well as the limited 
numbers of clinically available biomaterials for the implantable scaffold fabrication, 
the number of reports about surgical implantation using SLA-manufactured scaffold 




patient’s defect for guidance and planning of surgery, which is beneficial on 
preoperative evaluation [138-140].   
 
2.5.2. The Current Clinical Use of Computer Aided Design for Bone Implants 
Dean et al presented CAD of cranial implants [91] and the CAD models that 
were rendered using SFF were then recast in implantable materials, such as PMMA 
[92, 137] or titanium.  The milling of titanium (inert) prosthetic cranial plates has 
been demonstrated [141-143] and the performance of these implants and standard of 
care procedures was compared [144].  In addition, the level of post-operative 
complications in patients receiving custom cranial implants following decompressive 
craniectomies was also considered [145].  Research into the use of CAD for hip or 
knee implants has also been completed.  The advantages of patient specific knee 
implants was discussed, however the expense may prevent access to these implants 
[146].  It was suggested that custom hip implants were useful for patients with 
distorted anatomy [147], but the benefit of patient-specific hip implants was also 
questioned elsewhere [148].  Moreover, the advantages of custom patellofemoral 
implants were found and it was predicted that this work will shift towards the use of 
resorbable materials [149, 150].  The use of CAD for cervical spine drill guides and 






In bone tissue engineering, a series of structural cues including pore size, 
porosity, interconnectivity, and stiffness have been found to be critical factors in 
activating osteogenic signal expression.  Successful manipulation and fabrication of 
controlled architecture with optimal conditions of construction parameters may 
stimulate osteogenic signal expression as well as subsequent osteogenic 
differentiation.  To this end, SLA is a promising and feasible strategy for fabrication 
of a designed architecture, which may show the best performance in vitro and in vivo.  
Recently developed SLA-manufactured 3D scaffold systems have shown the 
possibility of clinical implantation.  Therefore, controlling the structural parameters 
may promise successful integration of the implants into the surgical sites and 
enhancement of bone regeneration.  Despite some limitations of a sequential 
procedure of the scaffold fabrication by SLA and the surgical implantation into 
humans, development in scaffold construction parameters and SLA fabrication is a 
promising means for the fabrication of functional bone tissue engineered substrates.  
These constructs facilitate osteogenic signal expressions and subsequent osteogenic 
differentiation of either scaffolds pre-loaded with cells or scaffold-recruited cells 
from surrounding tissues.  Therefore, it is suggested that the following research 
should be completed to enable successful clinical implementation of implants 
manufactured via SLA: 
 (1) Scaffold parameters: extensive investigation optimizing the individual scaffold 
design parameters and subsequent studies to find synergistic versus negative effects 




(2) Bulk material production: continued development of human implantable (FDA 
approved) biomaterials and investigation of composite materials [153]. 
(3) Tuned SLA fabrication: Achievement of a higher precision of SLA to control the 
specific range (less than tens of micron level) of scaffold architecture, validation of 
accuracy of CAD scaffolds, and feasible reproduction of the scaffolds. 
(4) Successful data acquisition from human patients: data acquisition using clinical 
visualization techniques and the transfer of this data to 3D images to reflect defect 
sites with higher resolution and minimal error. 
(5) Clinical applications: more intensive case studies to accrue clinical information 








The three fundamental components of bone tissue engineering have been well 
described as (a) parenchymal or progenitor cells which subsequently express tissue 
matrix, (b) scaffolds which can act as temporary frameworks to support bone growth, 
and (c) growth factors to induce bone-forming cell regeneration. Although a number 
of investigations have been performed to elucidate these bone regenerative strategies, 
these approaches are often associated with limitations including improper mechanical 
strength of scaffold materials, insufficient cell growth for bone fracture-healing, and 
low growth factors expression to stimulate osteogenic differentiation and 
proliferation. In order to overcome these drawbacks, nanoparticle technology has 
been increasingly combined with bone tissue engineering methods. Nanoparticles, 
defined as a submicron-sized particle and typically less than 100nm in diameter, have 
enormous potential to be used as pharmaceutical, therapeutic, and diagnostic agents 
for biomedical applications as well as enablement of tissue engineering.  Due to their 
extremely small size, surface-to-volume ratio, and surface functionality, nanoparticles 
may be one of the promising candidates to create novel composite materials and 
delivery system for bone regeneration. Therefore, this review provides the recent 
nanoparticle-based strategies utilized in bone tissue engineering applications.  
 
As published in K. Kim and J.P. Fisher, “Nanoparticle Technology in Bone Tissue Engineering”, 




 In particular, we emphasize on three major areas of bone regeneration which 
have been recently studied by bionanotechnology: (1) nanoparticle-composite bone 
tissue engineering scaffolds with enhanced mechanical properties, (2) nanofibrous 
scaffolds that promote cellular functions and (3) nanoparticles that deliver osteogenic 
genes. Several examples in each area are explored and critically discussed in order to 
introduce the state of the art nanotechnologies that have been recently applied to bone 
tissue engineering. 
 
3.2. Composite Scaffolds 
3.2.1. Nanoparticle/Polymer Composite Scaffolds 
Bone tissue engineering scaffolds are often designed to be mechanically 
strong, osteoconductive, biocompatible, and biodegradable. However, biodegradable 
polymeric materials or ceramics sometimes have significant limitations, including 
insufficient mechanical properties. Nanoparticles may be an excellent method to 
improve a tissue engineering scaffold’s properties since they have similar length scale 
of many cellular and molecular components. Furthermore, as organic substances and 
inorganic minerals in bone formations exhibit nanoscale structures, nanosized 
materials may provide the proper surface and mechanical properties for bonding to 
surrounding tissue and supporting a loading condition [154]. Similarly, stress and 
strain balances between an implanted scaffold and the surrounding tissue are required 
for proper implant-tissue integration and sufficient bone regeneration [154]. 
Composite materials, such as a polymeric scaffold blended with nanosized material, 




particles and the surrounding polymer material may result in better mechanical 
strength in the composite scaffold, while increased surface roughness may enhance 
osteoblastic functions. As a result, a number of investigations have been performed to 
develop nanoparticle-polymer composite materials. 
 Calcium phosphatase bioceramics, such as hydroxyapatite (HA) and 
tricalcium phosphate, are promising materials for bone tissue engineering since these 
ceramics reflect the chemistry and structure of the native mineral components of bone 
tissue.  Despite the fact that bioceramics enhance osteodifferentiation and osteoblast 
proliferation, a number of limitations are associated, including brittleness, difficulty 
of processing, and slow degradation rate. Therefore, the incorporation of HA 
nanoparticles into a poly(ethylene glycol) (PEG) and poly(butylene terephthalate) 
(PBT) copolymer has been examined [155]. This approach attempts to combine the 
osteoconductivity of HA with biodegradability of polymer. Based on the finding that 
organic isocyanate groups can react readily with surface hydroxyl groups of HA, 
direct chemical bonding of HA particles with the surrounding polymer had a 
significant improvement on mechanical properties (Young’s modulus, tensile 
strength, and elongation at a break) of the composites. Furthermore, composite 
scaffolds composed of HA nanoparticles and poly(L-lactic acid) (PLLA) showed not 
only increased compressive modulus, but also protein adsorption [156]. The 
incorporation of HA nanoparticles into the polymer scaffold altered the pore surface 
morphology of the composite scaffolds to be more suitable for protein adsorption, 
with the resulting properties dependant upon the ratio of HA and polymer. Higher 




composite scaffolds. In addition to bone binding ability of HA, mimicking the size 
scale of HA in natural bone may enable this composite scaffold to serve as a 
mechanically improved three dimensional substrate for cell attachment and migration. 
Alternatively, a poly(D,L-lactic-co-glycolic acid) (PLGA)/HA nanoparticle composite 
scaffold fabricated by gas forming and particulate leaching method improved 
mechanical properties and enhanced osteogenic potential in vitro and in vivo. This 
research also demonstrated that enhanced exposure of the bioactive HA particles 
allowed direct contact with cells and stimulated their proliferation and osteogenic 
differentiation [157]. 8 weeks after implantation of PLGA/HA composite scaffold 
into the succutaneous space of athymic mice [157] and to critical size defects in rat 
skulls [158], new bone with lamellar structure and osteoid formation was appeared. 
PLGA scaffold without HA had produced nearly no new bone in vivo and this 
indicated that the direct contact of cells with HA nanoparticles exposed on the 
scaffold surface may stimulate the cellular functions and enhanced bone regeneration.  
Single-walled carbon nanotubes (SWNT) have also been incorporated in a 
nanocomposite scaffold in an attempt to take advantage of their significant 
mechanical properties and high aspect ratio. After modification of the side walls of 
SWNT, a cross-linked poly(propylene fumarate) (PPF) nanocomposite showed an 
increase in compressive/flexural modulus, compressive offset yield strength, and 
flexural strength when compared to pure PPF networks [159]. It was also 
demonstrated that functionalization might result in more monodispersed SWNTs in 




mechanical properties may explained by the formation SWNT-PPF cross-links and 
resulting effective load transfer. 
 Silica nanoparticles may be the basis for an alternative approach for scaffold 
reinforcement. A silica nanoparticle composite with poly(ε-caprolactone) (PCL) 
exhibited improved mechanical strength and bioactivity [160]. The condensation 
reaction between the silanol groups in the silica and PCL end capped with 
triethoxysilane led to the formation of siloxane linkages and the reduction in the 
concentration of silanol groups in the composite. This structure resulted in an increase 
in tensile strength and Young’s modulus of the composite, but a decrease in the initial 
rate of apatite formation. Overall, the enhanced mechanical properties were similar to 
those of human cancellous bone. Another example can be seen in a bisphenol-a-
glycidyl methacrylate and calcium phosphate cement (CPC) composite with nano-
silica-fused whiskers which exhibited significantly higher flexural strength than the 
composite containing only CPC fillers [161]. Results showed that the cytocompatible 
composite possessed enhanced flexural strength, elastic modulus and hardness that 
nearly matched cortical and trabecular bone. It was also demonstrated that the 
increased whisker surface roughness by nanozised silica conjugation may result in its 
retention in the matrix and substantially increase composite strength and toughness 
[162].  
 Metal nanoparticles have also been investigated as a mean to augment cellular 
responses in bone regeneration as well as to enhance the mechanical strength of the 
composite scaffolds. Nanocomposite reinforcement with a fine dispersion of 




Alumoxane nanoparticles were hybridized with activating groups containing reactive 
double bonds and surfactant groups as separate ligands. This research reported that 
surfactant functional group improved the nanoparticle dispersion in the polymer 
matrix, which thereby enhanced the mechanical properties of composite, while 
activating groups provided additional covalent bonding with the control polymer. 
Significantly, the resulting 3-fold increase in flexural modulus of the nanocomposite 
compared to the polymer may allow the composite material to be utilized in load-
bearing hard tissue engineering applications. Similarly, a poly(methyl methacrylate) 
(PMMA) scaffold containing nano-sized titania particles showed superior 
osteoconductivity and compressive strengths [164]. The effect of nanophase alumina 
and titania has also been investigated in vitro and in vivo, with results demonstrating 
significant osteoblast and chondrocyte adhesion [165-169]. These works are a critical 
development as osteoblast adhesion is the first step for subsequent cellular responses 
including proliferation, formation of extracellular matrix protein and mineral deposits 
[168]. As biomaterial surface such as topography and chemistry controls the cellular 
and molecular events at the tissue-implant interface, simulating the normal bone 
surface using nanophase metal particle may enhance cellular responses and 
interactions, thus promoting osseointegration. In addition to increased cellular 
adhesion [165, 168], it has been also shown that the composite scaffolds with PLGA 
and metal nanoparticles stimulate increased long-term osteoblast functions including 
collagen synthesis, alkaline phosphatase (ALP) activity, and calcium deposition [166, 
167, 169]. Enhanced osteoblast adhesion is more dependent on the optimal surface 




Similarly, nanometer surface roughness may be the key factors stimulating osteoblast 







 Material Function and Biological Improvements Reference 
Bioceramics HA and 
PEG/PBT 
 
Increased Young’s modulus, tensile strength, 





Increased compressive modulus and protein 
adsorption 
[156] 
 HA/PLGA Stimulated cell proliferation and osteogenic 
differentiation 
In vivo bone formation after 8 week of 





Metals Titania Superior compressive strength and 
osteoconductivity of PMMA composite 
[164] 
  Enhanced cellular adhesion [165, 168] 




 Alumoxane Increased flexural and compressive strength 
of PPF composite scaffold 
[163] 
Others SWNT/PPF Significantly improved flexural and 
compressive modulus, compressive offset 
yield strength, flexural strength 
[159] 














 Overall, using various nanoparticles as fillers into scaffold material generally 
creates a superior nanocomposite material with enhanced mechanical properties and 
facilitated cellular function (See Table 6). Present investigations with 
nanoparticle/polymer composite scaffold demonstrate that such engineered composite 
scaffold could be considered for bone tissue engineering applications. However, it is 
not clear that any one approach is significantly superior to another for scaffold 
fabrication. Therefore, more development and investigations on the surface chemistry 
of materials as well as specific interactions between cell/material and 
material/polymeric scaffold may be required. 
 
3.3. Nanofibrous Scaffolds 
Nanofibrous scaffolds are another approach for engineering scaffolds with 
nanotechnology. In addition to the suitable mechanical strength for load-bearing 
applications, scaffolds for bone tissue engineering may have an artificial extracellular 
matrix (ECM) with morphologies that replicate the natural ECM, composed mainly of 
collagen and proteoglycans. Therefore, nanofibrous scaffold may provide a more 
favorable environment for cellular ingrowth and subsequent bone regeneration as they 
have architectural, functional, and morphological similarities to collagen fibrils, 
especially due to nanometer-order diameter, high porosity and high surface-to-volume 
ratio [170]. For example, as collagen is a natural ECM molecule in many tissues and 
plays an important role as a substrate for cell attachment, proliferation, and 
differentiation, a biomimetic nanofibrous scaffold may be developed with similar 




developed using various synthetic polymers including PLLA [111, 171-173], PCL 
[174-178], PLGA [179, 180], copolymer [181], and chitosan [181].  
 Three-dimensional PLLA nanofibrous scaffolds have been shown to improve 
protein adsorption, mediating cellular interactions within the scaffold. In particular, 
these PLLA nanofibrous scaffolds allowed for increased fibronectin and vitronectin 
adsorption from the surrounding media, promoting osteoblast attachment to increase 
more than 1.7 times when compared to control scaffolds [172]. As cell attachment is 
the very initial step to promote long-term cellular functions such as migration, 
proliferation, and differentiation, enhanced protein adsorption and cellular adhesion 
imply that nanofibrous scaffold may provide more biocompatible microenvironment 
for cell-matrix interaction.  
 Subsequently, it has been verified that osteoblast cultured on PLLA 
nanofibrous scaffolds exhibited significantly increased proliferation, mineralization 
throughout osteogenic differentiation, and bone marker protein expression [173] 
when compared to unmodified PLLA. Specifically, osteoblastic cells cultured on 
PLLA nano-fibrous scaffolds showed higher ALP activity, increased runx2 protein 
expression, increased bone sialoprotein mRNA, and increased mineralization versus 
solid-walled control scaffolds. Moreover, nanofibrous scaffolds are thought to be 
comparable to natural collagen fibers. Here, cells seeded on nanofibrous scaffolds 
sustained alpha2 integrin expression in the presence of dehydroproline, while 
suppression of the same marker protein was evident in cells seeded on solid-walled 
scaffolds. Similar results have been found in a series of PCL studies [178]. Under 




marrow were cultured on PCL nanofibrous scaffolds. After 1 week, significant cell 
migration and enhanced formation ECM were detected in the scaffold. Cell 
multilayers formation, mineral deposition, and type I collagen expression were also 
observed after 4 weeks. Similarly, in an in vivo study [176], it was confirmed that 
cell-PCL constructs gave rise to a bone-like appearance with sufficient cell/ECM 
formation on the surface of the scaffold construct, mineralization, and type I collagen 
expression. 
 Interestingly, it was also shown that the presence of nanofibers had an 
influence in cell shape and morphology, including increased cell spreading [177]. 
Cell culture studies with a SaOs-2 human osteoblast-like cell line and rat bone 
marrow stromal cells demonstrated stretched cell morphology, cytoskeletal 
rearrangement, and quicker scaffold colonization. Human mesenchymal stem cell 
(hMSC) studies in a nanofibrous scaffold have described the potential use of 
nanofibrous scaffold in injured bone healing. PCL nanofibrous scaffolds 
demonstrated the ability to support and maintain multilineage differentiation of bone 
marrow-derived hMSCs in vitro. For example, hMSCs seeded onto PCL nanofibrous 
scaffold differentiated into adipogenic, chondrogenic, and osteogenic lineages [174]. 
hMSCs cultured in PLGA nanofiber scaffolds (approximately 700nm in diameter) 
also demonstrated cell viability and proliferation as well as the promotion of multiple 
cell lineages [180]. Chitosan-based nanofibers, with an average diameter below 40 
nm, exhibited directional alignment and a potential for bone regeneration graft [101]. 




(PEO) blend promoted the attachment of human osteoblasts and chondrocytes, as well 
as maintained cell viability.  
Taken together, nanofibrous scaffolds with high surface-to-volume ratio may 
possess a great advantage by providing a more favorable environment for bone tissue 
formation such as enhanced cell attachment and proliferation (See Table 7). In 
addition to three dimensional configuration and similar nanometer order morphology 
to natural ECM, the relatively large porosity and pore size found in nanofibrous 
scaffolds may enable sufficient cell propagation and differentiation. These 
architectural characteristics may also enable to proper transport of cellular substances 
including signaling molecules, nutrients, and metabolic wastes [170]. As a result, 
nanofiber scaffolds may be a promising bone tissue engineering scaffold based on 





Material Function and Biological Improvements Reference 
PLLA Improved protein adsorption and osteoblastic cell attachment [172] 
 Increased proliferation, mineralization, bone marker protein 
expression 
[156] 
PCL Enhanced penetration of MSCs into the scaffold and 
increased formation of ECM in vitro 
[178] 
 Sufficient cell/ECM formation on the surface of scaffold in vivo [176] 
 Supports in vitro multilinage of hMSCs [174] 
PLGA Supports in vitro multilinage of hMSCs [180] 
 






3.4. Nanotechnology for Growth Factor Delivery 
Growth factors are one of the essential factors that induce or stimulate 
intracellular functions including cell recruitment to the healing site, mitogenesis, 
differentiation into the osteogenic linage, and renewal for bone formation [15, 182]. 
Considering some of the disadvantages of conventional scaffold implantation for 
bone tissue regeneration (inflammation, low growth factor expression, and low cell 
proliferation), a growth factor delivery system or the growth factor gene delivery 
system has become a probable and promising solution for improved bone 
regeneration. Among the various growth factors involved in bone tissue engineering, 
those of particular interest include, bone morphogenetic protein (BMP), transforming 
growth factor beta, platelet derived growth factor, and vascular endothelial growth 
factor (VEGF). These growth factors and the effect on bone formation has been well 
described [15, 183-186]. 
 Osteoblast growth and subsequent bone formation strongly depends on the 
growth factor signaling. The combination of various growth factors and their 
sequential functions directs osteogenic differentiation as well as other downstream 
cellular functions. Nevertheless, direct injection of growth factor in solution is often 
not effective strategy due to rapid diffusion and excretion from the defect site [187]. 
Furthermore, unstable biological activity of the growth factors, short half-life, and 
minimal tissue penetration could result in inefficient delivery [183]. To reduce growth 
factor delivery failures associated with direct injection, the utilization of various 
carrier materials has been attempted. Compared to direct adsorption of a growth 




controlled, long-term release with adequate efficacy [184]. Delivery carriers, 
themselves either implanted or injected, require materials that are biocompatible, 
biodegradable, as well as suitable for protein encapsulation. As many synthetic 
polymers possess these attributes, micron sized polymeric sphere have been widely 
used for encapsulation of growth factors. In particular, an encapsulated growth factor 
may be released as the polymer degrades following a controlled and predetermined 
profile. In addition to synthetic polymers [188-190], there are also other possible 
carrier materials including inorganic materials (hydroxyapatite, tricalcium phosphate, 
carbonate apatite, silica) and natural polymers (collagen, hyaluronic acid, chitosan, 
alginate). A series of reviews have already covered various types of growth factor 
delivery materials [183, 185, 191-194]. Here, we consider nanoparticle technology for 
the delivery of genes encoding growth factors (See Table 8). 
 
3.4.1. Nano-Scaled Gene Delivery Systems 
Growth factor gene delivery can be more effective than the delivery of growth 
factors due to the sustained production and secretion of growth factors achieved by 
gene transfection. Transport of exogenous DNA is a sequential process (Mansouri et 
al., 2004); (a) internalization of DNA-nanoparticle complex through the cell 
membrane, (b) uptake by intracellular endosome, (c) release into the cytoplasm, (d) 
uptake of the complex in the nucleus, (e) dissociation from the nanoparticle vector, (f) 
protein expression, and (g) secretion of the growth factor protein. Over these steps, 
the carrier vector should be small enough to be internalized into the cell over several 




DNA until it reaches the target cell [195]. Considering their size and physical 
properties, nanoparticles can be an excellent carrier vector. Nanoparticles with sub-
cellular size can penetrate into tissues and cells in the targeted sites, and easily deliver 
a therapeutic through endocytosis. In addition, nanoparticles are also able to cross the 
blood-brain barrier by opening tight junctions in the paracellular pathway and passage 
to the cellular nucleus. Finally, nanoparticles often allow more effective and efficient 
targeted delivery even in distant healing sites [196]. In contrast to viral vectors which 
are based on virus as a carrier system, non-viral vectors system using nanoparticles 
have several advantages like flexibility toward the molecular size of loaded DNA, 
nonimmunogenic route, the ability to target specific tissues, low toxicity, and no risk 
of recombination to an infectious virus [185, 186, 197]. Due to these reasons, non-
viral vector must be preferable for clinical usages despite low transfection efficiency 















System Function and Biological Improvements Reference 
Up to 70% high DNA encapsulation efficiency with sustained 
release both in vitro and in vivo 
[198] 
Polymerized nanogel with stability in aqueous media, low 
toxicity, and enhanced DNA uptake in HeLa cell 
[199] 
PLGA nanoparticle with tetracycline with affinity for HA [200] 




Penetration of PLGA-VEGF nanoparticle carrier in myocardial 
cells and successful in vivo angiogenesis 
[202] 
Extended half-life of BSA with PEG-PLGA nanoparticle [203] 
Effective gene release with AMPEG/PCL nanoparticle with low 
density of primary amine groups 
[204] 
Higher DNA protection to enzymatic degradation and higher 
reporter gene expression with PEG-cationized gelatin 
[205] 
PEGylation 
Increased DNA penetration into the cells and luciferase activity 
with DNA-PEG-gelatin nanoparticle 
[206] 
Micelle Adherence of aldehyde-terminated PEG-PLA block polymer to a 
tissue surface in vivo 
[207] 
 Efficient and less toxic transfection toward primary osteoblast 
cells using polyplex micelles 
[208] 
Enhanced bone formation in cranial defect on rabbit model using 
cationic liposome loading BMP-2 cDNA plasmids 
[209] 
Critical size defect healing in rat model, less efficient BMP-2 
gene transfer of liposome than adenoviral carriers 
[210] 
Liposome 
More effective bone formation in a rat bone-defect model using 
magnetic rhBMP-2 liposomes 
[211] 
Targeted delivery of anti-arthritic drug with folate-PAMAM 
dendrimer 
[212] 
LacZ gene transduction in human chondrocyte-like cell  without 
cytotoxic effect and morphological changes 
[213] 
Dendrimer 
Increased nucleus penetration and enhanced gene transfection 
using dexamethasone conjugated PAMAM 
[214] 
In vitro DNA transfection using DNA-chitosan nanoparticle [215] 
Enhanced DNA internalization of DNA mediated byfolate 





Co-precipitated DNA with calcium phosphate nanocomposites 
onto the cell-culture surface enhanced β-gal expression level 
in MG-63 and Saos-2 cells 
[217] 




3.4.2. Polymeric Nanoparticles 
Owing to the biodegradability of many synthetic polymers, nanosized 
polymeric particles are often some of the best candidates for non-viral gene delivery 
in tissue engineering applications. PLGA nanoparticles have been shown to offer 
protection of genes to nuclease degradation, increased DNA uptake, and sustained 
duration of DNA administration, as well as subsequent gene transfection and 
expression. In addition to the sustained release of encapsulated pDNA, biologically 
compatible degraded material such as lactic acid and glycolic acid may be another 
advantage of polymeric nanoparticle delivery. For example, PLGA containing human 
placental ALP plasmid DNA (pDNA) exhibited high encapsulation efficiency of 70% 
and sustained release of pDNA [198]. In vitro transfection using human endothelial 
cell lines demonstrated both higher gene expression level than naked pDNA and a 
sustained gene release (higher at 1 wk than 48 hr after transfection). Similarly, In vivo 
transfection utilizing a rat tibial muscle indicated that this nanoparticle gene delivery 
showed 28 d of sustained gene transfection although ALP expression level after 3 and 
7 d of a single intramuscular injection of naked pDNA injection is higher than that of 
pDNA-PLGA nanoparticle injection. Polymerized hydrophilic nanogels composed of 
2-acryloxyethyl trimethylammonium chloride, a nonionic crosslinker poly(ethylene 
glycol) diacrylate, and a nonionic monomer 2-hydroxyethlynacrylate were also 
fabricated into 40-200nm nanoparticles [199]. This monodispersed nanogel 
demonstrated stability in aqueous media, low toxicity and enhanced DNA uptake in 
HeLa cell culture. Surface-functionalized PLGA nanoparticles have also been 




tetracycline showed a great affinity with HA, a significant inorganic component of 
hard tissues such as bone and teeth. Tetracycline has a strong affinity for adsorption 
to calcium phosphate and serves as a targeting moiety for bone-specific drug delivery. 
This resulted confirmed that the PLGA complex can be utilized as the carrier and 
guided material for bone regeneration strategy. 
 Particle size can vary the efficiency of nanoparticle-mediated gene 
transfection. Smaller-sized PLGA nanoparticle (70nm in diameter) containing pDNA 
encoding luciferase marker protein produced 27-fold higher transfection in COS-7 
cell line and a 4 fold higher transfection in HEK-293 cell line than larger-sized 
particles (202nm in diameter) [201]. This work indicated that smaller particle size and 
uniform size distribution are critical factors for higher gene transfection efficiency. 
 In other tissue applications necessary for bone regeneration, such as blood 
vessel growth, polymeric nanoparticle has been utilized for gene delivery. For 
example, the stability, in vitro release, in vitro cell transfection efficiency, and in vivo 
gene transfer of VEGF-DNA loaded PLGA nanoparticles were investigated [202]. 
The diameter of VEGF pDNA-PLGA nanoparticle ranged 100-300nm in diameter 
and these gene carriers successfully penetrated in myocardial cytoplasm and nucleus. 
Furthermore, in vivo angiogenesis was identified by increased capillaries.  
 
3.4.3. PEGylation 
Critical parameters for gene delivery to target cells includes prolonged 
circulation time, stability within blood circulation, access to target tissue/cells, easy 




[218]. Surface coverage by amphiphilic polymeric surfactant like PEG over 
nanoparticles increases the blood circulation time by preventing recognition of 
reticuloendothelial system located in the liver and lung [218, 219]. PEG has a 
flexible, hydrophilic polymer chain that effectively creates a ‘water shell’ to help to 
mask the bound proteins [219] and provide steric protection to the entrapped DNA 
from DNase degradation. PEG has also been introduced to address low DNA 
encapsulation efficiency of polymeric nanoparticle by mediating the weakly bound 
hydrophilic DNA and hydrophobic polymeric nanoparticle.  
 To this end, PEG-PLGA nanoparticles have shown that PEG enhances protein 
delivery [203]. Here, PEG-PLGA particles extended the half-life of bovine serum 
albumin (BSA) from 13.6 min of loaded in PLGA nanoparticles to 4.5 h and, as a 
result, dramatically altered the protein biodistribution in rats. Similarly, methoxy 
poly(ethylene glycol) (MPEG)/ PCL diblock copolymers have been investigated for 
the effect of charge group on transfection efficiency [204]. This work confirmed that 
amine-terminated MPEG (AMPEG)/PCL nanoparticles with cationic charge groups 
exhibited somewhat higher DNA transfection efficiency in comparison with the 
nonionic MPEG/PCL nanoparticles. The terminal amine group may also allow more 
effective DNA condensation due to the electrostatic interaction, and therefore result 
smaller gene-loaded particle size. PEG-cationized gelatin has also been used as non-
viral gene delivery carrier. Gelatin was cationized by the introduction of amine 
residues to its carboxyl group. In particular, PEG was modified with one terminal of 
an active ester group coupled to the amino groups of cationized gelatin, resulting in 




DNA protection to enzymatic degradation compared to the cationized gelatin and, as 
a result, higher luciferase reporter gene expression compared with the injection of 
pDNA solution. DNA-gelatin nanoparticles, whose molecular size was approximately 
150 nm, were made by self-assembly due to electrostatic interaction between 
positively charged gelatin-derivatives and negatively charged DNA [206]. As it is 
difficult for negatively charged pDNA to internalize into cells due to repulsion, 
positively charged gelatin-DNA complex aids plasmid DNA to adhere onto the cell 
membrane and internalize into cells. As a result, this ionic interaction enhances the 
penetration of pDNA into the cell and the transfection efficiency. The amount of 
DNA penetrated into the cells was increased by the DNA-gelatin complexation, and 
luciferase activity was also significantly increased in the cell incubated with the 
DNA-gelatin nanoparticles than naked pDNA. Therefore, PEGylation could be used 
with other nanoparticle delivery system to enhance more growth factor secretion in 
defect sites due to two major advantages; higher pDNA transfection efficiency and 
pDNA protection from DNase degradation. 
 
3.4.4. Micelles 
Micelles are 50 - 100 nm sized spherical self-assemblies of block copolymers 
with a hydrophobic core and surrounding hydrophilic outer shell [220]. When 
fabricated with poly(ethylene glycol), the PEG outer shell often provides 
biocompatibility and longer blood circulation time, while the inner hydrophobic core 
allows encapsulation of a hydrophobic drug, DNA, or protein either physically or 




between the charged block copolymer and oppositely charged molecule, core-shell 
nanosized micelles have formed [221]. Polymeric micelles have several advantages as 
drug and gene carriers because of easy loading of drugs without chemical surface 
modification, wide availability to various therapeutics, simple fabrication methods, 
high loading capacity, and controlled release pattern [222]. A polymeric micelle 
consisting of an aldehyde-terminated poly(ethylene glycol)-poly(D,L-lactide) (PEG-
PLA) block copolymer was shown to adhere to tissue surfaces in vivo, and therefore 
may be applied as tissue-adhesive material [207].  A PEG/PLA hydrogel could be 
also used for bone tissue engineering applications as the copolymer introduces 
favorable characteristics to the hydrogel carrier including PEG core hydrophilicity 
and biodegradable PLA linkages. Polyplex micelles, consisting of pDNA and cationic 
polymer complexes, have also been utilized in gene transfection in primary 
osteoblasts [208]. Results showed that the block catiomers carrying the 
ethylenediamine unit at the side chain are capable of efficient and less toxic 
transfection of primary cells. 
Although many gene delivery researches using micelles have not been done in 
bone tissue engineering filed, DNA-micelle construct could be applied as potential 
gene delivery strategy.  As there are several advantages of polymeric micelles such as 
excellent ability to carry poorly soluble pharmaceutical molecules and very 
hydrophobic compounds, possible targeting by attaching specific ligand molecules, 
and tumor-infiltrating ability, micelles could also be a candidate for growth factor 
gene delivery system. The further development of micelle with specific tissue-





Liposomes are spherical vesicles encircled with a phospholipid bilayer 
membrane. Drug molecules or genes can be either entrapped in the aqueous space of 
the liposome or intercalated into the lipid bilayer [220]. Liposomes have been 
investigated as gene delivery device because of their ability to pass through lipid 
bilayers, including cell membranes, and amenability towards surface modification 
with targeting ligands or polymer [223]. Enclosed aqueous core can be utilized to 
carry hydrophilic agents, while multilamellar liposomes provide cargo space for 
lipophilic actives as well [224]. There are also some limitation of liposome based 
delivery; cellular and systemic impeding factors [225]. For cellular impeding factors, 
poor endosomal release of pDNA into the cell cytosol after internalization through the 
cell membrane is the major disadvantage of liposomal gene delivery. After releasing 
from the endosome, it might also be possible that the dissociation of polymer/pDNA 
complex is hard due to tight complex formation initially, that subsequent degradation 
of pDNA by cytosolic nucleases occurs, and that nuclear uptake efficiency of pDNA 
is very low. The instability of the injected liposome-gene complex in biological fluids 
containg serum proteins and high salt concentration may results in the systemic 
impeding factor. This is why lipofection is generally considered to be less potent in 
vivo than in vitro. For example, ALP expression after 7 d of injection resulting from 
pDNA-liposome complex in rat tibial muscle was found to be lower than that 
observed in naked pDNA and pDNA-PLGA nanoparticle injection [198]. 
Nevertheless, promising in vivo researches have also been performed recently 




plasmids showed great effect on bone formation within cranial defects of a rabbit 
model [209]. In this study, BMP-2 gene and liposome were sprayed with 1:4 wt ratio 
on the defect area. Histopathological examination and X-ray image analysis data 
exhibited that BMP-2 gene with liposome apparently promoted the progress of 
osteogenesis and the bone defect area was almost filled with new bone by six week.  
Ex vivo cell-mediated BMP-2 gene transfer has also proven that liposome vector can 
be an attractive option for bone regeneration [210]. Rat bone marrow stromal cells 
pre-treated with either an adenovirus or a liposome carrying human BMP-2 cDNA 
were transplanted into critical size defects in the rat mandible. Although adenoviral 
vector showed more efficient gene transfer, the critical size defects treated with 
liposome-gene complex were found completely healed at 6 weeks after the gene 
transfer. Furthermore, liposome may be further modified for bone tissue engineering 
applications with the assistance of magnetic particle targeting system. Nanosized 
magnetic liposomes with incorporated recombinant human BMP-2 (rhBMP-2) have 
been investigated in a rat bone-defect model [211]. Treatment with rhBMP-2 
liposomes under magnetic force showed nearly complete bone bridge formation. The 
greater efficacy of magnetic liposomes over conventional liposomes is due to the 
increased retention of BMP at the target site by magnetic induction. It is noteworthy 
that the combined treatment of topical magnetic rhBMP-2 liposomes and magnet 
implantation at the injured site was effective for bone defects treatment.  
 
3.4.6. Dendrimers 




series of polymerization reactions, dendrimers grow from a central core molecule in 
outward direction [220]. This growing pattern results in a highly branched dendritic 
architecture, which is similar to the structure of glycogen, amylopectin, and 
proteoglycans.  As a result of this structure, dendrimers may offer unique interfacial 
and functional advantages. [224]  As a nanoscale container, cavities in the core 
structure and folded branches of the interior shell create cages and channels which are 
protected from outside environments.  Furthermore, a muitivalent surface containing 
a number of active sites can be functionalized for the attachment of targeting groups 
[224]. As a dendrimer’s size, shape, branching length, branching density, and surface 
functionality may be easily controlled, these molecules may provide another avenue 
for nanoscaled delivery of proteins and genes to tissue defects, including 
osteochondral sites. For example, folate-polyamidoamine (PAMAM) dendrimer 
conjugates have been utilized as targeted delivery vehicles for the anti-arthritic drug 
indomethacin [212]. Folic acid was coupled to the surface amino groups of the 
dendrimer, with the resulting drug content and encapsulation efficiency increasing 
with increased folate content. Gene delivery with PAMAM dendrimer was also 
demonstrated in chondrocytes [213]. A pDNA containing LacZ gene was utilized to 
transduce a human chondrocyte-like cell line, HCS-2/8. As LacZ encodes β-
galactosidase (β-gal), transfected gene expression level was evaluated both by β-gal 
activity assay and by X-gal staining. The results showed that optimal DNA to 
dendrimer complex ratio for enhanced β-gal activity was 2 µg of the plasmid vector 
containing LacZ gene combined with 21 µg of dendrimer. At this ratio, the highest 




dendrimer-mediated transduction without any cytotoxic effect. This research 
demonstrated the potential use of nano-scaled dendrimers as gene delivery vehicles to 
chondrocytes. Finally, PAMAM-glucocorticoid conjugation has been attempted in 
order to increase nuclear membrane penetration and enhance subsequent gene 
transfection efficiency [214]. To this end, dexamethasone, a potent glucocorticoid, 
was conjugated to PAMAM dendrimer.  The resulting complex exhibited higher gene 
transfection efficiency, when compared to PAMAM or polyethyleneimine alone, as 
the glucocorticoid receptor dilated the nuclear pore and translocated into nucleus after 
ligand binding, demonstrating the utility of a dexamethasone conjugated 
dendrimer/DNA complex for non-viral gene delivery. 
 
3.4.7. Inorganic Nanoparticles 
Chitosan, a natural polymer derived from chitin, has also been used as a gene 
carrier as its cationic polyelectrolyte property allows a strong electrostatic interaction 
with negatively charged DNA. Chitosan has been shown to condense DNA and form 
nano-size discrete particles for gene delivery [215]. Stable DNA-chitosan particles, 
which are typically 50-100nm in diameter, were fabricated and successively 
transfected HeLa cells. In addition, transfection was resistant to 10% fetal calf serum 
condition, suggesting applicability as an in vivo gene delivery system. However, 
results have shown that the efficiency of chitosan-DNA nanoparticle mediated 
transfection may be cell type dependent. For example, transfection efficiency was 
tested with human MSCs, human osteosarcoma cells (MG63), and human embryonic 




transfection efficiency than embryonic kidney cell, chitosan mediated gene delivery 
still demonstrated homogeneous DNA distribution and cytocompatibility. In order to 
increase transfection efficiency, folic acid again has been used as a ligand for 
targeting cell membranes, with results indicating nanoparticle endocytosis via the 
folate receptor [216]. As cellular folic acid uptake may be utilized to promote 
targeting and internalization, a folic acid-chitosan nanoparticle can be used in gene 
therapy in diseases where folic acid receptors are overexpressed. 
Other inorganic materials such as calcium phosphate have also been 
developed as nano-scale delivery devices. Nanocomposites based on calcium 
phosphate co-precipitated with DNA have been evaluated as gene delivery systems 
[217]. While some gene delivery systems contain drawbacks including inefficiency 
and toxicity when maintaining a high DNA concentration near the cell surface, the 
resulting DNA nanocomposites provided regions of high DNA concentration in the 
immediate microenvironment of the cultured cells and enhanced gene transfer. 
Enhanced gene transfer was measured via β-galactosidase expression level in both the 
osteoblastic MG-63 cell line and the Saos-2 human bone tumor cell-line, with 




Nanoparticle technology has been increasingly applied to biological research 
due to advantageous characteristics of nanoparticles including extremely small size, 




engineering, nanoparticle technology may be the one of the best supporting strategies 
to solve existing limitations of conventional tissue engineering approaches. For 
example, the mechanical strength of scaffold materials may be improved by 
fabrication of nanoparticle/polymer composite scaffold. Nanofibrous scaffold may 
provide more favorable microenvironment for cell growth in healing sites, as they 
often resemble extracellular matrix components. Finally, nanoparticles are also able 
to act as a carrier device for gene delivery. With the assistance of nanoparticle non-
viral delivery system, more effective and efficient delivery of growth factor genes 
may be achieved and, as a result, enhanced bone regeneration realized.  
Each nanotechnology discussed in this review could provide significantly 
different improvement for bone regeneration including enhanced rigidity of bone 
substitute, biomimic architecture of implanted sites, and improved osteoinductive 
growth factor production. Future studies will consider the incorporation of each 
individual strategy to set up the integrated clinical platform. Furthermore, in vivo 
studies to verify effective gene delivery using each nanoparticle system, following 
growth factor secretion, and improved osteogenesis are essentially required to assure 
its clinical application. Nanoparticle technology conjugated with tissue engineering 




Chapter 4: The Effect of Initial Cell Seeding Density on Early 
Osteogenic Signal Expression of Rat Bone Marrow Stromal 




Functional engineering of natural bone tissues involves three fundamental 
components: (1) parenchymal or progenitor cells which enable lineage-specific 
differentiation and subsequently express tissue matrix, (2) scaffolds as temporary 
frameworks to support bone growth, and (3) osteogenic signals such as growth factors 
to induce bone-forming cell regeneration.  The successful conjugation of these 
principal components is the most critical and challenging problem to develop 
functional bone replacements. 
As a cell source in the tissue engineering field, bone marrow stromal cells 
(BMSCs) have been extensively investigated since this heterogeneous cell source 
contains mesenchymal stem cells.  These progenitor cells have distinctive 
characteristics that allow them to be (1) expanded cell numbers by replication in vitro 
and (2) differentiated into a variety of cell types such as osteoblasts, chondrocytes, 
and adipocytes [174, 227-229].  Since these differentiated cell types can be developed 
into various tissues and organs, including bone, cartilage, adipose, tendon and 
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and regenerative strategy in tissue engineering research [15, 230, 231].  Therefore,  
BMSC-seeded polymeric scaffolds have been widely utilized to create successful in 
vitro models for bone tissue repair.   
As a potential scaffold material, poly(propylene fumarate) (PPF) is known to 
be injectable, in situ polymerizable, and a biocompatible linear polyester [232].  This 
polymer contains carbon-carbon double bonds that allow constructs of cross-linked 
networks, and ester linkages that allow for hydrolytic degradation [233].  PPF 
degradation products, including propylene glycol, poly(acrylic acid-co-fumaric acid), 
and fumaric acid, do not shift pH to a level that is hazardous to natural tissues, and 
can be metabolized as a constituent of the Krebs cycle [233].  PPF can be crosslinked 
by ultraviolet (UV) radiation with the aid of a photoinitiator such as bis(2,4,6-
trimethylbenzoyl) phenylphosphine oxide [234].  PPF also possesses sufficient 
mechanical strength for use as a bone substitute at load bearing sites [235].  A series 
of studies have revealed that PPF is a promising biomaterial for bone tissue 
engineering.  It has been used for fabrication of composite materials [77, 163, 236-
238], rapid prototyping using laser-stereolithography to create controllable 
microarchitecture for patient-specific bone implants [102, 239, 240], and growth 
factor delivery vehicles [241, 242]. 
Lineage-specific differentiation of BMSCs on polymeric scaffolds is 
correlated with the activation of inductive signaling molecules such as various 
cytokines, hormones, and growth factors.  In order to establish the optimal fabrication 
parameters necessary for successful bone tissue engineering scaffolds, we propose 




transplanted cell population.  Our overall hypothesis is that the proper 
microenvironment could facilitate osteogenic signals among a transplanted cell 
population, and paracrine cell-to-cell distance is one of the critical parameter which is 
determined by initial cell seeding density. 
The artificial microenvironment of a cell population seeded on a synthesized 
polymeric material may facilitate osteogenic signals. A strong understanding of these 
signaling profiles may be critical to the successful development of a functional 
cell/scaffold construct.  There have been several recent studies to investigate the 
effect of cell seeding density on cellular activities. Rat bone marrow stromal cells 
(BMSCs) on three dimensional (3D) poly(DL-lactic-co-glycolic acid) scaffolds 
showed rapid proliferation at a lower seeding density over the first 7 days, but no 
changes in osteoblastic functions such as alkaline phosphatase (ALP) activity and 
mineralization after 56 days in culture [243].  However, increasing the seeding 
density of rat BMSCs in titanium fiber mesh had a positive effect on osteogenic 
expression [244] and a higher seeding density on polystyrene well plate led to higher 
ALP activity and more mineralization [245].  In addition, an optimal seeding density 
was determined to best promote intracellular signals, such as Runx2, in MG-63 cells 
cultured within dense 3D collagen gels [246].  Similarly, a recent study also 
demonstrated the existence of the minimum and optimum cell seeding density in 3D 
hydroxyapatite/tricalcium phosphate (TCP) scaffolds for bone yield (i.e., bone contact 
and bone area) in a goat in vivo model [247].  However, another study reporting a 
contrary result, found that a lower seeding density of human alveolar osteoblasts on 




(OC) secretion [248].  Despite of the fact that there have been many studies about the 
effect of adding growth factors (i.e., exogenous signals) on the osteogenic 
differentiation of BMSCs [6, 249-251], changes in endogenous gene expression of 
signaling growth factors caused by altering the intercellular paracrine communication 
distance have not been extensively studied.  Therefore, the objectives of the present 
study were to determine the effect of initial seeding density of rat BMSCs onto two 
dimensional (2D) PPF disks on cell viability, proliferation, and differentiation, as well 
as to describe the effect of cell seeding density on osteogenic signal expression 
profiles.  Most critically, this study demonstrates for the first time that the expression 
profiles of endogenous osteogenic growth factors can be controlled by the initial cell 
seeding density on PPF disks. 
 
4.2. Experimental Section 
4.2.1. Materials 
Diethyl fumarate, propylene glycol, zinc chloride, hydroquinone, ascorbic 
acid, β-mercaptoethanol, and Alizarin Red S were obtained from Sigma-Aldrich (St. 
Louis, MO). Analytical reagent grade methylene chloride was purchased from Fisher 
Scientific (Pittsburgh, PA).  Polystyrene standards were received from Polymer 
Laboratories (Amherst, MA).  Bis(2,4,6-trimethylbenzoyl) phenylphosphine oxide 
(BAPO) was obtained from Ciba Specialty Chemicals (Tarrytown, NY).  Alpha-
minimum essential medium (α-MEM), penicillin/streptomycin antibiotics, fetal 
bovine serum (FBS), and trypsin/EDTA were purchased from Invitrogen (Carlsbad, 




purchased from Roche (Indianapolis, IN).  RNeasy Mini plus kit was received from 
Qiagen (Valencia, CA).  High Capacity cDNA Archive kit, Universal PCR Master 
mix (2x), and Taqman® Gene Expression Assay for growth factors and osteogenic 
differentiation marker were purchased from Applied Biosystems (Foster City, CA).  
 
4.2.2. PPF Synthesis and PPF Disk Fabrication  
PPF was synthesized with diethyl fumarate and propylene glycol following a 
two step procedure [232, 234].  Briefly, 1 mol of diethyl fumarate and 3 mol of 
propylene glycol were reacted with 0.01 mol of zinc chloride as a catalyst and 0.002 
mol of hydroquinone as a crosslinking inhibitor with nitrogen gas purge, heat supply, 
and mechanical stirring.  The resulting diester intermediate, bis(2-hydroxypropyl) 
fumarate, underwent transesterification with vacuum, heat supply, and mechanical 
stirring until the desired molecular weight was obtained.  The final PPF polymer was 
dissolved in methylene chloride for further purification.  The PPF/solvent mixture 
was purified during serial washing steps with 5 v/v% HCl solution, water, and brine.  
Residual methylene chloride was evaporated using a rotor-evaporator and vacuum 
pump.  Then, hydroquinone was removed by ethyl-ether precipitation on ice, and 
excess ethyl ether was completely evaporated again using a rotor-evaporator and 
vacuum pump.  Gel permeation chromatography (GPC) was used to measure the 
molecular weight and polydispersity index (PDI) of purified PPF.  Polystyrene 
standards with a peak molecular weight of 580, 1180, 2360, and 4490 g mol-1 were 
used to create a calibration curve.  The resulting number average molecular weight 




the photoinitiator BAPO was employed (0.5 g BAPO/ g PPF) for photocrosslinked 
disk fabrication.  A homogeneous 1.5 mm thick PPF/BAPO mixture was placed 
between the glass plates.  After 2 hr of ultraviolet (UV) radiation exposure (intensity 
of 2.68 mW/cm2), a crosslinked sheet of PPF was retrieved and cut into disks that 
were 18 mm in diameter and 1.5 mm thick. 
 
4.2.3. Rat Bone Marrow Stromal Cell Isolation and Culture 
Rat BMSCs were isolated from femora and tibiae of young male Wistar 
Hanover rats (101-125g, Taconic, Hudson, NY) following a University of Maryland 
approved IACUC animal protocol (R-07-94).  Following euthanasia by carbon 
dioxide gas, the femora and tibiae were excised and all soft tissues were removed.  
The explanted bones were incubated in 10 ml of cell culture medium for 10 min three 
times.  The culture medium contained α-MEM supplemented with 10 % (v/v) 
penicillin/streptomycin antibiotics, 10 % (v/v) FBS, 0.2 mM of ascorbic acid.  Both 
ends of each bone were clipped off and bone marrow was flushed out with 10 ml of 
culture media using a syringe and 18-gauge needle under sterile conditions.  The 
collected marrow was homogenized by mixing with a syringe, passed through a 70 
µm cell strainer, and centrifuged at 500 g for 5 min.  The resulting cell pellets were 
resuspended with 5 ml of culture media and plated in T-25 cell culture flasks.  The 
media was first changed to remove non-adherent cells after 48 hrs, and changed every 
2-3 days over the course of each subculture periods.  When 80 % confluency of the 
cells was reached, cells were enzymatically lifted using trypsin/EDTA.  The cells 




cell seeding.  All flasks were incubated under standard cell culture conditions (37°C 
and 5% CO2 gas). 
 
4.2.4. Cell Seeding 
The PPF disks were prewashed before cell seeding in the following manner:  
All disks were soaked first in phosphate buffered saline (PBS) for 15 min to eliminate 
surface debris, second in acetone for 3 min to remove any unreacted monomers, and, 
third in PBS again for 30 min.  After these washing steps, the samples were sterilized 
with UV radiation in a biosafety laminar flow hood overnight. Each disk was placed 
in a 12 well tissue culture polystyrene (TCPS) plate.  Next, autoclaved stainless steel 
rings (outer diameter: 19 mm, inner diameter: 16 mm, height: 15mm) were placed 
onto each disk to confine the cell seeding area, to prevent the disk from floating, and 
to inhibit the loss of cells at the periphery between the disk and the well.  Second 
passage rat BMSCs were trypsinized from culture flasks and the total cell number 
was counted using a hemacytometer to calculate the required volume of media for 
resuspension.  After centrifugation, the cell pellet was resuspended with osteogenic 
media (control media supplemented with 10 mM Na-β-glycerophosphate and 10-8 M 
dexamethasone) to create a series of cell density (0.06, 0.15, 0.30 million cells/200 µl 
suspension).  All of the experimental groups are listed in Table 9.  Next, 200 µl of 
suspension was dropped onto the center of the PPF disks in the stainless steel ring, 
and 1800 µl of osteogenic media was added to the outer region between the ring and 
the well (Day 0).  The same volume of cell suspension with 0.06 and 0.30 million 




sample.  The cell/disk constructs were incubated for 24 hrs to allow complete cell-
attachment.  The steel rings were removed and the osteogenic media was changed 
every 2-3 days during the experimental time periods.  All the assays except the cell 








PPF Min 60,000 cells on PPF disk 30,000 
PPF Med 150,000 cells on PPF disk 75,000 
PPF Max 300,000 cells on PPF disk 149,000 
TCPS Min 60,000 cells per well of tissue culture polystyrene 12 well plate 30,000 




Table 9: Experimental and Control Groups 
 
4.2.5. Cell Viability 
Cell viability was examined using a Live/Dead viability/cytotoxicity assay kit 
to evaluate the initial cell attachment to PPF disks and the viability at day 1 and 8.  
Osteogenic media was removed from the well and the cell/disk constructs were rinsed 
with PBS two times to remove unattached cells.  Each construct was labeled with 700 
µl of calcein AM (2 µM) and ethidium homodimer-1 (4 µM) fluorescent dye/PBS 
solution per well.  After 30 min incubation at room temperature, images were taken to 
observe the cell attachment, localization, and viability over the culture periods under 
a fluorescence microscope (Axiovert 40 CFL with filter set 23, Zeiss, Göttingen, 
Germany) equipped with a digital camera (Diagnostic instruments 11.2 Color Mosaic, 




4.2.6. DNA Quantification 
To assess cellular proliferation, DNA was isolated and the double-strand DNA 
amount was quantified using a PicoGreen assay kit.  After removing the culture 
media from the well, the cell/disk constructs were washed with PBS two times.  Cell 
layers on the disks were lifted with 600 µl of trypsin/EDTA, and 600 µl of 
collagenase-P was added to disrupt the extracellular collagen matrix.  After 
transferring 1200 µl of cell suspension to a new sterile tube, each disk was rinsed with 
600 µl of culture media and then transferred to the same tube.  Calcein AM staining, 
and specifically the lack of any stain, was utilized to confirm that all cells had been 
removed from the disk.  A 1,800 µl suspension was centrifuged down (1,000 g, 5 
min) to form a cell pellet.  After aspirating the supernatant, 1 ml of autoclaved 
distilled water was placed in each tube and the pellet was homogeneously 
resuspended. DNA was extracted from the suspension by 3 cycles of freeze (30 min 
at -80°C), thaw (30 min at 37°C), and sonication in a bath sonicator (30min).  After 
cell-lysis, the cell debris was pelleted by centrifugation at 12,000 g for 10 min and 
900 µl of supernatant was transferred to a new sterile tube.  Next, 100 µl of 
supernatant containing DNA was mixed with 100 µl of diluted PicoGreen fluorescent 
dye in a 96 well plate.  The samples in the well plate were incubated for 10 min at 
room temperature.  Fluorescent intensity was recorded at 490 nm of excitation and 
520 nm of emission using a M5 SpectraMax microplate reader (Molecular Devices, 
Sunnyvale, CA).  The final double strand DNA amount was calculated based on an λ-





4.2.7. RNA Extraction 
Total RNA was isolated from each cell/disk construct with a RNeasy Mini 
plus kit following the protocol provided by the manufacturer.  First, cells were lifted 
and collected in the same manner described above.  Once the cell pellet was obtained, 
350 µl of RLT lysis buffer with 3.5 µl of β-mercaptoethanol was added.  Cells were 
homogenized by mixing within a 1 ml syringe using a 22 gauge needle.  Genomic 
DNA was removed by passing the lysate through a genomic DNA elimination 
membrane column.  After several washings in a spin column, total RNA was captured 
by a RNeasy mini-column membrane and eluted with 33 µl of Rnase-free water.  
RNA concentration and purity were assessed using Nanodrop UV/Vis 
spectrophotometry (Nanodrop Technologies, Wilmington, DE) with absorbance at 
260 and 280 nm. 
 
4.2.8. Quantitative Reverse Transcription Polymerase Chain Reaction (qRT-PCR) 
Isolated total RNA was reverse transcribed to complementary DNA (cDNA) 
using the High Capacity cDNA Archive kit.  The cDNA sample was subsequently 
mixed with Universal PCR Master mix (2x) and Taqman® Gene Expression Assays.  
Four target growth factor genes including bone morphogenic protein-2 (BMP-2, 
Taqman Assay ID: Rn00567818_m1), transforming growth factor-β1 (TGF-β1, 
Rn00572010_m1), platelet-derived growth factor-A (PDGF-A, Rn00709363_m1), 
and fibroblast growth factor-1 (FGF-1, Rn00563362_m1), as well as two osteogenic 




(OC), were assessed for relative gene expression level profiles.  Pre-developed 18s 
ribosomal RNA was used as an endogenous control gene.  The oligonucleotide primer 
and Taqman probe sequences for OC were 5’ GGCTTCCAGGACGCCTACA 3’ 
(forward primer), 5’ GGGCAACACATGCCCTAAAC 3’ (reverse primer), and 5’ 
CGCATCTATGGCACCAC 3’ (probe).  Real time quantitative polymerase chain 
reaction (qRT-PCR) was performed on an ABI Prism 7000 sequence detector 
(Applied Biosystems).  The thermal conditions for the PCR were 2 min at 50°C, 10 
min at 95°C, and 50 cycles of 15 s at 95°C and 1 min at 60°C.  The relative gene 
expression level of genes of interest (fold change) was first normalized to the mean of 
18s control gene data in each group.  The TCPS Min group was chosen as a calibrator 
and fold change was calculated by ∆∆Ct method using the mean of the calibrator 
data.  Mean of fold changes compared to the calibrator group (The TCPS Min group) 
and standard deviations are reported (n=3). 
 
4.2.9. Mineralization Assay 
Calcium mineralization was first qualitatively measured by Alizarin Red S 
staining and light microscopic images.  Generally, Alizarin Red S stains calcium 
deposition orange-red and indicates mineralization of tissues or cells.  At day 8, the 
cell layer on the PPF disk was washed with PBS two times and fixed with 4% 
paraformaldehyde for 10 min at 4 °C.  The fixed cells were stained with 700 µl of 0.5 
% Alizarin Red S/PBS solution (pH 4.2) for 10 min at room temperature, washed 
with PBS 5 times, and observed under an inverted light microscope to verify the 




taken from three different spots on each construct (i.e., one in the center and two at 
the corners, which were 5.66 mm away from the center along a diagonal axis) to 
quantitatively assess the images.  A total of 9 images were obtained from each PPF 
group (six from the TCPS group). Each image (1.5 × 1.1 mm2 dimension at a 
resolution of 1600 ×1200 pixels) was exported to the ImageJ program.  After the 
subtraction of the background image, all images were converted to black and white 
binary images.  The total black area was automatically calculated.  The result was 
normalized with the DNA amount and presented as total mineralized area per DNA 
amount.  
 
4.2.10. Statistical Analysis 
In order to demonstrate the reproducibility of the data, all experimental groups 
were analyzed with biological triplicates, and all control groups were analyzed with 
biological duplicates.  In addition, all measurements were collected in triplicate 
(technical triplicates).  The data from all experiments were analyzed by one-way 
analysis of variance (ANOVA) and Tukey’s multiple-comparison test was performed 
to verify the statistical difference between the experimental groups with 95% 







4.3.1. Attachment, Viability, and Differentiation of Rat BMSCs 
The initial cell attachment, cell distribution, and viability of the rat BMSCs 
over 8 days were demonstrated by Live/Dead fluorescent staining (Figure 4).  
Compared to the TCPS positive control, rat BMSCs showed the same initial 
attachment pattern and distribution throughout the seeding area (Figure 4A).  Cells 
were spread and exhibited cuboidal morphological changes (Figure 4B); few non-
viable cells were found in any of the experimental groups at any time points.  It was 
qualitatively demonstrated that as the culture period (i.e., 8 days) progressed, the cells 
proliferated to cover more surface area of the PPF disks, eventually initiating direct 
contact between adjacent cells.  In addition, rat BMSCs were viable for 8 days in all 
density groups, implying that the PPF biomaterial provided a suitable 2D substrate. 
 
As measured by DNA content, rat BMSCs proliferated on the surface of PPF 
disks over the 8 day period in all cell density groups (Figure 5).  Except for the PPF 
Max group, all groups on days 4 and 8 contained a significantly higher DNA amount 
than at previous time points.  The rate of proliferation in the PPF Min group was 
highest among the three different density groups, and this observation was in 
agreement with the qualitative fluorescent images in Figure 4.  On the other hand, the  
PPF Max group displayed minimal proliferation during the first 4 days of culture.  
These results demonstrated that the lower cell seeding density stimulated more rapid 








































Figure 4:  Qualitative Live/Dead fluorescent staining images with a 2.5x 
magnification in (A) and 10x magnification in (B) of PPF disks and TCPS well plates 
(positive control). The result demonstrated that rat BMSCs are viable over an 8 day 
culture period in all experimental groups. The fluorescent images also qualitatively 
demonstrated a similar attachment pattern and viability of rat BMSCs on PPF disks 
compared with the control groups. The scale bar shown in 1A represents 2000 µm and 






Figure 5:  The quantitative DNA amount represents levels of cellular proliferation on 
the 2D PPF disks and TCPS groups over the course of 8 days (n=3 per group). The 
DNA amount per experimental group is shown in µg per disk and as average ± 
standard deviation. ☆ indicates a statistical difference compared to data on day 1 
while † indicates a statistical difference compared to data on day 4 in each 
experimental group (p<0.05). 
 
 
ALP mRNA expression (Figure 6) in the PPF groups showed no significant 
differences on either day 1 or day 4.  ALP expression in the TCPS groups peaked on 
day 4 and was downregulated on day 8.  The lower cell seeding density group (TCPS 
Min) exhibited higher ALP expression than the higher cell seeding density group 
(TCPS Max) on day 4.  On day 8, the PPF Med group showed statistically higher 
ALP expression than the Min or Max PPF groups (p=1.75 ⅹ10-10).  This ALP mRNA 
expression pattern at the last time point of day 8 was recorded in all four growth 
factors.  PPF Min and PPF Med groups showed an increase from the initial level of 


































Figure 6: Quantitative RT-PCR analysis of gene expression profiles of ALP 
osteogenic differentiation markers for 1, 4, and 8 days. The fold changes in gene 
expression level are reported as average ± standard deviation (n=3) and the calibrator 




Figure 7: Quantitative RT-PCR analysis of gene expression profiles of OC 
osteogenic differentiation markers for 1, 4, and 8 days. The fold changes in gene 
expression level are reported as average ± standard deviation (n=3) and the calibrator 

















































expression of PPF Max peaked on day 4 and was more than one-fourth down-
regulated on day 8.  In Figure 7, all three PPF density groups had similarly low levels 
of OC expression on day 1.  By day 4, the PPF Max group exhibited a higher 
expression level than all of the other groups.  On day 8, there was no significant 
difference in OC expression between different cell densities on PPF, while TCPS 
Max showed higher OC expression than TCPS Min and all three PPF groups.  All 
three PPF groups showed an initially constant level of OC expression level that 
increased when next observed on day 8 (i.e., approximately a two-fold increase 
compared with day 1).  This trend was also observed for the two TCPS groups, where 
the OC expression level in the TCPS Max group on day 8 was more than nine times 
that of day 1. 
 
Calcium deposition was assessed by (1) qualitative microscopic images of 
Alizarin Red S stained specimens, and (2) subsequent quantitative image analysis 
(Figure 8).  The images of stained calcium deposition indicate that all density groups 
cultured in osteogenic-supplemented media for 8 days demonstrated mineralization, 
with higher cell density groups of both the PPF and TCPS substrates showing more 
extensive mineralization (Figure 8A).  Data in Figure 8B confirmed the qualitative 
assessment of the images shown in Figure 8A by showing that the PPF Med and Max 
groups had significantly larger mineralized areas than were seen in the PPF Min 
group specimens.  Similarly, TCPS Max was found to have a significantly larger area 
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Figure 8:  Mineralization assay by Alizarin Red S staining at Day 8. (A) Qualitative 
light microscopy images of calcium deposits in rat BMSCs. The scale bar represents 
300 µm and applies to all images. (B) Normalized calcium deposition. ☆ indicates a 

















































4.3.2. Osteogenic Signal Expression 
The BMP-2 expression of the PPF Min and Med groups were statistically 
higher than both the PPF Max and TCPS groups on day 1 (p = 1.60ⅹ10-7).  The PPF 
Min and Med groups showed a 4-fold downregulation in BMP-2 expression from day 
1 to day 4 (Figure 9A).  On day 8, the BMP-2 results demonstrated that both the PPF 
Min and Med groups exhibited significantly higher BMP-2 expression than did the 
PPF Max samples (p = 1.60ⅹ10-5), a result that was similar to what was seen on day 
1.  BMP-2 expression by rat BMSCs on PPF disks was seen to decrease between days 
1 and 4 and then, except for PPF Max, to increase by day 8.  Consistent BMP-2 
expression over 8 days was observed in All TCPS groups. 
Figure 9B represents rat BMSC expression of FGF-2.  The PPF Max group 
exhibited a statistically higher level of FGF-2 expression on day 4 versus the PPF 
Min and Med groups (p = 3.46ⅹ10-4).  The TCPS Min group showed a higher level of 
FGF-2 expression than all of the other groups at the day 1 and 4 time points.  On day 
8, all three PPF groups exhibited higher FGF-2 levels of expression than both TCPS 
groups.  The levels of FGF-2 expression in the PPF Med group were higher than that 








































































Figure 9: Quantitative RT-PCR analysis of gene expression profiles of growth factors 
(A: BMP-2, B: FGF-2, C: TFG- β1, and D: PDGF-A) for 1, 4, and 8 days. The fold 
changes in gene expression level are reported as average ± standard deviation (n=3) 




























































TGF-β1 expression exhibited a similar pattern to PDGF-A (Figures 9C and 
9D).  The expression of both TGF-β1 and PDGF-A in both TCPS groups peaked on 
day 4, followed by a more than one-fifth fold decrease between day 4 and day 8.  The 
PPF Med and PPF Max groups showed higher TGF-β1 expression on day 1 than the 
PPF Min group, while the PPF Max group showed higher TGF- β1 expression than 
the other two PPF groups on day 4.  The PPF Med group had significantly higher 
TGF-β1 expression than all other groups on day 8 (p= 3.85ⅹ10-9).  Overall, rat 
BMSCs on PPF disks showed decreasing TGF-β1 expression over 8 days, with a 
lower expression level than the TCPS groups by day 4.  The data in Figure 9D 
indicates that the PDGF-A levels presented an expression profile similar to the TGF-
β1 expression profile.  While the TCPS Min group exhibited a higher PDGF-A 
expression level than the TCPS Max group at all time points, both the PPF Min and 
PPF Med groups showed significantly higher levels of expression than the PPF Max 
group on day 1 only (p=1.03ⅹ10-3).  By day 4, there was no significant difference in 
PDGF-A expression between all three PPF groups, but the PPF Med group showed a 
higher level of PDGF-A expression on day 8 than the other two PPF groups 
(p=3.99ⅹ10-6).  Sustained expression levels were observed in all three PPF groups 
over the 8 days; however PDGF-A expression levels of rat BMSCs on the TCPS 
substrate peaked on day 4 and then decreased on day 8. 
 
4.4. Discussion 
Intercellular signaling via endogenous signal molecules among a transplanted 




surrounding environment.  To mimic a natural bone healing environment, and to 
optimize the components for an engineered bone substitute, it is of particular 
importance to characterize the endogenous signaling profiles of that cell population.  
Cell seeding density, which can alter cell-cell distance, may be a critical parameter 
controlling subsequent cell proliferation and/or osteogenic signal expression due to 
changes in paracrine signaling distance among the cells.  Furthermore, to determine 
the optimum seeding density for a specific type of scaffold (i.e., material substrate 
and surface geometry), it is imperative to stimulate sustained expression of some 
signals and not others.  To this end, we aimed to investigate the effect of initial cell 
seeding density on the osteogenic gene expression of BMSCs on two dimensional 
crosslinked PPF disks.  Two objectives were addressed in this study: (1) the effect of 
cell density on rat BMSC viability, proliferation, and osteogenic differentiation and 
(2) the effect of cell density on signalling profiles of osteogenic growth factors. 
We first demonstrated the effect of cell seeding density on the attachment and 
viability of rat BMSCs (Figure 4).  Although it is not possible to conclude there is a 
direct correlation between cell seeding density and the quality of attachment (or cell 
viability) from Figure 4, the extent of cellular attachment depends on surface 
properties of the substrate material.  As cell attachment can be affected more by 
surface wettability and hydrophilicity rather than by surface topology [236], we 
observed that our PPF disk post-fabrication methods resulted in a suitable 
environment for the attachment of anchorage-dependent cells such as bone marrow 




Our next goal was to demonstrate the effect of cell seeding density on cell 
proliferation.  As shown in recent literature, cell proliferation is strongly regulated by 
(1) surface area to allow attachment and (2) contact-inhibition between adjacent cells 
[243, 246, 252].  Although a highly interconnected porous scaffold is recommended 
to mimic the native bone, there remains a problem of achieving sufficient seeding 
efficiency. Alternatively, over-loaded cell numbers may result in limiting nutrient 
transport, hypoxia of interior cells, and insufficient waste removal from the internal 
structures. Surface area dependence was also observed in our 2D study, as indicated 
by a proliferation rate that was lowest in the PPF Max groups (Figure 5).  Distribution 
of rat BMSCs on PPF disks in Figure 1 indicates that lower cell seeding density 
resulted in a rapid proliferation rate over 8 days.  Despite of the fact that high 
cellularity enhances cell-cell contact, contact-inhibition by gap junctional intercellular 
communication may suppress cell proliferation [253, 254].  As seen in a previously 
reported study [252], Figure 5 indicates that contact inhibition reduces cellular 
proliferation.  As a result, we observed that 0.30 million cells per 18 mm diameter 
PPF disk was sufficient to induce contact inhibition and reduce rat BMSC 
proliferation rate. 
Next, the effect of cell seeding density on the osteogenic differentiation of rat 
BMSCs was investigated.  As a transient early osteogenic differentiation marker, 
ALP mRNA expression was measured (Figure 6).  These data indicate that the PPF 
Med group exhibited statistically higher ALP expression on day 8 (p = 1.75ⅹ10-10) 
and that the PPF Max group showed the lowest expression level.  It is known that 




expression level in all groups peaked or started to plateau in the middle of the culture 
period, on day 4, it could be concluded that lower cell density induced early 
osteogenic differentiation of rat BMSCs after only 8 days.  Therefore, it appears to be 
necessary to optimize rat BMSC cell density in order to stimulate the ALP expression 
on PPF disks.  
Mineralization occurs late during the transition from cellular to osteoid tissue, 
following a sequential cascade of cell proliferation, ALP expression, and osteoblast 
phenotypic commitment (i.e., maturation) [256].  As a late marker of osteoid 
commitment, OC mRNA expression was assessed and calcium deposition was also 
measured (Figures 7 and 8).  OC expression was seen to increase over 8 days and the 
PPF groups with higher seeding density (i.e., PPF Med and PPF Max) exhibited 
higher levels of OC expression; OC expression increased significantly in the TCPS 
Max also by day 8. OC expression, as seen in Figure 7, was consistent with the 
calcium deposition profile in Figure 8.  Thus, the groups with higher cell seeding 
density presented higher levels of mineralization. Therefore, it would seem that late 
stage osteogenic differentiation was enhanced by higher cell seeding density, while 
cell proliferation and early osteogenic differentiation were stimulated by lower cell 
seeding density.  
Our results indicate that three distinct periods in osteoblastic phenotype 
development may be sensitive to implant cell seeding density.  According to the study 
by Lian and Stein [257], the first period of osteogenic progenitor cell growth exhibits 
strong proliferation with the formation of extracellular matrix.  The second period 




expression, a sequence of events also seen in our study.  At these two stages, lower 
cell seeding density might enhance cellular proliferation and ALP expression due to 
reduced contact inhibition.  In contrast, higher cell seeding density may stimulate 
mineralization, as is expected during the last period of osteoblast formation, along 
with downregulation of ALP activity and synthesis of osteopontin and bone 
proteoglycans such as decorin and biglycan.  As described earlier, the rat BMSCs 
temporal growth pattern observed in this study agreed well with the expected cascade 
of bone formation events.  Our observation also suggests that it may be possible to 
use cell seeding density to promote osteogenic differentiation in a 2D environment.  
However, optimization of cell seeding density needs to be tested in a 3D scaffold in 
order to confirm our hypothesis of the consistency between 2D and 3D 
microenvironments and the possibility of promoting the healing of bone wounds 
through the use of a tissue engineered implant. 
Finally, qRT-PCR was performed to investigate the gene expression profile of 
endogenous growth factors relevant to bone formation, including BMP-2, FGF-2, 
TGF- β1, and PDGF-A1.  Natural bone matrix contains a number of growth factors 
and these growth factors play a critical role in proliferation, differentiation, and other 
cellular activities that are associated with these signaling molecules [194].  BMP-2 is 
one of the most investigated signaling molecules in the field of bone biology due to 
the following hypothesized roles: (1) regulation of cell growth, differentiation, 
apoptosis, and organ development, and (2) induction of osteoprogenitor cells found in 
bone fracture sites that are healing [192].  As shown in Figure 9, the two lower 




group on day 1 (p = 1.60ⅹ10-7). The general trend of BMP-2 expression level over 
culture periods showed a decline on day 4 and then increased again by day 8.  This 
expression pattern is the opposite of the ALP mRNA expression profile (i.e., peaked 
on day 4 and downregulated again by day 8), and this may be due to the opposing 
signal transduction for BMP-2 and ALP during early osteogenic differentiation.  
BMP-2 is thought to induce ALP production through Wnt expression and the 
Wnt/LRP5 signaling cascade [258].  Early expression of BMP-2 on day 1 might result 
in a BMP-2-rich extracellular environment.  Subsequently, perhaps through the Wnt 
autocrine loop, ALP expression was observed to be downregulated by day 4 in our 
study.  This expression profile can be found in other studies with 3D titanium 
scaffolds seeded with rat BMSCs [259] and 3D coralline hydroxyapatite scaffolds 
seeded with human mesenchymal stem cells (hMSC-TERT4) [255].  Interestingly, the 
PPF Med group showed higher expression of BMP-2 than the other two PPF groups 
on day 8, indicating that cell seeding density might be useful as a means to alter or 
optimize the BMP-2 expression of rat BMSCs. 
It has been suggested that FGF-2 is associated with (1) regulation of skeletal 
growth and development including the balance between bone forming cells and bone 
resorbing cells, and (2) stimulation of osteoblasts by activating the Cbfa-1/Runx2 
transcription factor [18, 260].  FGF-2 expression in Figure 9B was initially sustained 
on the PPF disks by day 4, but increased at day 8, showing significantly higher 
expression levels than in the TCPS groups.  An increasing trend of FGF-2 expression 
at later time points may be due to Runx2-mediated signal transduction.  FGF-2 




protein kinase (MAPK) pathway, but Runx2 upregulation can also be induced by 
BMP-2 or TGF- β1 stimulation via Smad and the MAPK intracellular signaling 
pathway [18, 261].  We also speculate that an early decline of BMP-2 expression may 
deactivate Runx2, and subsequently enhance FGF-2 expression in order to restore 
Runx2 activation via the MAPK pathway. 
This hypothesis about the intracellular signaling pattern that is associated with 
growth factor signaling found during bone formation may also be applied to TGF- β1 
expression in Figure 9C.  The decease in TGF- β1 expression over time was similar to 
the BMP-2 expression profile, and it may also contribute to Runx2 deactivation and 
subsequent FGF-2 expression.  This is consistent with the PPF Med groups on day 8 
that presented statistically higher FGF-2 (p = 3.35ⅹ10-8) and TGF- β1 (p = 3.85ⅹ10-9) 
expression levels.  This result may suggest that over a period of 8 days rat BMSC 
cultures on PPF disks require an optimized cell density of approximately 75,000 cells 
per cm2 (0.15 million cells/disk) to induce an optimal FGF-2 and TGF- β1 expression 
profile that is compatible with bone formation.  This may also suggest that there is an 
optimal cell seeding density for 3D scaffolds that is necessary to induce and/or 
promote the osteogenic differentiation and bone healing cascade.   
Finally, it is also been observed that PDGF-A may stimulate DNA synthesis 
during in vitro bone formation [262].  In the present study, sustained PDGF-A mRNA 
expression was not correlated with DNA content (Figures 5 and 9D).  However, the 
difference of PDGF-A expression patterns over 8 days between the PPF and TCPS 






The optimum level of bone progenitor cell seeding density for many different 
implant engraftment strategies is a critical issue for the clinical application of bone 
tissue engineering.  The present study indicates that varying cell seeding density on 
PPF disks may be utilized to enhance the proliferation and differentiation of rat 
BMSCs.  This study demonstrated (1) the effect of cell seeding density on viability, 
proliferation, and differentiation of rat BMSCs, and (2) the endogenous growth factor 
mRNA expression profiles of rat BMSCs on 2D PPF disks.  The results of this study 
revealed that: (1) cell proliferation rate and early osteogenic differentiation were 
stimulated by a lower cell seeding density, (2) later differentiation, as indicated by 
mineralization, was enhanced by increasing cell seeding density, and (3) the temporal 





Chapter 5: Osteogenic Signal Expression of Rat Bone Marrow 
Stromal Cells is Influenced by Both Hydroxyapatite 
Nanoparticle Content and Initial Cell Seeding Density in 
Biodegradable Nanocomposite Scaffolds 
 
5.1. Introduction 
Calcium phosphate bioceramics, such as hydroxyapatite (HA) and tricalcium 
phosphate (TCP), are promising materials for bone tissue engineered composites due 
to their mineral composition reflecting native bone tissue both chemically and 
structurally, with the latter being in regards to their nano-scale features.  HA 
especially is known to posses biocompatibility and osteoconductivity as well as to 
enhance the functionality of composite materials when combined with biodegradable 
polymer matrices.  However, 3D scaffolds fabricated with only HA or other ceramic 
materials often exhibit brittleness, difficult manufacturing, and slow degradation 
rates. Therefore, incorporation of HA within a degradable polymeric network may 
provide a more favorable synthetic microenvironment to more closely mimicking 
natural tissue physiology with the additional properties of a higher mechanical 
strength.  Since fabrication of HA/biopolymer composites could take advantages of 
the properties of both the components, there have been many studies utilizing the 
incorporation of HA with various synthetic polymers including poly(D,L-lactic acid-
co-glycolic acid) (PLGA) [263-265], poly(L-lactic acid) (PLLA) [266], 
poly(propylene fumarate) (PPF) [236, 267], poly(caprolactone) (PCL) [268], a 




Nanoscale features of HA particles exhibit more advantageous cellular 
responses when compared to microsized HA particles.  For example, HA 
nanoparticles coated on glasses demonstrated higher MG-63 cell attachment and 
proliferation than microsized HA particles due to higher surface area for cell adhesion 
and lower crystalinity [272].  Similarly, HA nanoparticles embedded in 3D PCL 
scaffolds have shown enhanced levels of attachment, proliferation, alkaline 
phosphatase activity, and calcium deposition (i.e., mineralization) of mesenchymal 
stem cells (MSC) [268].  Therefore, the size of HA particles can affect cell response, 
particularly attachment, proliferation, and maturation.  If nanocomposite materials 
produced favorable conditions for tissue formation, they could be a candidate material 
to improve the surface properties of bone tissue substitutes. 
Poly(propylene fumarate) (PPF) offers a variety of advantageous properties as 
a bone substitute material including degradability in physiological environments and 
suitable mechanical strength.  Crosslinked PPF networks can be fabricated via 
ultraviolet (UV) radiation with the aid of a photoinitiator such as bis(2,4,6-
trimethylbenzoyl) phenylphosphine oxide (BAPO) [273].  This photoinitiation 
technique for crosslinking allows PPF to be used as a resin material for 
stereolithography, other additive manufacturing strategies, or even as a translucent 
mold [102, 104, 105].  PPF composite scaffolds incorporating nanosized materials 
such as alumoxane [163, 274-276], carbon nanotubes [159], and β-TCP [8, 277] have 
exhibited improved mechanical properties, enhanced cell attachment, and increased 
osteoconductivity in an in vivo model.  Moreover, PPF/HA composite materials have 




observed to improve MC3TC cell proliferation on 2D PPF composite disks over a 7 
day period of in vitro culture [236].  In an in vivo study using rat tibia metaphysic 
implantation, 3D composite scaffolds with PPF and HA particles with 40 nm in 
diameter showed a faster rate of new bone formation in tibial defect sites than 
PPF/microsized HA scaffolds, resulting in superior osseointegration [267].  However, 
the effect of HA addition to PPF on the endogenous gene expression of a seeded cell 
population at the molecular level has not previously been investigated, and is the 
subject of this study.  
Heterogeneous bone marrow stromal cell (BMSC) populations may contain 
mesenchymal stem cells.  Lineage specific differentiation of BMSCs on synthetic 
scaffolds depends upon effective induction of particular signal molecules such as 
growth factors, hormones, and cytokines, associated with the desired lineage.  One of 
the crucial factors facilitating osteogenic signal expressions may be cell-to-cell 
distance, which potentially alters paracrine signaling mechanisms.  Another factor 
may be scaffold construction parameters such as 3D geometry or surface properties.  
In our previous study, the initial cell seeding density of 2D PPF disks was found to be 
a factor contributing to the enhancement of requisite osteogenic signal expression of 
implanted heterogeneous cell populations [273].  In addition to the surface 
modification of 3D PPF scaffolds through the addition of HA nanoparticles, changing 
the cell-cell signaling distance by varying the cell seeding density may similarly 
affect the cellular responses within 3D porous environments.  There have been many 
studies describing the effects of cell seeding density on osteolastic differentiation in 




environment may enhance this response and thus promote tissue regeneration [246, 
278-280]. 
 
Moreover, controlling construction parameters to optimize engineered bone 
substitutes could affect various cellular functions such as attachment, migration, 
proliferation and differentiation.  In order to achieve the optimized properties of 3D 
scaffolds inducing host cell integration, we fabricated 3D macroporous composite 
scaffolds with PPF/HA nanoparticles by porogen leaching techniques and a 
photocrosslinking reaction.  Using these scaffolds, we investigated how both the 
surface properties altered by HA nanoparticle incorporation and the intercellular 
signaling distance changed in relation to cell seeding density.  The global hypothesis 
in this study is that the modification of 3D composite scaffold microenvironment of 
may facilitate enhanced osteogenic signaling among the implanted cell population, 
where both incorporation of HA nanoparticles and alteration of paracrine cell-cell 
signaling distance could be controlling parameters.  The specific objectives of this 
study were: (1) to fabricate and characterize the physical properties of the 3D 
macroporous PPF/HA scaffolds, (2) to investigate the effects of HA content and 
initial cell seeding densities on osteoblastic differentiation of rat BMSCs, and (3) to 
determine whether endogenous osteogenic growth factor gene expression profiles 





5.2. Materials and Methods 
5.2.1. PPF/HA composite scaffold fabrication 
PPF was synthesized as described previously [234, 273].  PPF with number 
average molecular weight (Mn) of 1300 g/mol and PDI of 3.7 was used throughout 
this study.  Purified PPF was heated to reduce the viscosity and first mixed with 0.5 
wt% of BAPO (Ciba Specialty Chemicals Corp., Tarrytown, NY).  For composite 
disk and scaffold fabrication, HA nanoparticles (100 nm, Berkeley Advanced 
Biomaterials, Berkeley, CA) with the ratio of 0, 10, and 20% of PPF:HA were 
incorporated into the PPF/BAPO mixture.  For 2D solid disks, the PPF/BAPO/HA 
mixture without any porogen was uniformly placed between the glass plate and 
crosslinked in an ultraviolet (UV) light box (intensity of 2.68 mW/cm2) for 2 hrs.  
Crosslinked composite sheets were cut into the disks with 18 mm in diameter and 1.5 
mm thickness.  For 3D macroporous scaffolds, the PPF/BAPO mixture was 
homogeneously mixed with a NaCl porogen (180 - 300 µm, 75 wt %) and HA 
nanoparticles, respectively.  The total mixture was then packed into a glass mold.  
After 2 hr of UV radiation, the crosslinked PPF/HA cylinders were retrieved by 
breaking the glass molds and cut into small disks (6.5 mm in diameter and 3 mm in 
thickness).  The disks were then placed in the water for 72 hr to leach out the NaCl 
porogen.  After salt leaching, the resulting macroporous scaffolds were dried and 
post-cured in the same UV light box for 2 hr.  Both 2D disks and 3D scaffolds were 
washed in acetone for 3 min to dissolve any unreacted components, and air trapped in 
the inner pores of the scaffold were removed by creating a vacuum by drawing air 




remove the residual acetone.  Finally, the samples were then either characterized after 
complete drying or sterilized in 70 % EtOH for cell seeding in subsequent in vitro 
experiments.  
 
5.2.2. Surface morphology, particle distribution, and atomic composition 
A scanning electron microscope (SEM) (SU-70, Hitachi, Tokyo, Japan) was 
used to examine the morphology of the top surface of the composite substrates and 
the surface distribution of HA particles on the 2D composite disks.  SEM images 
were obtained after gold sputter coating.  Concurrently, the presence of the HA 
nanoparticles onto the composite surfaces and their atomic composition were assessed 
by energy dispersive spectroscopy (EDS). 
 
5.2.3. Surface roughness and topography 
The surface roughness and topography of the 2D disks was examined by an 
atomic force microscope (AFM) (Asylum Research, Santa Barbara, CA).  The 
topography of the surface (i.e., a height image) was captured in a tapping mode with 
20 x 20 µm2 scan size and 1 Hz scan rate.  A silicon tip with a spring constant of 48 
N/m was used for all scans. The height images were flattened with a zero order 
polynomial function and converted to 3D images.  The root mean square (RMS) 
roughness was calculated from processed images.  This test was completed with four 





5.2.4. 3D PPF/HA composite scaffold characterization 
For 3D porous scaffolds, top surface, cross-section, and particle distribution 
onto the surface were observed by SEM.  HA distribution over the 3D macroporous 
scaffold was qualitatively determined by the simple trypan blue staining as previously 
described [157, 281].  Briefly, scaffolds were soaked in a 0.4 (w/v) trypan blue for 10 
sec with vigorous shaking.  After washing the samples twice with diH20, each 
scaffold was placed in 100% EtOH for 1 min and sonicated for 5 sec to remove any 
unbound dye.  A top surface image of uniformly stained scaffolds depicting the 
distribution of HA within each composite scaffold was acquired.  The level of 
adsorbed protein onto the scaffold surface was measured by a previously described 
method [172].  Briefly, the scaffolds were first completely wetted by a series of pre-
soaking: 1hr in ethanol, 2 x 30 min in PBS, and overnight incubation in PBS.  
Samples were then placed in culture media with 10% FBS for 4 hr at 37°C on a 
shaker table (25 rpm).  After incubation, samples were washed with PBS three times, 
and adsorbed proteins were extracted during two cycles of 1 hr incubation in 250 µl 
of 1% sodium dodecyl sulfate solution.  A BCA protein assay kit (Pierce, Rockford, 
IL) was used to determine protein concentration.  This test was completed with 
triplicate samples and triplicate measurements. 
 
5.2.5. Mechanical testing 
Compressive mechanical testing was conducted according to the American 
Society of Testing Materials Standard D695-2a using an Instron mechanical tester 




20% were prepared as cylinders with  13 mm in height and 6.5 mm in diameter.  
Samples were compressed along their vertical axis at a speed of 1.3 mm/min until the 
compressive strain reached 0.5 mm/mm.  The Young’s modulus and yield 
compressive stress at 1% offset were calculated using Bluehill 2.16 software 
(Instron). This test was completed with five replicates in each experimental group. 
 
5.2.6. Flow cytometry analysis  
Flow cytometry was performed at the Bioengineering Flow Cytometry Core 
Facility at the University of Maryland.  Briefly, rat BMSCs were isolated from the 
femurs and tibias of young male Wistar Hanover rats (101-125 g, Taconic) according 
to methods previously described [273].  Both harvested bone marrow and 3rd 
passaged cells were then placed in red cell lysis buffer (10 mM KHCO3, 150 mM 
NH4Cl, 0.1 mM EDTA for 10 min and washed once with complete media.  
Approximately 1×106 cells were transferred to a 5 ml BD Falcon polystyrene tube 
and labeled for the following antibodies: CD45-Alexa Fluor 647 (clone OX-1, 
Biolegend, San Diego, CA); CD29-FITC (clone Ha2/5, BD Biosciences, San Jose, 
CA); CD90-PE (clone OX7, Santa Cruz Biotech, Santa Cruz, CA); CD34-PE-Cy7 
(clone ICO115, Santa Cruz Biotech); and CD44 (clone OX49, Santa Cruz Biotech) 
with goat anti-mouse Alexa Fluor 700 (Invitrogen, Carlsbad, CA), as well as 
unstained and appropriate isotype controls, and a panel stain including all surface 
markers.  Each tube was washed with 2 mL FACS staining buffer (1x PBS/1% FBS) 
and centrifuged for 5 min at 500 rpm at 4°C.  The supernatant was discarded and the 




were added.  The tubes were incubated on ice for 20 min during antibody binding in 
the dark and then washed twice with 2 ml of PBS and centrifuged for 10 min at 500 
rpm at 4°C.  The supernatant was discarded and the pellet was resuspended in the 
final volume of 500 µl.  The samples were analyzed on a BD FACSAria II flow 
cytometer BD Biosciences (San Jose, CA) and the data was analyzed using the BD 
FACSDiva software. 
 
5.2.7. 2D attachment of rat BMSCs 
2D PPF/HA composite disks were pre-washed after acetone etching prior to 
cell seeding in the following manner.  Each disk was sterilized with 70% EtOH for 30 
min and washed twice with PBS buffer.  Then, the disks were soaked in FBS 
overnight to increase the level of adsorbed serum protein on the composite surfaces.  
Each disk was then placed in a 12 well plate and an autoclaved stainless steel ring 
(inner diameter: 16 mm) was also placed onto each disk to confine the seeding area as 
well as prevent floating of disks [273].  Rat BMSCs in culture flasks that had 
undergone 3 passages were trypsinzed, resuspended in osteogenic (OS) media 
(Control media contained α-MEM, 10% (v/v) penicillin/streptomycin antibiotics, and 
0.2 mM of ascorbic acid while OS media was made of control media supplemented 
with 10 mM Na-β-glycerophophate and 10-8 M dexamethasone) with 10% FBS, and 
seeded onto composite disks (60,000 cells per disk, 30,000 cells/cm2) as well as tissue 
culture polystyrene (TCPS) well plates as a positive control.  After 24 hr incubation, 
the cells on the disks were washed with PBS and stained with 2 µM calcein 




Images were obtained using a fluorescence microscope (Axiovert 40 CFL with filter 
set 23, Zeiss, Thornwood, Swiss) equipped with a digital camera (Diagnostic 
instruments 11.2 Color Mosaic, Sterling Heights, MI) from five spots (i.e., one in the 
center and four along each major axis) to quantify the percent attachment area of cells 
compared to the TCPS control.  A total of 20 images (four biological replicates) were 
acquired and transferred to Matlab software (The MathWorks, Natick, MA) and 
converted to black and white binary images.  The percentage of cell attachment (total 
cell attached area per group / total cell attached area in the TCPS group × 100%) was 
determined. 
 
5.2.8. 3D cell culture 
3D PPF/HA composite scaffolds were also pre-washed, as described above, 
before cell seeding.  PPF/HA scaffolds were sterilized in 70 % EtOH and soaked in 
FBS, and then the cells were seeded onto the scaffold.  One million cells per scaffold 
were seeded for the visualization assays while scaffolds with two different cell 
densities (0.33 million and 1 million cells per scaffold) were tested for alkaline 
phosphatase (ALP) expression, mineralization, and quantitative real time polymerase 
chain reaction (qRT-PCR) experiments (see the experimental groups in Table 10).  


















0 High 100% - 75.83 ± 0.80% 
10 High 90% 10% 76.54 ± 0.35% 
20 High 80% 20% 76.25 ± 1.10% 
1.00 × 106 
0 Low 100% - 75.83 ± 0.80% 
10 Low 90% 10% 76.54 ± 0.35% 
20 Low 80% 20% 76.25 ± 1.10% 
0.33 × 106 
 
Table 10: Experimental groups for 3D in vitro culture.  
 
5.2.9. Visualization of cells on the 3D scaffolds 
Cell viability was assessed up to day 8 following cell seeding on 3D PPF/HA 
scaffolds by using Calcein AM fluorescent staining.  The cell culture media was 
removed and the cell/scaffold constructs were rinsed twice with PBS.  Staining and 
microscopic procedures were performed as described previously.  The cytoskeleton 
development of rat BMSCs on composite scaffolds was assessed by F-actin staining.  
After the aspiration of media from each well, each scaffold was washed with PBS, 
fixed with 500 µl of 4% paraformaldehyde for 30 min, washed three times with PBS, 
and then incubated in 500µl of 0.2% Triton X-100 in PBS for 2 min.  Samples were 
then washed twice with PBS again, and incubated in 700 µl of phalloidin (Alexa 
Fluor 488, Invitrogen) for 1 hr at room temperature.  Stained cytoskeletons were 
observed under a fluorescence microscope.  Cell morphology on the composite 
surfaces was also examined by SEM.  After cell culture media removal, each scaffold 
was washed with PBS, fixed with 500 µl of 4% paraformaldehyde for 30 minutes, 




using a gold sputter, and observed via SEM.  All three assays were performed on day 
1 and 8. 
 
5.2.10. Quantitative reverse transcription polymerase chain reaction (qRT-PCR) 
Total RNA was isolated from cell/scaffold constructs using Trizol (Sigma-
Aldrich) according to the manufacturer’s protocol.  cDNA was prepared from the 
isolated RNA using a High Capacity cDNA Archive kit (Applied Biosystems, Foster 
City, CA).  Pre-amplification of cDNA was performed by the manufacturer’s 
protocol.  Briefly, the cDNA sample was mixed with 0.2X pooled Taqman Gene 
Expression assay mixture (Applied Biosystems) of genes of interest, and a PreAmp 
Master Mix (Applied Biosystems).  The genes of interest included three growth 
factors (bone morphogenetic protein-2 (BMP-2, Taqman Assay ID: 
Rn00567818_m1), fibroblast growth factors-2 (FGF-2, Rn00570809_m1), and 
transforming growth factor-β1 (TGF-β1, Rn00572010_m1)), one transcriptional 
factor of Runx2 (Rn01512296_m1), and one osteoblastic differentiation marker of 
osteocalcin (OC, Rn00566386_g1).  The thermal condition for the pre-amplification 
reaction was 10 min at 95°C, and 10 cycles of 15 sec at 95°C and 4 min at 60°C.  
This pre-amplified cDNA sample was diluted with 1x TE buffer (1:5) and then was 
utilized to investigate the relative gene expression level of target genes.  A house-
keeping gene, glyceraldehyde-3-phosphate dehydrogenase (GAPDH, 
Rn99999916_s1) was used as an endogenous control gene.  qRT-PCR was conducted 
on an ABI Prism 7000 sequence detector (Applied Biosystems), using a thermal 




min at 60°C.  The relative gene expression level of the genes of interest was 
normalized using the GAPDH control gene.  The mean of fold changes compared to 
the calibrator group (0 Low Group at day 1) was analyzed using a ΔΔCt method and 
its standard deviation is reported (n=3). 
 
5.2.11. Alkaline phosphatase assay 
ALP activity was determined using p-nitrophenyl phosphate (pNPP) 
enzymatic assay (Sigma-Aldrich, St. Louis, MO) based on the hydrolysis of pNPP to 
para-nitrophenol, where spectroscopic data of the final yellow product indicates ALP 
activity.  The cell/scaffold constructs were washed with PBS and placed in 600 µl of 
autoclaved distilled water.  Protein and DNA were extracted through three cycles of 
cell-lysis: freeze (30 min at -80°C), thaw (30 min at 37°C), and sonication (30min).  
The resulting debris was centrifuged at 12,000 g for 10 min and the supernatant was 
transferred to a new sterile tube.  The supernatant was mixed with a pNPP liquid 
substrate and after 1 hr incubation at 37°C  in the dark, 2 M NaOH solution was 
added to stop the reaction.  The absorbance was recorded at 405 nm using a M5 
SpectraMax microplate reader (Molecular Devices, Sunnyvale, CA).  The DNA 
amount was also quantified using a PicoGreen assay kit (Invitrogen) and the ALP 
activity level was normalized to the DNA amount and the mM ALP/µg DNA was 




5.2.12. Mineralization assay 
Calcium mineralization was measured by selective binding of alizarin Red S 
(ARS, Sigma-Aldrich) to calcium salts.  On day 8 and 15, cell/scaffold constructs 
were washed with PBS, fixed with 4% paraformaldehyde for 30 min at room 
temperature, and then stained with 40 mM ARS/PBS solution (pH 4.1) on the shaker 
(150 rpm) for 30 min at room temperature.  After washing five times with dH2O to 
remove any unbound ARS, 10 v/v% acetic acid was applied to each sample to 
dissolve the crystals.  Optical density was recorded at 405 nm using a microplate 
reader and the background intensity of a control scaffold (i.e., a scaffold without 
cells) was subtracted from each sample.  The calcium amount was normalized to the 
DNA amount and mM ARS/µg DNA was reported.  Each experimental group was 
analyzed in triplicate. 
 
5.2.13. Statistical analysis 
The data from all studies were analyzed by an analysis of variance (ANOVA) 
and Turkey’s multiple-comparison test.  A p value < 0.05 was utilized to demonstrate 
significant difference between the experimental groups.  The means and the standard 






5.3.1. 2D surface characterization 
The PPF/HA composite material was fabricated through a simple physical mixing 
technique and a crosslinked PPF network was obtained by UV light photoinitiation.  
The surface morphology and atomic composition on the composite surface were 
observed by SEM imaging and EDS analysis.  In addition, the surface topography and 
RMS roughness were assessed by AFM.  Increasing the amount of HA nanoparticles 
incorporated within a PPF polymer network resulted in more particles being exposed 
on the composites material’s surface (Figure 10(A), (C), and (E)).  Atomic 
composition data is correlated with these morphological surface images (Table 11).  
By adding more HA nanoparticles, more calcium and phosphate are detected onto the 
composite surface.  HA incorporation also resulted in increasing surface roughness 
(Figure 10(B), (D), and (F)).  3D height images using AFM also qualitatively 
demonstrated that a rougher surface was obtained by mixing larger amounts of HA 
particles into the PPF.  RMS roughness data in Figure 10(G) shows a significant 
increase in roughness in the PPF/HA 10% and 20% groups compared to the PPF 
control group (p = 2.96×10-6).  Moreover, these two groups also shows a significant 
increase in roughness when simply etched by acetone compared with non-etched 
samples (p = 4.79×10-4 and 3.18×10-5, respectively) implying that some portion of the 
embedded HA particles in PPF were exposed by acetone washing and resulted in a 
rougher surface than in either the PPF control or the non-treated PPF/HA samples.  




photocrosslinking reaction, and acetone etching are suitable to create higher surface 
roughness with a different chemical composition. 
 
5.3.2. 3D scaffold characterization 
SEM analysis was also performed on the structure of 3D macroporous 
PPF/HA scaffolds (Figure 11).  Top surface (Figure 11(A)) and cross-section (Figure 
11(B)) images demonstrated highly interconnected 3D porous structures.  The overall 
porosity measured by the amount of salt leached (see data in Table 10) is correlated 
with this SEM observation.  All three experimental groups showed over 75 wt% of 
leaching (n=6), implying that the pores in the scaffold are interconnected which 
would allow water to flow through the inner structure.  For the higher magnification 
of the surface of 3D PPF/HA scaffolds, the same trends associated with HA particle 
distribution were observed, as were seen on the 2D disks (Figure 11(C)).  This 
suggests that a simple porogen leaching technique could be applied to fabricate well- 
interconnected 3D PPF/HA scaffolds with high porosity.  The compressive Young’s 
modulus of porous PPF/HA scaffolds showed an increasing trend as the concentration 
of HA increased (Figure 12(A)).  Specifically, the PPF/HA 20% group showed a 
significantly higher modulus than either the PPF control or the PPF/HA 10% group (p 
= 1.05×10-2).  The offset yield strength in PPF/HA 20% was also higher than in the 
other groups (Figure 12(B)).  In addition, the adsorption of hydrophilic trypan blue 
dye to the composite scaffolds qualitatively demonstrated the uniform distribution of 



































Figure 10: Surface morphology as observed by scanning electron microscopy (SEM) 
images of 2D disks with PPF (A), PPF/HA10% (C), and PPF/HA20% (E).  All 
images were obtained with 600x magnification and the scale bar represents 50 µm.  
These qualitative results demonstrate that HA nanoparticles were homogeneously 
distributed over the surface of the 2D disks and more HA content was observed with 
increasing HA amount.  Topographic images of the surfaces by atomic force 
microscope (AFM) with PPF (B), PPF/HA10% (D), and PPF/HA20% (F) 
demonstrated that rougher surface was obtained by increasing the amount of HA.  
Additionally, the root mean square (RMS) roughness after the acetone washing 
increased significantly by adding more HA nanoparticles while the values before the 
acetone washing were independent of HA particle amount.  + indicates a significant 
difference between different HA amount groups after washing (p<0.05), and indicates 
a significant difference between before and after washing in scaffolds with the same 
composition (p<0.05).  
 
 Element Percentages from EDS Spectrum Analysis 
Composition Carbon Oxygen Calcium Phosphate 





















Table 11: Percentage of elemental carbon (C), oxygen (O), calcium (Ca), and 





amount of incorporated HA (Figure 13).  The hydrophobic PPF control (Figure 
13(A)) did not adsorb trypan blue while more dye was adsorbed in the PPF/HA 10% 
and 20% groups (Figure 13(B) and (C)).  Similarly, the amount of protein adsorbed to 
the surface of the 3D scaffolds increased with the addition of more HA particles 
(Figure 13(D)).  The PPF/HA 20% group showed a significantly higher protein 
adsorption compared to the PPF control group (p = 3.76×10-3).  This result suggests 
that a higher level of HA incorporation resulted in increasing surface roughness and 
that a higher concentration of HA exposed on the surface might elevate the 
hydrophilicity and subsequent protein adsorption level.  Along with the improved 
physical characteristics with increasing the amount of HA, the mechanical properties 




















 PPF PPF/HA 10% PPF/HA 20% 
(A) 
   
(B) 
   
(C) 
   
 
 
Figure 11: SEM structural images of the top surface (A), cross sections (B), and 
particle distribution (C) of 3D macroporous PPF and PPF/HA scaffolds by SEM.  The 
scale represents 500 µm in (A) and (B), and 30 µm in (C).  This qualitative result 
demonstrates that 3D macroporous scaffolds fabricated by simple salt leaching 
technique showed interconnective porous structures and more HA particles were seen 













Figure 12: Compressive properties, including Young’s modulus (A) and off-set yield 
strength (B), of 3D macroporous PPF and PPF/HA scaffolds.  The result 
demonstrated that the PPF/HA 20% group showed significantly higher Young’s 
modulus than the PPF control and PPF/HA 10% groups.  Off-set yield strength in the 
PPF/HA 20% group was also higher than in the other groups.  # indicates a significant 










Figure 13: HA particle distribution over the surface of scaffolds was assessed by 
trypan blue staining with PPF (A), PPF/HA10% (B), and PPF/HA20% (C).  Protein 
adsorption on the PPF/HA composite scaffolds with different concentration of HA 
nanoparticle is shown in (D).  ☆ indicates a significant difference compared to the 









5.3.3. BMSC characterization by flow cytometry 
The mesenchymal stem cell population in a heterogenous bone marrow 
stromal cell sample can be characterized by cell surface marker staining.  In 
particular, MSCs are thought to be positive for CD29 and CD90, while negative for 
CD34 and CD45 [282, 283].  Results showed that freshly harvested BMSCs are a 
heterogeneous cell population including leukocytes, monocytes, and granulocytes.  
Bone marrow aspirate contained 86.7% of CD45(+) cells, but this percentage fell to 
17.0% after three passages (Table 12).  The percentage of CD29(+) and CD90(+) 
cells increased after 3 passages (92.1 to 100 % and 76.4 to 80.1 %, respectively).  The 
percentage of the total mesenchymal stem cell population, defined here as CD29(+), 
CD90(+), CD34(-), and CD45(-), was only 0.1% for freshly harvested BMSCs, 
however it was 49.6% for subcultured cells.  As shown in Figure 14, it is concluded 
that a subculture procedure is suitable for expanding rat MSC populations from 
primary bone marrow stromal cells. 
 
 
 Cell Population Composition 
Cell Surface Markers Fresh Bone Marrow Cells Passage 3 Cells 
CD34 0.4% 1.1% 
CD45 86.7% 17.0% 
CD29 92.1% 100.0% 
CD90 76.4% 80.1% 
CD34-/CD45-
/CD29+/CD90+ 0.1% 49.6% 
 
Table 12: FACS characterization of the mesenchymal stem cell population (as 
defined by CD29(+)/CD90(+)/CD34(-)/CD45(-)) of fresh bone marrow stromal cells 














Figure 14: Flow cytometry analysis of freshly derived BMSCs from rats (A) and 
subcultured cells after three passages (B).  Approximately  50% of the BMSCs 







5.3.4. Cell attachment 
As measured by fluorescently stained cell-area, the qualitative images of 
Calcein AM staining in Figure 15(A) reveals that more cells are attached to the 
composite scaffolds as HA concentration increases.  For quantification (Figure 
15(B)), the total cell-attached area in each group was normalized by that of the TCPS 
control.  The percent attachment in the PPF/HA 20% group was significantly higher 
than the other groups (p = 2.05×10-4).  Rat BMSC attachment was increased with 
increasing surface roughness which in turn depended on HA particle concentration in 
these composite scaffolds.  These results demonstrated that increased HA particle 
incorporation in PPF scaffolds increased surface roughness, subsequent protein 
adsorption from the media to the surface of the composite, and resulted in more cells 
favorably attaching to the composite scaffold surface. 
5.3.5. Viability, cytoskeleton development, and cellular morphology 
To characterize rat BMSC viability on 3D porous PPF/HA scaffolds, Calcein 
AM staining was performed (Figure 16(A)).  The cytoskeleton development of cells 
was examined by F-actin staining (Figure 16(B)) while cellular morphology was 
observed by SEM (Figure 16(C)).  Calcein AM staining data demonstrated that the 
cells in all experimental groups were viable for up to 8 days of in vitro culture in OS-
conditioned media.  Along with 2D attachment data on day 1 (Figure 15(A)), PPF and 
PPF/HA composite materials supported a suitable environment for rat BMSCs in the 
3D scaffolds.  Images of F-actin staining qualitatively demonstrated that more 
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Figure 15: Live/dead fluorescent staining images of initially attached cells on 2D 
disks (A) and percent attachment pattern compared to a TCPS positive control sample 
(B). The result in (A) qualitatively demonstrated that more viable rat BMSCs were 
observed in composite disks with higher amount of HA and the result in (B) verified 
that the percent attachment in the PPF/HA 20% group was significantly higher than in 
























Figure 16: Visualization of viability by Calcein AM fluorescent staining (A), 
cytoskeleton development (B), and cellular morphology by SEM (C) onto PPF 
composite scaffolds with different HA nanoparticle amount.  The scale bar represents 
300 µm in (A) and 100 µm in (B). 
 
group on day 1, however all groups showed similar levels of cytoskeleton 
development on day 8 (Figure 16(B)).  This result is also correlated with the change 
of cellular morphology observed by SEM on day 1, where observable cell flattening 
was seen on the surface of the PPF/HA 20% groups, while some of cells on control 
PPF retained a rounded shape (Figure 16(C)).  On day 8, the cells on PPF/HA 
composite scaffolds were highly flattened and covered the surface of these scaffolds. 
5.3.6. Osteogenic signal expression profiles 
Quantitative RT-PCR was performed to investigate the effect of HA 
nanoparticle incorporation with various seeding densities on osteogenic signal 




decreased or was stagnant for all HA amount groups (Figure 17(A)).  However, the 
addition of HA along with high cell seeding density increased BMP-2 expression 
compared to the PPF control on day 8 (p = 9.83×10-6).  This observation was similar 
to the low cell seeding groups: PPF control group with low cell seeding showed 
decreasing BMP-2 expression over 8 days while 10 Low and 20 Low groups 
exhibited significantly higher expression level than PPF control on day 8 (p = 
2.96×10-8), and this level was also significantly higher than 10 High and 20 High 
groups (p = 4.38×10-5 and p = 1.46×10-5, respectively).  Increased HA incorporation 
in the low cell seeding density groups (10 Low and 20 Low) was also observed to be 
correlated with increased BMP-2 expression after 8 days of culture over the initial 
expression level on day 1.  
FGF-2 expression represents a similar pattern to the TGF-β1 expression 
profile (Figure 17(B) and 17(C)).  Among high cell seeding density groups, 20 High 
exhibited 3 fold up-regulation of FGF-2 on day 4 and kept this level until day 8 (p = 
3.81×10-4).  Moreover, 10 High also showed a 2.95 fold up-regulated FGF-2 
expression on day 8 and both 10 High and 20 High exhibited significantly higher 
FGF-2 expression than the PPF control group on day 8 (p = 6.94×10-3).  A similar up-
regulation pattern was also observed in the low cell seeding density groups on day 8: 
FGF-2 expressions of both 10 Low and 20 Low were significantly higher than 0 Low 
on day 8 (p = 1.03×10-8) and this level was also up-regulated over the day 1 
expression level.  Specifically, 20 Low exhibited more than a 4.7 fold change 




was also observed in the PPF control groups for both cell seeding density groups over 














Figure 17: Quantitative RT-PCR analysis of gene expression profiles of growth 
factors (A: BMP-2, B: FGF-2, C: TFG- β1, and D: Runx2) for 1, 4, and 8 days.  The 
fold changes in gene expression level are reported as average ± standard deviation 
(n=3) and the calibrator for all experimental groups is indicated by a Δ marker.  + 
indicates a statistical difference in HA amount within the same cell seeding density 
group as compared to the 0% HA control group while # indicates a statistical 




For the higher cell seeding density groups, HA addition induced more TGF-β1 
expression than in the PPF control, but this level was below than the expression of the 
calibrator group on day 1.  A significant increase of TGF-β1 was found in 20 Low 
group on day 8 versus 0 Low and 10 Low groups (p = 1.48×10-2), and this up-
regulation was more than a 2 fold increase compared to the calibrator group. 
The Runx2 transcription factor expression in the high cell seeding density 
groups showed a decreasing pattern over 8 days except 20 High group, which showed 
a peak on day 4 (Figure 17(D)).  All groups with low cell seeding density exhibited 
down-regulation of Runx2 expression on day 4 and an increased expression by day 8. 
 
5.3.7. Osteoblastic differentiation 
In order to investigate whether the cell population would differentiate into an 
osteoblastic lineage by changing the HA amount in the scaffolds, and/or the initial 
cell seeding density, ALP protein activity was assessed (Figure 18).  A 
correspondence between ALP activity and the HA particle amount was only observed 
in lower cell seeding density groups on day 1 and a higher cell seeding group (20 
High) on day 4, compared to the PPF control group.  During the later time points, 0 
Low group on day 4 (p = 8.01×10-4) and both 0 Low and 10 Low groups on day 8 (p 
= 1.01×10-2 and 4.31×10-3, respectively) exhibited significantly higher ALP activity 
compared to higher cell seeding density groups.  Late osteoblastic differentiation was 
assessed by calcium deposition (Figure 19) and the OC mRNA expression (Figure 
20).  Increasing HA content in both cell seeding density groups resulted in higher 




deposition than the PPF control group and both 10 and 20 Low groups also showed 
significantly higher mineral contents (p = 6.62×10-6).  On day 15, 20 High group at 
both cell seeding densities showed significantly increased calcium deposition over the 
PPF control group (p = 4.53×10-4).  Moreover, 10 and 20 Low groups presented a 
significant increase in mineralization versus the high cell density groups on day 8 
while mineralization on day 15 was statistically unchanged when cell seeding density 
was varied.  In Figure 20, it can be seen that the OC mRNA expression in all groups 
exhibited an increasing trend over 8 days.  By day 4, 20 High group exhibited a 
significantly higher OC expression level than did the other groups.  On day 8, the 
expression level of HA incorporated PPF groups was higher than the PPF control 
group for both cell seeding densities (p = 3.08×10-5).  Although the effect of cell 
seeding density on OC expression was not observed on day 8, the effect of HA 
amount on the expression (i.e., increased osteoblastic differentiation with higher HA 
concentration) was correlated with calcium deposition, as seen in Figure 19.  
 
5.4. Discussion 
 The main objective of this study was to determine which 3D PPF/HA 
nanoparticle composite scaffold parameters facilitate osteoblastic differentiation and 
endogenous osteogenic signal expressions.  In order to optimize the construct 
properties that mimic the native bone healing process, controlling parameters that 
enhance the expression of signaling molecules such as the physical properties of the 





Figure 18: ALP protein activity of rat BMSCs on PPF composite scaffolds with 
different HA contents and cell seeding densities for 1, 4, and 8 days.  ALP protein 
expression level was normalized by DNA amount and average ± standard deviation 
(n=3 per group) is reported.  + indicates a statistical difference in HA amount within 
the same cell seeding density group while # indicates a statistical difference in cell 







Figure 19: Quantitative mineralization assay by alizarin red S staining on day 8 and 
15.  Calcium deposition level was normalized by DNA amount and average ± 
standard deviation (n=3 per group) is reported.  + indicates a statistical difference in 
HA amount within same cell seeding density group while # indicates a statistical 










Figure 20: Quantitative RT-PCR analysis of gene expression profiles of OC 
osteogenic differentiation markers for 1, 4, and 8 days.  The fold changes in gene 
expression level are reported as average ± standard deviation (n=3) and the calibrator 
for all experimental groups is indicated by a Δ marker.  + indicates a statistical 
difference in HA amount within the same cell seeding density group as compared to 
the 0% HA control group while # indicates a statistical difference in cell seeding 














incorporation of HA nanoparticles into PPF resulted in an alteration of surface 
properties of these composite materials including topography, roughness, calcium and 
phosphate atomic ratio, and ability to adsorb proteins.  In addition, changing initial 
cell seeding density altered cell-cell paracrine signaling distance among the 
transplanted cell population.  Therefore, it is of importance to characterize the proper 
conditions of those parameters that control or at least facilitate the stimulation of 
specific osteogenic growth factor expression.  To this end, we aim to investigate both 
the effect of the amount of HA incorporated in PPF scaffolds and the initial cell 
seeding density on endogenous osteogenic growth factor gene expression profiles and 
osteoblastic differentiation.  
We fabricated well-interconnected 3D macroporous PPF/HA scaffolds via 
simple techniques using porogen leaching and photocrosslinking.  The 
characterization data in Figure 10 demonstrates that HA nanoparticle incorporation 
resulted in uniform distribution of HA and higher level of calcium and phosphate on 
the surface of composites.  Moreover, HA incorporated composite scaffolds exhibited 
rougher surface topography as confirmed by RMS roughness data.  Subsequently, 
surface properties modified by HA nanoparticle incorporation also resulted in higher 
levels of passive protein adsorption onto the scaffold surface and higher 
hydrophilicity (i.e., wettability) of scaffolds (Figure 13).  Both of these factors may 
improve initial cell attachment since higher roughness provides more surface area 
with more complex geometry for cells to attach to, and increasing hydrophilicity is 
directly related with the adsorption of proteins existing in the aqueous media [268].  




attachment was observed in PPF/HA 20% composite than in control PPF samples in a 
2D environment (Figure 15).  In addition, qualitative visualization of cells on 3D 
PPF/HA composite scaffolds also demonstrated more cytoskeleton development on 
PPF/HA 20% scaffolds than on PPF control scaffolds on day 1 as assessed by F-actin 
staining (Figure 16(B)).  The SEM images also qualitatively demonstrated 
morphological changes in cell flattening with more cell flattening observed as HA 
incorporation in composite scaffolds was increased (Figure 16(C)).  This result may 
be explained by HA nanoparticles potentially playing a functional role in the integrin-
mediated cell adhesion.  Generally, initial cell adhesion to extracellular matrix (ECM) 
is mediated by an integrin transmembrane receptor [284].  Integrin binding to ECM 
proteins physically connects the cell’s cytoskeleton and the surrounding ECM.  This 
initiates the intracellular signaling pathway to nucleate the signaling proteins such as 
focal adhesion kinase.  For example, controlled HA deposition has been observed to 
induce MC3T3-E1 cell adhesion, integrin presentation and clustering, and focal 
adhesion complex mediation[285].  Since the integrin binding and initial cell 
attachment play a critical role in downstream signaling cascades such as the 
interaction of cytoskeleton protein/cellular membrane protein/ECM proteins, 
induction of signal transduction, stimulation of transcription factors, and consequent 
gene expression [286, 287], HA nanoparticle incorporation may stimulate not only 
initial cell adhesion but also osteogenic growth factor gene expressions during 
osteoblastic differentiation.  
The compressive Young’s modulus and off-set yield strength of PPF/HA 




capacity and its potential as a bone substitute (Figure 12).  The compressive modulus 
of the 3D PPF/HA composite scaffolds exhibited similar levels to that of native 
human cancellous bone (i.e., 2 to 10 MPa) [288].  The PPF/HA 20% group exhibited 
significantly higher Young’s modulus than the PPF control and PPF/HA 10% groups.  
Composite scaffolds presented a trend of increasing Young’s modulus relative to HA 
nanoparticle reinforcement, and this has been observed in other studies.  For example, 
polycarbonate/HA nanoparticle composite scaffolds exhibited an increase of Young’s 
modulus from 0.6 GPa to 4.5 GPa when the amount of HA was increased from 10% 
to 30% [289].  Similarly, PLG/HA composite also showed an increase in Young’s 
modulus when the ratio of PLG:HA was increased up to 1:5 [281].  One possible 
explanation of observed mechanical enhancement could be the intrinsic contribution 
of HA as well as an increase in surface to volume ratio with HA nanoparticle 
addition, which also found in PCL/HA composites [290].  Therefore, the mechanical 
properties of photocrosslinked porous PPF/HA nanocomposite scaffolds observed in 
this study demonstrated that these properties can be controlled during fabrication, a 
possibly useful fact for manufacturing bone tissue engineering scaffolds. 
The effect of HA amount on endogenous osteogenic gene expression in 
composite scaffolds with varying cell seeding density was investigated.  There have 
been many studies about the effect of exogenous growth factors on osteoblastic 
differentiation; however, the present research has shown for the first time the effect of 
HA presence on endogenous osteogenic gene expression including BMP-2, FGF-2, 
TGF-β1, and Runx2.  BMP-2 is known to participate in the regulation of cell growth 




defect sites during the healing process.  Although there have been many studies on 
exogenous BMP-2 administration to culture media as well as delivery of this growth 
factor to the healing defect site, the present study demonstrated that endogenous 
osteogenic signal expressions could be facilitated by altering scaffold construction 
properties of cell/scaffold integration through the incorporation of HA nanoparticles 
and changing the initial cell seeding density.  Despite of the fact that BMP-2 gene 
expression level was decreased or was unchanging for PPF control scaffolds, the HA 
incorporated composite scaffolds induced significantly higher BMP-2 expression than 
the control on day 8 (p = 9.83×10-6 in high cell seeding and 2.96×10-8 in low cell 
seeding).  This HA-induced BMP-2 upregulation was observed for both cell seeding 
densities (Figure 17(A)).  The upregulated level of BMP-2 expression was higher in 
the lower cell seeding density on day 8.  Therefore, it seems that PPF/HA composite 
scaffolds may stimulate higher endogenous BMP-2 expression and its expression 
level may be also be responsive to the initial cell seeding density. 
We have previously speculated on the interaction of endogenous signal 
expression with other signaling factors of rat BMSCs cultured on 2D PPF disks 
previously [273].  BMP-2 signaling is dependent on the expression of Runx2 
transcription factor through the Smad and MAPK intracellular signaling pathways 
[16, 291], and our comparison with BMP-2 and Runx2 expression profiles in this 
study might confirm this interaction.  Early decline of BMP-2 in all groups except the 
20 High group in a 3D scaffold by day 4 was also associated with Runx2 deactivation 
as seen in Figure 17(D).  Specifically, an increase in BMP-2 expression in the 20 




later time points, from day 4 to 8, the high cell seeding density groups exhibited a 
general decline of BMP-2 expression although HA incorporation resulted in different 
levels of expression on day 8 and Runx2 expression profile in high cell seeding 
groups showed the same decreasing pattern by day 8.  During this period, low cell 
seeding groups exhibited increasing BMP-2 expression that might be also related to 
an increase in Runx2 expression in all HA incorporated groups.  Moreover, Runx2-
mediated growth factor gene expression was also observed in FGF-2 expression 
(Figure 17(B)), which is also associated with Runx2 induction via the MAPK 
pathway [292].  For the low cell seeding density groups, the decreasing trend of FGF-
2 expression from day 4 to 8 is correlated with a decrease in the Runx2 expression 
pattern.  However, a discrepancy in the high cell seeding density groups was 
observed, which is that up-regulation of FGF-2 expression in 10 and 20 High groups 
during the later time points was not related to the down-regulation of Runx2 in the 
same groups.  This might be explained by the possibility that Runx2 stimulation was 
more affected by BMP-2 stimulation via both the Smad and MAPK pathways, rather 
than FGF-2 expression through the MAPK pathway.  Therefore, the decline of BMP-
2 in high cell seeding groups on day 8 might correlate with Runx2 down-regulation, 
even in the presence of FGF-2 up-regulation. 
FGF-2 is associated with the stimulation of osteoblast through the Cbfa-
1/Runx2 transcription factor activation [18] as well as angiogenic development [293].  
Therefore it is imperative to investigate its signaling profiles to promote the 
integration of implanted scaffolds with surrounding host tissues for bone tissue 




its expression increased at a later time point of day 8 and that the HA addition in 
composite scaffolds may have facilitated statistically higher FGF-2 expression that 
was not observed in the PPF control group.  The PPF/HA 10% and 20% groups 
exhibited higher FGF-2 expression level than did the PPF control on day 8 for both 
cell seeding densities.  In particular, 20% HA nanoparticle addition to composite with 
0.33 million cell seeding showed up to a 5 fold change by day 8.  This observation of 
upregulated osteogenic signal expression with HA nanoparticle incorporation was 
correlated with BMP-2 expression and could be evidence of an effect on osteogenic 
signal expression by altering scaffold construction properties.  The results in Figure 
17(D) also demonstrated that HA incorporation into composite scaffolds at both cell 
seeding densities enhanced the TGF-β1 expression on day 8 from both cell seeding 
densities, as was the case with FGF-2 expression.  Our previous study demonstrated 
that the existence of optimal cell seeding density of transplanted rat BMSC 
populations on 2D PPF disks appeared to facilitate BMP-2, FGF-2, and TGF-
β1expression [273].  This present study using 3D PPF/HA porous scaffolds also 
demonstrated that the optimum condition to induce more osteogenic signal expression 
was the PPF/HA 20% group with 0.33 million cells.  
The effect of HA nanoparticle contents on the osteoblastic differentiation of 
rat BMSCs was investigated with two different cell seeding densities.  ALP protein 
expression was examined as a transient early osteoblastic differentiation marker, 
while calcium deposition and OC mRNA expression was assessed as an indicator of a 
later stage of differentiation.  The ALP expression level depended on the amount of 




parameter in lower cell seeding density groups on day 8 (Figure 18).  In addition, the 
results also demonstrated that mineralization and OC mRNA expression also 
depended on HA addition to the scaffolds (Figure 19 and 20).  Both HA incorporated 
composite scaffolds exhibited significantly higher calcium deposition with both cell 
seeding densities on day 8 (p = 6.50×10-4 in high cell seeding and 1.48×10-3 in low 
cell seeding) and the effect of HA amount on mineralization was greater in the lower 
cell seeding density groups.  The PPF/HA 20% groups showed higher levels of 
mineralization for both cell seeding densities on day 15.  Similarly, the OC mRNA 
expression data also showed the dependence of late osteoblastic differentiation of 
BMSCs on the amount of HA present.  Significantly higher OC expression was 
observed when HA concentration increased on day 8 even though an effect of cell 
seeding densities was not observed.  The potential dependence of osteoblastic 
differentiation on incorporated HA amount is in agreement with several other studies.  
One of these recent studies showed that the incorporation of 50 ng of HA 
nanoparticles into cyclic acetal hydrogels stimulated more endogenous ALP mRNA 
expression of encapsulated rat BMSCs than 5 ng and control hydrogel groups on day 
8.  In the same study, OC mRNA expression in 5 and 50 ng of HA groups was 
significantly higher than the control on day 1, 4, and 8 [271].  OC and osteopontin 
(OP) mRNA expression of rabbit BMSCs in a 2D monolayer has also been observed 
to be dependent on HA nanoparticle concentration [294].  Moreover, osteoblastic 
differentiation with HA dependence has also been observed in human MCSCs on 
PLG/HA composite scaffolds and both ALP and OP protein expression levels were 




PPF/HA composite scaffold may also facilitate osteoblastic differentiation of 
transplanted rat BMSCs by increasing the amount of incorporated HA amount and by 
varying the initial cell seeding density.  
 
5.5. Conclusions 
This investigation of scaffold construction properties for 3D macroporous 
PPF/HA scaffolds appears to have found parameters that facilitate osteoblastic 
differentiation of transplanted cell populations and evidence of associated osteogenic 
signal gene expression that suggests these conditions might induce further bone 
regeneration as well as facilitate integration of scaffolds with the surrounding host 
tissues.  This study revealed that altering both the level of HA nanoparticle 
incorporation and the initial cell seeding density can effect osteoblastic differentiation 
and growth factor gene expression.  Our results demonstrated that (1) HA addition 
improved surface properties of composite scaffolds by showing increased roughness, 
hydrophilicity, protein adsorption, and initial cell attachment, (2) up-regulation of 
osteogenic signal expression was also controlled by both HA amount and initial cell 
seeding density, and (3) subsequent osteoblastic differentiation of rat BMSCs on 3D 





Chapter 6: Optimization of Scaffold Design Parameters to 
Induce Osteogenic Signal Expressions in 3D Poly(Propylene 
Fumarate)/Diethyl Fumarate Composite Scaffolds 
 
6.1. Introduction 
Scaffold design parameters are considered important in order to achieve a 
functional complex of cell/scaffold constructs, including pore size, porosity, 
interconnectivity, surface properties, mechanical strength, the amounts and types of 
filler material, cell seeding density, and exogenous growth factors [295].  In general, 
transplanted cell population could recognize the differences in these physical and 
mechanical cues and the subsequent cellular functions might be changed.  Modulation 
in the physical properties as well as changes in scaffold design parameters may 
influence the various cellular functions, and both stiffness (mechanical cues) and pore 
geometry (structural cue) among these parameters are of importance to induce the 
endogenous osteogenic signal expressions.  
It is known that the stiffness of scaffold influences adhesion [296], motility 
[22, 297], morphology [72, 298, 299], proliferation [22, 300, 301], and osteoblastic 
differentiation [16, 70, 88, 300-302] of cells.  Since cells can recognize the modulated 
mechanical cues (or the changes in stiffness) of the scaffold and the secondary signal 
transduction occurs through cell-matrix interaction [69].  Recent study reveals that 
specific lineage of stem cell differentiation cascades can be directed by matrix 
elasticity [69, 302].  In particular, it has been shown that ECM mechanical properties 




through the sequential activation of FAK, RhoA/ROCK, the extracellular signal 
regulated kinase/mitogen-activated protein, and Runx2 [16, 22, 70].  Moreover, 
another study demonstrated that a combination of other stimuli such as ligand 
presentations on ECM with mechanical cues may enhance the mechano-transduction 
[72].  
In addition to mechanical stimuli, architectural cues for a 3D porous scaffold 
including porosity, pore size, interconnectivity, and channel orientation of scaffolds 
are also important scaffold design parameters to affect cellular behaviors [43, 295].  
A study with human mesenchymal stem cells on coralline hydroxyapatite scaffolds 
has shown that pore size could be a controlling factor to vary the BMP-2 mRNA 
expression level and osteoblastic differentiation determined by alkaline phosphatase 
(ALP) and osteocalcin (OC) expression.  Another in vitro study also demonstrated the 
effect of porous architecture of 3D silk fibroin scaffolds on ALP and OC expression 
of BMSCs [303].  An in vivo study using implanted ß-TCP scaffolds in skin folds of 
mice showed that significantly higher osteoblastic differentiation was observed in 
higher porosity groups (over 65 %) than lower porosity groups [21]. Moreover, 
continuous channeled geometry fabricated by solid free form technique has shown a 
significantly higher cell ingrowth depth compared to a scaffold with random porous 
structure [304].  
In order to investigate the effect of mechanical and architectural cues on the 
stimulation of osteogenic signal expression, a composite material of poly(propylene 
fumarate) (PPF) and diethyl fumarate (DEF) was used in the study.  This composite 




weight of PPF, the amount of photoinitiator (bis(2,4,6,-trimethylbenzoyl) 
phenylphosphine oxide, BAPO) and the ratio of PPF and DEF, its crosslinking 
density and mechanical properties could be modulated.  Due to this controllability, 
the mechanical stiffness of PPF/DEF composite scaffold can easily modulated during 
fabrication process.  Besides of the controllable stiffness, another significant 
importance of PPF/DEF material is the feasibility as a resin material for 
stereolithography (SLA).  DEF incorporation with PPF reduces the viscosity of PPF 
and this liquidic polymeric mixture can be utilized for SLA as a resin.  SLA uses a 
laser to initiate photocrosslinking reaction and fabricate a 3D scaffold by vertical 
layering.  Hence, the simultaneous fabrication of desired shape of scaffolds is one of 
the advantage of SLA compared to other solid free form fabrication techniques, 
which usually require the secondary step such as a removal of molding.   
Another advantage of SLA technique is the capability of controlling scaffold design 
parameters such as inner pore architecture and mechanical stiffness by the principle 
of photocrosslinking reaction, then the optimized scaffold properties may stimulate 
osteogenic signal expression and differentiation. Moreover, SLA fabrication have 
shown the feasibility of patient- and defect-specific external shape design of bone 
implants based on a patient’s 3D CT scan and transferred computer aided design 
(CAD) files [91, 92].  
The global hypothesis in this study is that the modification in design 
parameters of 3D PPF/DEF composite scaffolds may facilitate osteogenic signal 
expression and the enhanced level of signal expressions may be associated with the 




study investigated the effect of crosslinking density (i.e., stiffness) and pore size on 
the endogenous osteogenic signal expression and downstream osteoblastic 
differentiation of seeded BMSCs on 3D PPF/DEF scaffolds.  The specific objective 
of this study is (1) to characterize the physical properties of 3D macroporous 
PPF/DEF composite scaffolds, (2) to investigate the effect of DEF content 
(subsequent changes in stiffness as a mechanical cue) and pore size (structural cue) 
on osteogenic signal expression profiles and downstream osteoblastic differentiation 
of rat BMSCs.  
 
6.2. Materials and Methods 
6.2.1. Materials 
For PPF synthesis, diethyl fumarate, propylene glycol, zinc chloride, and 
hydroquinone were obtained from Sigma-Aldrich (St. Louis, MO) and analytical 
reagent grade methylene chloride was purchased from Fisher Scientific (Pittsburgh, 
PA). Polystyrene standards fro GPC analysis was received from Polymer 
Laboratories (Amherst, MA).  Photoinitiator bis(2,4,6-trimethylbenzoyl) 
phenylphosphine oxide (BAPO) was obtained from Ciba Specialty Chemicals 
(Tarrytown, NY).  For cell culture reagents, ascorbic acid and β-mercaptoethanol 
were purchased from Sigma-Aldrich (St. Louis, MO) and alpha-minimum essential 
medium (α-MEM), penicillin/streptomycin antibiotics, fetal bovine serum (FBS), and 
trypsin/EDTA were purchased from Invitrogen (Carlsbad, CA).  BCA protein assay 
kit was received from Pierce (Rockford, IL).  MTT assay kit was obtained from 




Molecular Probes.  Trisol for RNA extraction was purchased from Sigma-Aldrich.  
For real time quantitative polymerase chain reaction (qRT-PCR), High Capacity 
cDNA Archive kit, Universal PCR Master mix (2x), and Taqman® Gene Expression 
Assays were purchased from Applied Biosystems (Foster City, CA).  
 
6.2.2. PPF synthesis and scaffolds fabrication 
PPF was synthesized according to previously reported methods [38]. Briefly, 
diethyl fumarate and propylene glycol were reacted with zinc chloride as a catalyst 
and hydroquinone as a crosslinking inhibitor to form intermediate. Then, 
transesterification was occurred to create final PPF under vacuum condition. After a 
series of purification, number average molecular weight (Mn) and poly diversity was 
determined by gel permeation chromatography.  For PPF/DEF composite scaffold 
fabrication, PPF was mixed with DEF with a various weight ratio (Table 13), and 75 
wt% of salt porogen crystals (>500 µm for large pore size and 180 - 300 µm for small 
pore size) as well as 0.5 wt% of photoinitiator bis(2,4,6-trimethylbenzoyl) 
phenylphosphine oxide compared to polymer mixture amount were homogeneously 
mixed together. Resulting paste was packed into the glass cylinder mold, and 
photocrosslinked under UV light for 2 hrs. Crosslinked polymer networks with salt 
porogens was cut into disks (6.3 mm in diameter and 3 mm in thickness) and placed 
in water for 3 days to leach out salt. Resulting macroporous PPF/DEF scaffolds were 
first air-dried for 24 hrs and dried again in vacuum oven for 24 hrs.  All experimental 







Groups PPF DEF 
Pore Size 
(µm) Porosity (wt %) 
L1 100 - 77.41 ± 0.48 
L2 90 10 79.51 ± 1.14 
L3 75 25 78.43 ± 0.55 
L4 66 33 
> 500 
81.67 ± 0.58 
S1 100 - 75.36 ± 0.24 
S2 90 10 77.37 ± 0.52 
S3 75 25 79.77 ± 0.58 
S4 66 33 
180 - 300 
77.48 ±0.37 
Table 13: Experimental groups 
 
6.2.3. Characterization of physical properties of composite scaffolds 
6.2.3.1. SEM imaging 
Top surface of scaffolds were visualized using scanning electron microscope 
(SEM) (SU-70, Hitachi, Tokyo, Japan).  Samples were coated by a gold sputter, and 
images were obtained at 3 kV accelerating voltage. 
 
6.2.3.2. Sol fraction test 
To assess the crosslinking density of PPF/DEF scaffolds, sol fraction test was 
performed by previous method [77].  Each photocrosslinked scaffold was placed in 
20 ml of methylene chloride solvent in a glass vial. Weight of initial sample before 
the incubation in solvent (Wi) was measured, and samples were incubated on a shaker 




transferred onto a weighed filter paper (Wp).  These were completely dried in an oven 
at 70℃ for 2 hrs, and weighed again (Wp+s).  The sol fraction was calculated from 
the formula below and five independent samples were assessed  (n=5). 
 
Sol fraction =  
 
6.2.3.3. Mechanical properties 
According to the American Society of Testing Materials (ASTM) Standard 
D695-2a, compressive mechanical testing was performed using the Instron 
mechanical tester (Instron 5565, Norwood, MA) to measure the compressive modulus 
and offset yield strength.  Each cylindrical porous scaffold with 6 mm in diameter and 
12 mm in length was compressed along its vertical axis.  Compression was applied at 
a speed of 1.3 mm/min until the compressive strain reached 0.5 mm/mm.  The 
compressive modulus and yield strength at 1% offset were calculated using Bluehill 
2.16 software (Instron).  Six replicates in each experimental group were tested (n=6). 
 
6.2.3.4. Permeability 
The water permeability of scaffolds was measured by the methods described 
previously based on Darcey’s law [305, 306].  An apparatus was constructed using a 
2-liter open container functioning as a water reservoir large enough to keep the 
pressure across the scaffold near constant (by keeping the height of the water in the 
apparatus near constant).  Attached to the bottom of this reservoir was a short tube in 
which the scaffold, first wrapped in parafilm to create an air-tight seal along the side 
! 





wall, was held.  One liter of water was added to the reservoir, and the water 
penetrated through the scaffold vertically was collected.  After 120 seconds, the mass 
of water collected was recorded and the mass flow rate was calculated.  This mass 
flow rate was converted to volumetric flow rate by using the density of water.  This 
procedure was repeated with 5 independent samples (n=5).  The permeability (K) was 
then calculated using the equation below:  
 
 
where ∆Q is a volumetric flow rate, L is the length of a scaffold, 
 
is the viscosity 
of water (8.90 x 10-4 Pa s at 25°C), ∆P is a hydrostatic pressure difference between 
top and bottom of water column, and ACS is the cross-sectional area of a scaffold. 
 
6.2.3.5. Surface hydrophilicity 
The hydrophilicity of the surface of the composite material was determined by 
a static contact angle measurement.  Composite disks were fabricated by placing the 
PPF/DEF/BAPO mixture into rectangular mold on glass plates and crosslinked under 
UV light for 2 hrs [38].  5 µl droplet of water was dropped onto the disk surface and a 
picture was then taken after 15 sec.  Image J software was used to analyze the angles 
at both sides of each water droplet and the average of both values was utilized for the 
further statistical analysis.  Three measurements were performed for each sample and 











6.2.3.6. Protein adsorption test 
The level of adsorbed protein onto the scaffold surface was measured by the 
method previously described [172]. Briefly, scaffolds were first completely wetted by 
a series of pre-socking: 1hr in ethanol, 30 min in PBS (twice), and overnight 
incubation in PBS again. Samples were then placed in culture media with 10% FBS 
for 4 hrs at 37℃ on the shaker (25 RPM).  After incubation, samples were washed 
with PBS 3 times, and adsorbed proteins were extracted by 1 hr incubation in 250 µl 
of 1% sodium dodecyl sulfate (SDS) solution (repeated 2 times).  BCA protein assay 
kit was used to determine the protein concentration. This test was completed with 
triplicate samples and three measurements (n=3). 
 
6.2.4. Rat Bone Marrow Stromal Cell Isolation and Culture 
Rat BMSCs were isolated from Wistar Hanover rats (male, 101-125g, 
Taconic) following a University of Maryland approved IACUC animal protocol 
according to the method previously described [38].  Briefly, femur and tibia were 
dissected from a rat euthanized by carbon dioxide gas and incubated in α-MEM 
culture media containing 10 (v/v)% of penicillin/streptomycin for 10 min. This 
incubation step was repeated three times. Then, both sides of explanted bones were 
clipped off and whole bone marrow inside was flushed out with 10 ml of fresh culture 
media using a syringe. Collected bone marrow was first suspended, filtered through a 
cell strainer with 70 µm pores. Filtered bone marrow was centrifuged, resuspended 
with culture media containing 10 % of FBS, and plated in a T-25 cell culture flask. 




samples were incubated under standard cell culture conditions of 37 and 5 % of CO2 
level.   
 
6.2.5. Initial metabolic activity of rat BMSCs  
MTT assay was used to determine metabolic activity of implanted BMSC 
population influenced by (1) dissolved DEF in aqueous cell culture media and (2) the 
PPF:DEF ratio in composite scaffolds. In order to demonstrate the cytotoxic effect of 
dissolved DEF amount in cell culture media on monolayer cell, 0.1 million cells were 
seeded in each well of a 24 well plate and allowed to attach for 24 hrs. 0, 5, 10, and 
20 mM of DEF in 10% FBS cell culture media was applied in a well and the plate 
was incubated for 1, 2, and 4 hrs in a incubator. 50 (v/v)% of methanol in same 
culture media was used as a negative control. To determine the effect of PPF:DEF 
ratio in 3D composite scaffolds on metabolic activity of seeded BMSC population, 
0.3 million cells were seeded onto a sterilized scaffold with 100:0, 90:10, 75:25, and 
66:33 of PPF:DEF ratio. After 4 hrs of incubation to allow cells to attach to the 
surface of scaffolds, cell/scaffold constructs were washed with PBS. Then, 200 µl of 
5 mg/ml of reconstituted MTT was added with 2 ml of 10% FBS media to each well 
for both assays, and incubated 2.5 hrs to allow the formation of MTT formazan 
crystals. Resulting crystals were dissolved with 200 µl of solublization solution and 
200 µl of supernatant was transferred to 96 well plate to record the optical density at 






6.2.6. Osteogenic signal expressions 
Total RNA was isolated from cell/scaffold construct with Trisol following the 
protocol provided by the manufacturer.  Isolated RNA was reverse transcribed using 
the High Capacity cDNA Archive kit.  For the pre-amplification, cDNA sample was 
first mixed with the same volume of pooled 20x Taqman Gene Expression assay 
including four osteogenic growth factor genes including bone morphogenic protein-2 
(BMP-2), fibroblast growth factors-2 (FGF-2), transforming growth factor-β1 (TGF-
β1), and vascular endothelial growth factor (VEGF), two osteogenic marker genes 
including ALP and OC, and a transcriptional factor of Runx2 as listed in Table 14.  
This mixture was then incorporated with two volume of PreAmp master mix.  
Thermal condition for the PCR pre-amplification reaction was 10 min at 95℃ and 10 
cycles of 15 sec at 95℃, and 4 min at 60℃.  The pre-amplified cDNA sample was 
diluted with 1x TE buffer (1:5) and utilized to investigate the relative gene expression 
level profiles of target genes.  A house-keeping gene, glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) was used as an endogenous control gene.  qRT-PCR was 
conducted on the ABI Prism 7000 sequence detector (Applied Biosystems), using 
thermal condition of 2 min at 50℃, 10 min at 95℃, and 50 cycles of 15 s at 95℃ and 
1 min at 60℃.  Relative gene expression level of genes of interest was normalized 
GAPDH control gene.  Mean of fold changes compared to the calibrator group was 

















Table 14: Taqman ID list of osteogenic markers and signals 
 
6.2.7. Osteogenic differentiation of implanted cell population 
Early osteogenic differentiation of rat BMSCs was first determined by ALP 
protein activity.  ALP activity was determined by para-nitrophenol production using 
p-nitrophenyl phosphate (pNPP) assay (Sigma-Aldrich).  Cell lysate was obtained 
from cell/scaffold constructs as described previously [38].  Briefly, samples in 1 ml of 
distilled water in a small tube were lysated through three cycles of freeze (30 min at -
80℃), thaw (30 min at 37℃), and sonication in the bath sonicator (30 min).  The 
supernatant containing protein and DNA was mixed with pNPP liquid substrate, 
incubated for 1 hr at 37℃.  After stopping the reaction using 2 M NaOH, the 
absorbance was recorded at 405 nm using a microplate.  ALP activity was normalized 




PicoGreen assay kit.  mM ALP/µg DNA was reported and each experimental group 
was analyzed with triplicate.  
6.2.8. Statistical analysis 
The data from all studies were analyzed by one-way analysis of variance (ANOVA) 
and Turkey’s multiple-comparison test.  p<0.05 was considered to show significant 
difference between experimental groups.  The means and the standard deviations 
were reported in each figure.  
 
6.3. Results 
6.3.1. Characterization of 3D PPF/DEF scaffolds 
3D macroporous composite PPF:DEF scaffolds with high interconnectivity 
were fabricated by a simple salt porogen leaching method.  Top surface images by 
SEM showed the porous structure of the scaffolds with two different pore sizes (Fig 
21A and 21B).  The physical properties of PPF/DEF scaffolds were modified by 
varying the scaffold design parameters including the PPF:DEF ratio and the pore size. 
In order to investigate the photo-crosslinking characteristics of these composite 
scaffolds, sol fraction was first determined (Fig 22).  After 120 hrs of incubation in 
organic solvent, DEF incorporated scaffold groups exhibited significantly lower sol 
fraction in both pore sizes compared to the PPF control group (p = 2.38×10-8 for large 
pore groups and 2.36×10-5 for small pore groups).  Moreover, 75 and 66% of PPF 
groups with small pore size (S3 and S4) showed significantly higher sol fraction (p = 




contents is related with an increase in a crosslinking density of the composite 
scaffolds and this relationship is also confirmed by the mechanical testing (Fig 23).  
 
(A)              (B) 
         
Figure 21: Top surface of scaffolds of 66:33 ratio of PPF/DEF.  (A) Large pore size 




Figure 22: Sol fraction test.  # indicates a significant differences between different 
PFP contents within a large pore size groups while + indicates a significant 
differences within a small pore size groups (p<0.05).  & indicates a significant 































Figure 23: Mechanical testing. (A) compressive modulus and (B) off-set yield 
strength.  # indicates a significant differences between different PFP contents within a 
large pore size groups while + indicates a significant differences within a small pore 
size groups (p<0.05).  & indicates a significant difference between two pore size 





Compressive modulus data in Fig 23A demonstrated that increasing DEF 
content up to 25% resulted in increasing scaffold modulus. 75% of PPF group showed 
the highest mechanical property in both pore size groups and all DEF incorporated 
groups with small pores exhibited significantly higher modulus compared to the PPF 
control (p = 4.67×10-5).  In addition, Increasing mechanical strength of PPF:DEF 
composite scaffold by increasing amount of DEF was also found in offset yield 
strength data (Fig 23B) and these observations in 3D macroporous scaffolds was also 
seen in nonporous photo-crosslinked composites [77].  
Water permeability from the top to the bottom of porous scaffolds was 
assessed (Fig 24).  Due to the hydrophobicity of PPF polymer, 100 and 90% of PPF 
groups showed a low level of water permeability, however 75 and 66% PPF groups 
exhibited increased permeability. 75% of PPF and 25% of DEF incorporation resulted 
in significantly higher water permeability in both pore size groups (p = 1.73×10-3 for 
L3 and 2.23×10-2 for S3).  In these PPF:DEF ratios, as expected, large pore groups 
showed higher permeability but without any significance between pore sizes.  Then, 
hydrophilicity of the PPF/DEF composite was evaluated by the contact angle 
measurement (Fig 25).  Decreasing contact angle by increasing DEF content indicated 
increasing hydrophilicity and both 75 and 66 % of PPF groups showed significantly 
higher hydrophilicity (lower hydrophobicity) than both 100 and 90 % of PPF groups 
(p = 1.15×10-12).  Passive protein adsorption to PPF:DEF composite surfaces was also 
determined (Fig 26).  In small pore groups, DEF incorporated groups showed 
significantly higher protein adsorption compared to the PPF control groups (p = 




significantly different.  DEF incorporated groups with small pores exhibited 
significantly higher protein adsorption.  
 
Figure 24: Permeability. # indicates a significant differences between different PFP 
contents within a large pore size groups while + indicates a significant differences 
within a small pore size groups (p<0.05).   
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Figure 26: Protein adsorption. + indicates a significant differences within a small 
pore size groups (p<0.05).  & indicates a significant difference between two pore size 




6.3.2. Initial metabolic activity of BMSCs onto 3D PPF/DEF scaffolds 
The effect of free DEF molecules in aqueous cell culture media on the metabolic 
activity of monolayer cell was investigated (Fig 27A).  By using MTT assay, 
increasing DEF content in the media resulted in a decrease in initial metabolic 
activity of cells in tissue culture well plates for up to 4 hrs.  20 mM of DEF showed 
similar level of the metabolic activity to the negative control (50% methanol group) 
and all DEF added groups from 5 to 20 mM exhibited the same level as the negative 
control after 4 hr of incubation.  Then, the effect of DEF incorporation on the 
transplanted BMSCs onto photocrosslinked PPF/DEF composite scaffolds was also 
assessed.  In Fig 27B, all DEF incorporated groups showed the same level of cellular 
metabolic activity to the PPF control up to 24 hrs incubation.  Therefore, once the 
DEF molecules were participated in photo-crosslinking reactions with PPF polymer 
chains, the negative effect on cellular metabolic activity by increasing DEF amounts 









































Figure 27: Initial metabolic activity of rat BMSCs exposed to DEF molecules in 
aqueous culture media (A) and seeded onto photo-crosslinked PPF/DEF scaffolds 




6.3.3. Osteogenic signal expression profiles of rat BMSCs cultured in 3D PPF/DEF 
scaffolds 
The effect of DEF incorporation and pore size of scaffolds on osteogenic 
signal expression was investigated by using quantitative RT-PCR on day 8 (Fig 28).  
For BMP-2 (Fig 28A), DEF incorporated groups with a large pore exhibited 
significantly higher expression level compared to the PPF control (p = 2.74×10-6) and 
75% PPF group showed more than 4.4 fold changes.  These DEF incorporated groups 
also showed significantly higher BMP-2 expression than small pore groups although 
PPF control with small pore group showed higher expression than any experimental 
groups.   
Other osteogenic signals including FGF-2 and TGF-β1, and angiogenic factor 
VEGF showed similar expression profiles.  For FGF-2 (Fig 28B), a clear trend of 
increasing expression was observed in large pore groups by increasing DEF amount.  
66% of PPF and 33% of DEF scaffolds with large pore (group L4) have shown about 
4 fold increase compared to the PPF control as a calibrator group (group L1).  
Significantly higher FGF-2 expression was observed in DEF incorporated groups 
with large pores compared to the PPF control (p = 6.62×10-6) and these groups with 
large pore showed significantly higher expression level than those with small pores.  
In small pore groups, DEF incorporated scaffolds did not show higher expression 
than the PPF control.  This observation indicating the relationship between increasing 
DEF amount and increasing mRNA expression was also found in TGF-β1 (Fig 28C) 
and VEGF (Fig 28D).  For both osteogenic signals, a similar trend of increasing 




PPF and 33% of DEF scaffolds with large pore (group L4) exhibited about 4.4 fold 
increase in TGF-β1 expression and 5.4 fold increase in VEGF expression compared 
to the PPF control.  Groups with two higher DEF amount with large pores (group L3 
and L4) showed significantly higher TGF-β1 expression (p = 1.07×10-5) and all DEF 
incorporated groups with large pores showed significantly higher VEGF expression 
(p = 4.74×10-8) than the PPF control.  The pattern of higher expression in large pore 
groups than in small pore groups was also found in both osteogenic signal expression 
profiles.  
In Fig 28E, Runx2 transcription factor expression in large pore groups showed 
the same clear trend of significantly increasing profile by increasing the DEF 
incorporation level  (p = 2.01×10-5) while small pore groups did not exhibit any 
significant difference between groups with different PPF:DEF ratio.  In large pores, 
66% PPF group (L4) showed more than 3 fold increase than the calibrator group (L1) 
and both 75:25 and 66:33 of PPF:DEF ratio with large pore (L3 and L4) showed 
significantly higher Runx2 expression levels compared to those with small pores (S3 














































































































































Figure 28: Osteogenic signal expression profiles of tranplanted rat BMSCs 
population on day 8 including BMP-2 (A), FGF-2 (B), TGF-β1 (C), VEGF (D), and 
Runx2 (E).  # indicates a significant differences between different PFP contents 
within a large pore size groups while + indicates a significant differences within a 
small pore size groups (p<0.05).  & indicates a significant difference between two 
pore size groups in the same PPF:DEF ratio (p<0.05). 
 
6.3.4. Osteoblastic differentiation 
ALP and OC mRNA expressions were assessed by using RT-PCR (Fig 29A 
an 29B) to determine the relation between stimulated osteogenic signal expressions 
by changing scaffold parameters and downstream osteoblastic differentiation of 
transplanted BMSCs in 3D PPF/DEF scaffolds.  As an early osteoblastic 
differentiation marker, ALP mRNA expression on day 8 also showed a correlated 
trend of increasing expression by incorporating more DEF in composite scaffolds 
with large pores (Fig 29A).  DEF incorporated groups with large pores showed 






























3.42×10-7) and these groups also exhibited significantly higher expression than small 
pore groups.  In small pore groups, upper limit of DEF incorporation (group S4) 
showed significantly higher expression than the PPF control (group S1) (p = 2.02×10-
8).  In addition, as a late osteoblastic differentiation marker, it is indicated that DEF 
incorporation would enhance the OC expression in both pore sizes compared to PPF 
control (p = 9.73×10-6 in large pores and 8.81×10-7 in small pores) (Fig 29B).  To 
confirm the influence of enhanced expression of osteogenic signals into osteoblastic 
differentiation, ALP protein activity was also measured over the 8 days of culture 
periods (Fig 30).  The result demonstrated that all experimental groups showed 
generally increasing intracellular ALP production (normalized by DNA level) up to 
day 8.  In large pore scaffolds, group L4 (66% of PPF and 33% of DEF) showed 
significantly higher ALP protein level compared to the PPF control (group L1) at 
each time point (p = 7.62×10-9, 1.14×10-2 and 2.40×10-3, respectively).  
 
6.4. Discussion 
The main objective of this study was to determine which 3D PPF/DEF 
composite scaffold parameters facilitate endogenous osteogenic signal expressions 
and downstream osteoblastic differentiation.  Two main scaffold design parameters 
on the first study are the DEF content and the pore size of PPF/DEF porous scaffolds.  
It has been shown that DEF incorporation in PPF polymer increased crosslinking 
density decreased the sol fraction of cylindrical composite material, and therefore the 
mechanical properties including compressive modulus and fracture strength were 









Figure 29: Osteogenic differentiation was determined by ALP and OC mRNA 
expression on day 8.  # indicates a significant differences between different PFP 
contents within a large pore size groups while + indicates a significant differences 
within a small pore size groups (p<0.05).  & indicates a significant difference 





















































Figure 30: Normalized ALP protein expression over 8 days of culture.  # indicates a 
significant differences between different PFP contents within a large pore size groups 
while + indicates a significant differences within a small pore size groups (p<0.05).  
& indicates a significant difference between two pore size groups in the same 
PPF:DEF ratio (p<0.05). 
 
 
characteristics, the photocrosslinking properties of 3D macroporous PPF/DEF 
scaffolds were first examined in this study.  By a simple salt porogen leaching 
method, interconnected porous structure of PPF/DEF scaffold was obtained while the 
pore size was controlled with the size of porogen salt crystals (Fig 21).  Sol fraction 
(Fig 22) and mechanical properties (Fig 23) of 3D macroporous PPF/DEF scaffolds 
have exhibited the similar trend to the non-porous PPF/DEF constructs in the 
previous study [77].  Lower sol fraction levels in DEF incorporated groups in both 
pore size groups indicated higher crosslinked fraction in PPF/DEF composites and 66 
and 75% of PPF groups exhibited the highest level of crosslinked fractions, indicated 













































compared to L3 and L4 might be related to an easier transport of solvent and 
subsequent contact with scaffold surfaces, rather than the actual increase in 
crosslinking density in scaffolds with a small pore.  The penetration of methylene 
chloride solvent into inner region of scaffolds is more efficient in large pore scaffolds, 
and the solvent then dissolved more polymers in the scaffold surface.  This could be 
associated with lowering the sol fraction level.  The mechanical testing data of 
macroporous PPF/DEF scaffolds in Figure 23 indicated that 25 % of DEF is an 
optimal level to achieve the highest compressive modulus and offset yield stength. 
This result also indicated that the compressive modulus and yield strength of 
PPF/DEF composite scaffolds are within a range of those of native human cancellous 
bone (10-900 MPa of compressive modulus and 0.2-14 MPa of yield strength) [307-
309].    
75:25 of PPF:DEF incorporation also showed the highest water permeability 
in both pore sizes (Fig 24) and the result indicated that DEF incorporation might 
change the hydrophilicity of scaffold surface and the permeability might be related to 
the modified hydrophilicity.  In addition, changing DEF contents in PPF/DEF 
scaffolds and subsequent surface properties might be more effective in order to 
increase water permeability than changing pore sizes.  As a structural cue, 
permeability could be one of the stimuli to enhance the signal expression of 
progenitor cells.  It has been demonstrated that increasing permeability induced 
chondrogenic differentiation of BMSCs on 3D poly(ε-caprolactone) scaffolds since 
diffusion, oxygen tension, and nutrient exchange would be affected by the level of 




as well as increased expression ratio of collagen type 2 to collagen type 1, which was 
not shown in scaffolds with low permeability.  The contact angle measurement (Fig 
25) confirmed this relationship.  DEF incorporation increased the hydrophlicity as 
shown in decreased contact angles, and increasing surface hydrophilicity might be 
related to increasing permeability of 3D scaffolds.  
Although the free DEF molecules in aqueous media showed the negative 
effect on the monolayer cells (Fig 27A), crosslinked PPF/DEF scaffolds did not show 
any decrease in the metabolic activity of transplanted BMSCs up to 24 hrs (Fig 27B).  
This result demonstrated that the crosslinking reaction with the aid of photoinitiator 
and UV light is suitable to allow DEF molecules participate in the formation of 
polymeric network.  Moreover, the crosslinked PPF/DEF scaffolds could be a proper 
platform for bone tissue engineering in terms of both mechanical strength (Fig 23) 
and biocompatibility (Fig 27).  
In order to investigate the optimized scaffold design parameters on the 
osteogenic signal expression, quantitative RT-PCR was performed on day 8 (Fig 28).  
It is demonstrated that DEF incorporated groups with a large pore size might facilitate 
the osteogenic signal expressions including BMP-2, FGF-2 and TGF-β1 as well as the 
expression of both angiogenic signal VEGF a transcriptional factor Runx2.  Within 
large pore groups, these signal expressions were dependent on the DEF contents and 
the subsequent changes in crosslinking density or stiffness of composite scaffolds. 
General increasing expression of these signals in large pore groups might be 
explained by the Runx2 mediated intracellular signaling transduction.  The binding 




factor expression via Smad and MAPK pathway [5, 18, 311, 312] while FGF-
2/MAPK/Runx2 pathway might promote the osteoblast maturation [18, 19, 292].  
Hence, the increasing Runx2 expression pattern by increasing DEF content in large 
pore groups (Fig 28E) might be associated with enhanced level of BMP-2, TGF-β1, 
and FGF-2 expression.  It might be speculated that modulation of PPF/DEF properties 
could upregulate of these growth factor genes and enhanced expression might 
increase the possible binding of these proteins to the cells. Finally, the bindings might 
stimulate the downstream signal pathway to induce the Runx2 expression [18] and 
further osteoblastic differentiation marker expression such as ALP and OC [6, 313].  
This correlated expression pattern of osteogenic signals demonstrated that altering the 
scaffold design parameters, especially varying DEF content within large pore 
geometry in this study, influenced the stimulation of endogenous signal expression 
through the intracellular signaling mechanisms.  In addition, upregulated VEGF 
expression is also related with increasing DEF amount (Fig 28D).  Proper 
osteointegration of implant materials and bone tissue regeneration must be closely 
related with neovascularization and angiogenesis, it is of importance to investigate the 
VEGF expression profile along with other osteogenic signal expressions.  FGF is 
involved both osteogenesis and angiogenesis [314-316], and its angiogenic exertion is 
in the direct way [315] and through VEGF [317].  VEGF expression is also 
implicated in aspect of the stimulation of osteoblastic differentiation and the 
regulation of bone remodeling [318, 319].  In addition, FGF-2 may regulate VEGF 
expression [320] and VEGF release from osteoblasts was stimulated by FGF-2 




Therefore, similar expression profiles of FGF-2 and VEGF in Figure 28B and 28D 
could confirm the relationship between those signal expressions during osteoblastic 
differentiation.  Upregulated expression pattern by increasing incorporated DEF 
amount in composite scaffolds shows 4 fold increase in FGF-2 and 5.3 fold increase 
in VEGF in L4 group compared to L1 calibrator group.  From this observation, it 
might be speculated that the modulation of PPF/DEF scaffold’s mechanical properties 
by varying the DEF content could stimulate the Runx2 mediated osteogenic signal 
expressions and VEGF mRNA expression.  
However, this close relation between the DEF incorporation and the 
stimulated signal expression was not observed in small pore groups.  Although 
increasing signal expression by increasing DEF content in group S2, S3, and S4 was 
seen, however the fold changes in these groups were lower than the control S1 group 
in small pore scaffolds (Fig 28).  This might indicate the possible existence of other 
controlling factor, and the pore size of scaffolds could influence the signal expression 
profiles.  We speculated that the large pore geometry is more advantageous for 
transport of nutrient and waste removal in aqueous in vitro environment, and water 
permeability data in Figure 4 confirms that large pore groups allow higher level of 
transport than small pore groups.  Another studies also suggested that large pore sizes 
(325 µm) would help cell migration toward the center of the scaffold and reduce the 
formation of cell aggregation that might inhibit the diffusion [325] while in vivo bone 
ingrowth was increased as the pore size increased from 350 to 800 µm at 4 weeks 
post-implantation [326].  Therefore, in the present study, it is suggested that a large 




influenced by the stiffness of PPF/DEF scaffolds.  Moreover, the expression levels in 
DEF incorporated scaffolds with large pores (group L2, L3, and L4) are higher than 
that of DEF incorporated scaffolds with small pores (group S2, S3, and S4) for FGF-2, 
TGF-β1, VEGF, and Runx2.  Therefore, we speculated that both scaffold design 
parameters in the present study including DEF incorporation and pore size could 
influence the upregulation of signal expression.  DEF content and subsequent changes 
in stiffness are not the only factor to induce the signal expressions, and the combined 
effect with pore geometry design could affect the signal expressions of implanted 
BMSC population.  
To validate if the enhanced signal expression is related to downstream 
osteoblastic differentiation, both ALP and OC mRNA expression on day 8 (Fig 29) 
and ALP protein activity over 8 days (Fig 30) were determined.  The highest 
expression of ALP in L4 group was more than 7 fold change compared to L1 
calibrator (Fig 29A), and the enhanced level of ALP expression in this group might 
indicate the synergetic effect of DEF incorporation and pore size design.  In addition, 
it might be anticipated that upregulated signal expressions could be associate with 
osteoblastic differentiation of BMSCs.  Upregulated endogenous expression of BMP-
2, TGF-β1, and FGF-2 might stimulate the activation of Runx2 expression, and 
activated Runx2 could express the downstream ALP expression through the Smad 
pathway [311, 327, 328].  Fig 29B also indicated the combined effect of DEF 
incorporation and pore size on the OC expression as the late osteoblastic 
differentiation marker although the expression level was higher in small pore groups.  




been determined that L4 and S4 groups showed statistically higher ALP activity on 
day 8.  
 
6.5. Conclusions 
This investigation to optimize the scaffold design parameters including 
PPF/DEF ratio and pore size in 3D macroporous PPF/DEF composite scaffolds 
demonstrated that the enhancement of osteogenic signal expression of rat BMSCs 
cultured on the scaffolds could be modulated by changing the parameters.  
Transplanted BMSC population could recognize the changes in the stiffness and 
surface properties of PPF/DEF scaffolds.  In addition, varying pore sizes might also 
influence the endogenous signal expression profiles by helping the media transport.  
The result revealed that (1) the modulation of PPF/DEF ratio and pore size changed 
the physical properties including mechanical stiffness, permeability, and 
hydrophilicity, (2) osteogenic signal expressions could be stimulated by the 
modulation of scaffold design parameters, and (3) downstream osteoblastic 






Chapter 7: Summary 
 
The goal of this project was to investigate how scaffold design parameters 
including physical, mechanical, and biological factors stimulate the endogenous 
osteogenic signal expression and enhance the subsequent osteoblastic differentiation 
of transplanted BMSC population in PPF and PPF composite scaffolds.  Optimizing 
the scaffold construct parameters would enhance the gene expression level of 
osteogenic growth factors and the stimulated osteogenic signal expression could 
enhance the osteoblastic differentiation of progenitor cells.  
The first objective of this work was to investigate the effect of initial cell 
seeding density of rat BMSCs on 2D PPF disks on the osteogenic signal expression.  
The optimum level of progenitor cell seeding density could be one of the controlling 
scaffold design parameters to affect the osteoblastic differentiation of recruited cell 
population after implantation and successful bone regeneration.  It is demonstrated 
that the temporal gene expression profiles of endogenous osteogenic signals can be 
upregulated by initial cell seeding density and there could exist the optimal level of 
progenitor cell seeding density to enhance the expression level.  
Then, it was investigated if scaffold construction properties for 3D 
macroporous PPF/HA scaffolds would facilitate osteoblastic differentiation of 
transplanted cell populations and evidence of associated osteogenic signal gene 
expression.  This study revealed that altering both the level of HA nanoparticle 
incorporation and the initial cell seeding density could affect osteoblastic 




incorporation of HA particles in PPF improved surface properties of composite 
scaffolds by showing increased roughness, hydrophilicity, protein adsorption, and 
initial cell attachment.  Furthermore, increasing HA amount with lower cell seeding 
density in 3D PPF/HA scaffolds enhanced osteogenic signal expression and 
subsequent osteoblastic differentiation of rat BMSCs was facilitated.   
Last, we investigated the effect of mechanical as well as structural cues on 
transplanted cell responses on PPF/DEF composite scaffolds.  This study 
demonstrated that mechanical and structural properties of 3D macroporous PPF/DEF 
composite scaffolds could be modulated by PPF/DEF incorporation ratio and pore 
size of the scaffolds.  The enhancement of osteogenic signal expression of rat BMSCs 
cultured on the PPF/DEF scaffolds could be modulated by optimizing these scaffold 
design parameters since transplanted BMSC population could recognize the changes 
in the stiffness and surface properties of PPF/DEF scaffolds.  The result revealed that   
the modulation of PPF/DEF incorporation ratio and pore size altered the physical 
properties including mechanical stiffness, permeability, and hydrophilicity, and 
osteogenic signal expressions as well as downstream osteoblastic differentiation 
could be stimulated by the increased DEF incorporation in large pore size of scaffolds. 
In order to expand this project to the practical fabrication of clinically 
available patient specific and defect site specific bone implants, it is necessary to 
investigate the feasible stereolithographical fabrication of tissue engineered scaffolds 
as well as the interaction between the transplanted cell population and the 
sterolithographically fabricated bone grafts. For instance, the effect of inner pore 




enhanced osteoblastic differentiation could be investigated. It could be hypothesized 
that an increased level of nutrient and oxygen transport as well as waste removal from 
the inner pore region of the scaffold in the continuous channel geometry obtained by 
SLA fabrication techniques, would promote endogenous expression of osteogenic 
signals compared to random pore architecture fabricated by conventional porogen 
leaching method. In addition, in vivo study could be performed to investigate the 
optimized scaffold design parameters from the in vitro study could also functionally 
induce the bone regeneration and tissue integration for the clinical implantation of the 
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